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1 Zusammenfassung 
Genregulation durch kleine nichtcodierende Ribonukleinsäuren (RNAs) ist evolutionär 
hochkonserviert und lässt sich in Pilzen, Pflanzen und im Tierreich finden. Drosophila 
melanogaster ist einer der am besten untersuchten Modellorganismen für Genregulierung 
durch kleine RNAs. Eine Vielzahl von unterschiedlichen Klassen kleiner RNA-Moleküle ist an 
einem breiten Spektrum von zellulären Prozessen beteiligt, die von der Steuerung der 
Embryonalentwicklung bis hin zu der Entwicklung von Krebs reichen. Mikro-RNAs (miRNAs) 
sind im Genom codiert und unterdrücken die Expression eigener Gene des Organismus. 
Exogene kleine interferierende RNAs (exo-siRNAs) sind nicht nur an der Abwehr von viralen 
Infektionen beteiligt, sondern werden auch zum experimentellen Ausschalten von Genen, 
der sogenannten RNA-Interferenz (RNAi), eingesetzt. Piwi-Protein interagierende RNAs 
(piRNAs) unterdrücken bewegliche genetische Elemente, sogenannte Transposons, in der 
Keimbahn, während die erst kürzlich endeckten endogenen kleinen interferierenden RNAs 
(endo-siRNAs) diese Aufgabe in somatischen Zellen übernehmen. 
Wenn man die etwas andersgearteten piRNAs außen vor lässt, gibt es einige Elemente, die 
miRNAs, exo-siRNAs und endo-siRNAs gemein haben. In allen drei Fällen werden längere 
Vorläufermoleküle durch Komplexe aus jeweils einer Endonuklease des RNAseIII-Typs und 
einem Doppelstrang-RNA Bindedomänen-Protein (dsRBP) prozessiert. Die 
zurechtgeschnittenen kurzen, doppelsträngigen Vorläufer werden dann in Effektorkomplexe 
geladen, wo aber nur einer der Stränge zurückbehalten wird. Dieser kann danach die 
Effektorkomplexe mittels spezifischer Basenpaarung zu den dazu passenden Boten-RNAs 
(mRNAs) rekrutieren. Da Doppelstrang-RNA Bindedomänen-Proteine sowohl die 
doppelsträngigen RNA Vorläufermoleküle als auch die RNAseIII Enzyme binden können, 
gelten sie als Spezifitätsfaktoren für die richtige Sortierung von kleinen RNAs in ihre 
jeweiligen Zielkomplexe. 
siRNA vermittelte Genregulation in Drosophila lässt sich unterteilen in endo- und exo-siRNA-
abhängige Wege. In beiden Fällen werden 21 nt lange Stücke durch die RNAseIII 
Endonuklease Dcr-2 aus längeren Vorläufern ausgeschnitten. Diese werden dann in 
Effektorkomplexe geladen, die als charakteristische Komponente das Argonaut-Protein Ago2 
beinhalten. Die beiden Wege unterscheiden sich durch die beteiligten dsRBPs: R2D2 ist 
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nötig, um exo-siRNAs in Ago2 zu laden, während die vorliegende Arbeit eine neue Isoform 
von Loquacious, Loqs-PD, analysiert, die für den endo-siRNA Weg gebraucht wird. Die 
Eigenschaften von Loqs-PD unterscheiden sich von den bereits beschriebenen 
Charakteristika der Loqs-PB Isoform, die in der miRNA-Biogenese zu finden ist. Loqs-PD 
entsteht aus einer Genvariante, die ein alternatives Poly-Adenylierungs-Signal besitzt. 
Außerdem befinden sich am C-Terminus von Loqs-PD 22 Aminosäuren, die in keiner anderen 
Loqs-Spleißvariante auftauchen. Dieser C-Terminus reicht für die Interaktion mit der 
DExH/D-Helikase-Domäne von Drosophila Dcr-2 aus. Eine Interaktion findet sich sowohl in 
vitro als auch in vivo und ist unabdingbar für die endo-siRNA-Biogenese und die Regulation 
von künstlich eingeführten Transgenen. Für die endo-siRNA bedingte Genregulation in 
Drosophila Zellkultur Zellen (S2-Zellen) verhält sich R2D2 als Antagonist zu Loqs-PD. R2D2 
wird zudem nicht für das Laden von endo-siRNAs in Ago2 gebraucht. Andere Isoformen von 
Loqs (Loqs-PA und Loqs-PB) binden vor allem an Dcr-1, das RNAseIII Enzym des miRNA 
Weges; sie können aber mit niedrigerer Affinität als Loqs-PD mit diesem um die Bindung zu 
Dcr-2 konkurrieren. Zusammengenommen helfen meine Ergebnisse, ein klareres Bild zu 
entwerfen, wie die Spezifität zwischen unterschiedlichen RNA-abhängigen Regulationswegen 
aufrecht erhalten wird. 
Summary 
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2 Summary 
Small non-coding RNA-dependent gene silencing is a highly conserved mechanism found in 
fungi, plants and animals. Drosophila melanogaster is one of the best studied model-
organisms for small RNA-dependent silencing. A variety of small RNA classes are involved in 
regulating a wide array of cellular processes ranging from development to cancer. Micro 
RNAs (miRNAs) are genomically encoded and repress expression of endogenous genes. 
Exogenous small interfering RNAs (exo-siRNAs) serve to defend cells from viral infections and 
are widely used in artificial gene silencing by RNA interference (RNAi). Piwi-interacting RNAs 
(piRNAs) act to suppress transposable elements in the germ-line. Most recently, endogenous 
small interfering RNAs (endo-siRNAs) were discovered to silence transposons in somatic 
cells. 
Leaving the special biogenesis of piRNAs aside, there are certain elements that are common 
to miRNAs, exo-siRNAs and endo-siRNAs. All three have to be processed from longer RNA 
precursors by pairs of an RNAseIII class endonuclease together with a double-stranded RNA 
binding-domain protein (dsRBP). Processed short double-stranded precursors are loaded 
into effector complexes where they become single-stranded and target the silencing 
machinery to a complementary mRNA. Since dsRBPs can interact with both the RNA 
substrate and the RNAseIII enzyme they are considered to be specificity factors that 
contribute to faithful sorting of small RNAs into their respective effectors. 
siRNA mediated silencing in Drosophila can be subdivided into exo- and endo-siRNA 
dependent pathways. In both cases 21 nt siRNAs are excised from stretches of long double-
stranded precursors by the RNaseIII endonuclease Dcr-2 and loaded into the Argonaute 
protein Ago2. The pathways are set apart by the double-stranded RNA binding domain 
proteins they require: R2D2 is needed to load exo-siRNAs into Ago2 while this thesis 
analyzes a novel isoform of Loquacious, Loqs-PD, which is required for endo-siRNA silencing. 
Its properties are distinct from the described Loqs-PB isoform which acts in miRNA 
biogenesis. Loqs-PD arises from an alternatively poly-adenylated variant of the gene and has 
a stretch of 22 isoform-specific amino acids at its C-terminus. The C-terminal peptide is 
sufficient to interact with the DExH/D-helicase domain of Drosophila Dcr-2. This association 
can be found in vitro and in vivo and is essential for endo-siRNA biogenesis and silencing of 
Summary 
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artificially introduced transgenes. In Schneider 2 Drosophila cell culture cells (S2 cells), R2D2 
acts as an antagonist of Loqs-PD in endo-siRNA silencing and is not required for loading of 
endo-siRNAs into Ago2. Other isoforms of Loqs (Loqs-PA and Loqs-PB) preferentially bind to 
Dcr-1 but can compete with Loqs-PD for binding to Dcr-2, albeit with lower affinity. Thus my 
findings illustrate how specificity between the small RNA-dependent silencing pathways is 
achieved. 
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3 Introduction 
3.1 Classes of small RNAs 
Since the discovery of small RNA silencing little more than a decade ago, an increasingly 
complicated variety of classes and pathways has been described. The most important ones 
in animals include micro RNAs (miRNAs), small-interfering RNAs (siRNAs) and Piwi-
interacting RNAs (piRNAs). miRNAs and siRNAs were the first small RNA species to be 
discovered (Lee et al., 1993; Dalmay et al., 2000). Most of the small RNA silencing pathways 
are highly conserved and can be found in all eukaryotic phyla from the yeast S. pombe to 
plants and animals, but not in bacteria or archea (reviewed in Ghildiyal et al., 2009). Table 1 
shows an overview of small RNA dependent silencing pathways in the fruit fly Drosophila 
melanogaster, one of the best studied model-systems for small RNA silencing. 
3.1.1 Micro RNAs (miRNAs) 
As depicted in Figure 1A, miRNAs are encoded in the genome (Bartel, 2004a) and – in most 
cases – transcribed by RNA Polymerase (Pol II) (Lee et al., 2004). The transcripts, called pri-
miRNAs, form hairpins with imperfect complementarity (Lee et al., 2002). Two pairs of an 
RNAseIII enzyme and a double-stranded RNA binding domain protein (dsRBP) then process 
the primary miRNA to form a double-stranded precursor: Drosha and Pasha perform the first 
cleavage in the nucleus, Dicer-1 (Dcr-1) and its dsRBP partner Loquacious (Loqs) remove the 
hairpin loop in the cytoplasm (Forstemann et al., 2005; Jiang et al., 2005; Saito et al., 2005; 
Park et al., 2007). The double-stranded precursor is then loaded into an effector complex, 
termed RNA-induced silencing complex (RISC). In Drosophila most miRNAs are loaded into 
the effector endonuclease Argonaute 1 (Ago1) (Lee et al., 2004; Okamura et al., 2004). 
Depending on thermodynamic characteristics of the precursor, one strand, the miRNA*, is 
then expelled from the complex. After that complementary base-pairing with an mRNA can 
silence gene expression by inhibiting translation or favoring degradation of the message 
(Okamura et al., 2004). 
Table 1:
 
 Overview of small RNA silencing pathways in Drosophila melanogaster 
 
 
small RNA 
class 
origin precursor 
structure 
mature 
length 
processing 
machinery 
RISC loading 
complex 
Argonaute 
protein 
mode of silencing 
miRNA endogenous ~70 nt hairpin ~22 nt Dcr-1/Loqs ? Ago1 translational 
repression/mRNA 
degradation 
exo-siRNA external; viruses, 
RNAi 
long dsRNA ~21 nt Dcr-2 (R2D2) Dcr-2/R2D2 Ago2 mRNA and viral RNA 
cleavage ("slicing") 
endo-siRNA endogenous long 
hairpin/long 
dsRNA from 
convergent 
transcription 
~21 nt Dcr-2/Loqs ? Ago2 transposon silencing in 
somatic cells 
piRNA endogenous; 
clustered in 
piRNA master 
loci 
single-
stranded 
transposon 
transcript 
24-30 nt Piwi-subfamily 
Argonaute 
proteins (Aub, 
Piwi; Ago3); 
ping-pong 
mechanism 
 Piwi-subfamily 
Argonaute 
protein (Aub, 
Piwi; Ago3); 
ping-pong 
mechanism 
transposon silencing in 
the germline 
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3.1.2 Exogenous siRNAs (exo-siRNAs) 
siRNAs are derived from long double-stranded precursors (Figure 1B, left). These are either 
introduced into the cell with the purpose of inducing RNAi or appear during replication of 
certain RNA viruses (reviewed in Golden et al., 2008). In a similar biogenesis pathway as 
before cleavage by an RNAseIII enzyme, Dcr-2, with the help of a dsRBP, R2D2, yields a 
double-stranded precursor (Liu et al., 2003). Due to their origins from long double-stranded 
RNA siRNA precursors are perfectly complementary. Therefore they are preferentially 
loaded into a RISC featuring the more efficient endonuclease Ago2 (Liu et al., 2003; Pham et 
al., 2004). Unlike canonical miRNAs, siRNAs thus silence their targets by cleavage of the 
corresponding message (Tuschl et al., 1999; Okamura et al., 2004). 
 
 
Figure 1: Exo-siRNA, endo-siRNA and miRNA silencing pathways in flies (legend continued on p. 13) 
Introduction 
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(legend Figure 1 continued) 
The pathways differ in their substrates, biogeneses, effector proteins and modes of target regulation: 
A) miRNAs are encoded in the genome and are transcribed to yield a primary miRNA (pri-miRNA) transcript, 
which is cleaved by Drosha to yield a short precursor miRNA (pre-miRNA). Alternatively, miRNAs can be 
present in introns (termed mirtrons) that are liberated following splicing to yield authentic pre-miRNAs. 
pre-miRNAs are exported from the nucleus to the cytoplasm, where they are further processed by DCR-1 
to generate a duplex containing two strands, miRNA and miRNA*. Once loaded into AGO1, the miRNA 
strand guides translational repression of target RNAs. 
B) Left: dsRNA precursors are processed by Dicer-2 (DCR-2) to generate siRNA duplexes containing guide and 
passenger strands. DCR-2 and the dsRNA-binding protein R2D2 (which together form the RISC-loading 
complex, RLC) load the duplex into Argonaute2 (AGO2).  
Right: A subset of endogenous siRNAs (endo-siRNAs) exhibits dependence on dsRNA-binding protein 
Loquacious (LOQS), rather than on R2D2.  
The passenger strand is later destroyed and the guide strand directs AGO2 to the target RNA.  
Adapted from Ghildiyal et al., 2009 
 
3.1.3 Endogenous siRNAs (endo-siRNAs) 
Endo-siRNAs are derived from long double-stranded RNA precursors with endogenous 
origin, hence the term “endo” (Figure 1B, right). These are produced in cis from long hairpin 
structures with extensive stretches of complementarity (Okamura et al., 2008b), in trans 
from convergent transcription (Czech et al., 2008; Kawamura et al., 2008; Okamura et al., 
2008a; Okamura et al., 2008c), or potentially by low levels of cryptic antisense transcription 
throughout the genome (reviewed in Berretta et al., 2009). The endo-siRNA pathway in 
Drosophila depends on Dicer-2 and Ago2 (Chung et al., 2008; Czech et al., 2008; Ghildiyal et 
al., 2008; Kawamura et al., 2008), the RNAseIII enzyme and the RISC factor usually associated 
with exo-siRNA biogenesis and function, hence the name “siRNA”. Surprisingly, cell culture 
assays found involvement of Loqs instead of R2D2, the dsRBP acting with Dcr-2 in the exo-
siRNA pathway (Czech et al., 2008; Kawamura et al., 2008; Okamura et al., 2008b). 
3.1.4 Piwi-interacting RNAs (piRNAs) 
Figure 2 shows that piRNA biogenesis in Drosophila is distinct from the other small RNA 
silencing pathways since it is Dicer-independent (Forstemann et al., 2005). Instead, 
Argonaute proteins of the germline-specific Piwi-subfamily (Le et al., 2007) take over the 
tasks of processing and target cleavage in a self-amplifying ping-pong mechanism 
(Brennecke et al., 2007; Gunawardane et al., 2007). Transposon anti-sense transcripts from 
hot-spots in the genome with large clusters of selfish genetic elements, so-called piRNA 
master loci, are cleaved at their 5´-ends by Ago3. After processing of the 3´-end by a yet 
unknown mechanism they can serve to prime the Piwi-class Argonaute proteins Aub and 
Introduction 
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Piwi to target transposon mRNAs. Cleavage products can then in turn serve as a new 
template for Ago3 (reviewed in Aravin et al., 2007; Hartig et al., 2007; Malone et al., 2009).  
 
Figure 2:
Sense transcripts from transposons – the kind that needs to be destroyed – are cleaved by Piwi or Aub RISCs 
loaded with a piRNA guide. The cleaved transcript is not merely degraded but used to program Ago3 RISC. This 
complex in turn cleaves the antisense transcripts that originate from the master control loci. Again, the cleaved 
RNA serves to program Piwi or Aub RISC. Thus, sense and antisense transcripts fuel an amplification cycle. 
While the 5'-ends of piRNAs are defined by RISC cleavage, the 3'-ends could be shortened by a 3’ exonuclease 
until their length fits into the binding pocket between PAZ and PIWI domains. Presumably a 2’-O-Me is 
subsequently attached to the 3’-end by a yet unidentified methyltransferase. 
 The ping-pong model for piRNA biogenesis 
Figure from Hartig et al., 2007 
 
3.2 The significance of small RNA silencing 
3.2.1 Roles of small RNA silencing pathways 
Piwi-interacting RNAs counteract the mobilization of transposable elements in the germline 
(reviewed in Hartig et al., 2007; Malone et al., 2009). They are essential for genomic integrity 
of the offspring but require a maternally contributed pool of piRNAs for an efficient response 
(Blumenstiel et al., 2005; Czech et al., 2008). miRNAs regulate gene expression and are 
important in development and oncogenesis (reviewed in Ghildiyal et al., 2009; Kim et al., 
2009). The evolutionary purpose of exo-siRNAs is defense against RNA viruses that involve 
the production of long dsRNA in their amplification cycle. The machinery can be exploited for 
RNA interference (RNAi), that is artificial gene silencing by introduction of double-stranded 
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RNA into the organism (reviewed in Ghildiyal et al., 2009; Kim et al., 2009). Endo-siRNAs 
suppress transposable elements in the soma and regulate expression of endogenous genes 
(Chung et al., 2008; Czech et al., 2008; Ghildiyal et al., 2008; Kawamura et al., 2008). Certain 
recurrent principles can be found among small silencing RNAs regarding types of precursors, 
modes of biogenesis and mechanisms of gene regulation. However, small RNA silencing 
pathways have distinct roles in maintaining optimal conditions for defense against external 
and internal threats. The focus of my thesis is a closer functional understanding of the endo-
siRNA pathway and its role for transposon silencing. 
3.2.2 Transposable elements 
Transposons are nucleic acid “parasites” that are able to integrate into the genome of a host 
as well as mobilize and propagate themselves (Kazazian, 2004). This is highly detrimental to 
the genomic stability of an organism, especially if selfish genetic elements invade the 
germline. Genetic parasites can be found in all phyla but the prevalence of individual 
transposon classes varies between organisms. In the yeast Saccharomyces cerevisiae, only 
3% of the genome are taken over by transposons (Kim et al., 1998), while in humans they 
constitute 50% and in corn even 80% of the genetic material (Flavell et al., 1974; Lander et 
al., 2001). Selfish genetic elements are characterized by their high copy number and their 
integration in tandem arrays in the genome. Their ability to excise themselves from one 
locus and integrate at another poses several immediate risks for the host (Deininger et al., 
1999; Girard et al., 1999; Druker et al., 2004): First, integration in a promotor region or an 
open reading frame (ORF) can disrupt expression of a gene or deregulate its expression. 
Second, excision of a transposon leaves a DNA double-strand break that can lead to 
chromosome aberrations upon faulty repair. Last, tandem arrays of transposons cause 
recombination between non-homologous chromosomes during meiosis. Considering this 
wide array of disruptive effects it is surprising that only 1 in 600 germline mutations in 
humans is caused by transposons (Kazazian, 1999). This requires an effective mechanism to 
counter the threat of selfish genetic elements. In Drosophila melanogaster this role is taken 
over by piRNAs in the germline and endo-siRNAs in somatic cells. 
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3.3 The problem of pathway specificity 
As indicated above miRNAs, exo-siRNAs and endo-siRNA depend on a mechanistically similar 
nucleolytic processing step in the cytoplasm carried out by a complex of Dicer and a double-
stranded RNA binding domain protein (reviewed in Ghildiyal et al., 2009; Kim et al., 2009). 
The summary for the Drosophila system demonstrates the problem of specificity between 
the pathways: Dicer-1 together with the dsRBP Loquacious processes miRNAs (Forstemann 
et al., 2005; Jiang et al., 2005; Saito et al., 2005). In contrast, exo-siRNA precursors are 
processed by Dicer-2 and then loaded by the complex of Dcr-2 and R2D2 into Ago2 (Liu et al., 
2003; Pham et al., 2004; Tomari et al., 2004). The endo-siRNA pathway combines factors 
from both miRNAs and exo-siRNAs: Dcr-2 interacts with Loqs, while an Ago2-RISC serves as 
the effector (Czech et al., 2008; Ghildiyal et al., 2008; Kawamura et al., 2008; Okamura et al., 
2008b). 
 
3.3.1 dsRBPs as specificity factors for small RNA sorting 
3.3.1.1 Properties of double-stranded RNA binding domains 
Double-stranded RNA binding domains (dsRBDs) are approximately 70 amino acid long 
domains with high evolutionary conservation. According to their similarity to a defined 
consensus they can be grouped into two types (Doyle et al., 2002): Type A dsRBDs are highly 
conserved in their entire length, while type B dsRBDs deviate from the consensus in their N-
terminal region and bind dsRNA only poorly. dsRNA interaction is mediated via the sugar-
phosphate backbone and is not sequence-specific (Ryter et al., 1998), however it can be 
sensitive to the structure and can recognize base-pairing mismatches, as can be seen by site-
specific RNA-editing (Stefl et al., 2006). In addition to their RNA-binding activity, double-
stranded RNA binding domains can mediate protein-protein interactions as well (Doyle et al., 
2002). These properties make dsRBPs perfectly suited to act as specificity factors to funnel 
RNA precursors into the correct processing and effector complexes: They are able to 
recognize the double-stranded RNA precursor, possibly including the extent of 
complementary base pairing, and mediate protein-protein interaction with the 
corresponding Dicer enzyme for processing and subsequent loading into the appropriate 
RISC. R2D2 and Loquacious are the cytoplasmic dsRBDs in Drosophila that decide between 
miRNA, endo-siRNA or exo-siRNA fate. 
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3.3.1.2 R2D2 
R2D2 contains two dsRBDs and a C-terminal part (later abbreviated R1R2RCterm). The latter 
mediates association with Dcr-2 (Liu et al., 2003; Ye et al., 2007). The complex of Dcr-2 and 
R2D2 does not have enhanced dsRNA processing activity; instead, it serves as the RISC 
loading complex (RLC) that loads double-stranded exo-siRNA precursors into Ago2 and 
interprets their thermodynamic asymmetry to select the incorporated strand of the mature 
siRNA (Pham et al., 2004; Tomari et al., 2004; Liu et al., 2006).  
3.3.1.3 Loquacious 
At the beginning of my work there were three known splice-variants of Loquacious 
(Forstemann et al., 2005).  Loqs-PA and Loqs-PB both have three dsRBDs (L1L2L3) and can be 
found in adult flies as well as Drosophila Schneider cells (S2) (Forstemann et al., 2005; 
Miyoshi et al., 2009). The role of Loqs-PA is still largely uncharacterized, but Loqs-PB 
increases the efficiency of miRNA precursor processing by Dcr-1 (Forstemann et al., 2005; 
Jiang et al., 2005; Saito et al., 2005; Liu et al., 2007). Loqs-PC lacks the third dsRBD and 
instead carries a short peptide sequence at its C-terminus (abbreviated L1L2PCspec; 54 
amino acids; Forstemann et al., 2005). The third dsRBD of Loqs is essential for Dcr-1 
interaction, which is strongest for Loqs-PB but significant for Loqs-PA as well, while Loqs-PC 
does not form complexes with Dcr-1 (Forstemann et al., 2005; Ye et al., 2007). 
 
3.3.2 Sorting and specificity problems 
If we assume that dsRBPs are the decisive specificity factor for small RNA pathways the 
problem is immediately obvious: How can two dsRBPs, namely Loqs and R2D2, define three 
different pathways, namely miRNAs, endo-siRNAs and exo-siRNAs? Especially surprising was 
the promiscuity of Loqs which was reported to interact with both Dcr-1 and Dcr-2. 
3.3.2.1 Sorting between miRNAs and exo-siRNAs 
miRNA and exo-siRNA are processed by two completely distinct complexes: Typical miRNA-
precursors with a certain degree of base-mismatches in the stem-structure are recognized 
by Dcr-1/Loqs, perfectly base-paired siRNA precursors by Dcr-2/R2D2. However, some highly 
complementary miRNAs are loaded into Ago2 RISCs (Förstemann, 2007; Seitz et al., 2008) 
and some siRNAs are more likely to enter Ago1 complexes (Lee et al., 2004; Forstemann et 
al., 2005). Thus it is not the processing step that determines the most suitable effector 
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complex but the position and number of base-pairing mismatches in the double-stranded 
precursors (Förstemann, 2007; Tomari, 2007). Interestingly, only one isoform of Loqs, Loqs-
PB, was necessary and sufficient for miRNA biogenesis (Forstemann et al., 2005; Park et al., 
2007). 
3.3.2.2 Sorting between miRNAs and endo-siRNAs  
In order to act in both the miRNA- and the endo-siRNA pathway, Loqs would have to interact 
with both Dcr-1 and Dcr-2 as well as recognize completely distinct RNA substrates. A 
straightforward explanation to resolve this sorting dilemma would be that different Loqs 
isoforms are specific for each pathway. With Loqs-PB being the essential miRNA factor, this 
would leave Loqs-PA or -PC to act in endo-siRNA silencing. 
3.3.2.3 Sorting between endo-siRNAs and exo-siRNAs 
Endo-siRNA and exo-siRNA pathways are functionally distinct but mechanistically very 
similar: long perfectly complementary RNA precursors, albeit with different origins, dicing by 
the RNAseIII enzyme Dcr-2 and loading into Ago2 RISCs. Yet, it remains unclear how both 
R2D2 and a putative endo-siRNA-specific Loqs isoform bind Dcr-2 and how this binding 
influences the two pathways. 
 
3.4 Drosophila genetics 
Drosophila melanogaster is one of the most intensely studied model organisms with an array 
of established genetic tools. Additional advantages are the availability of immortalized cell 
lines and the possibility to produce and collect large amounts of material for biochemical 
analyses. 
3.4.1 GFP-based cell culture reporter systems 
Cell culture studies have the advantage of working with a large uniform population that can 
easily be manipulated. Transgene expression is possible after transient transfection of an 
expression vector or stably by selection of clonal transgenic cell lines. Drosophila Schneider 2 
(S2) cells (Schneider, 1972) have the additional benefit of easy RNAi treatment by soaking, 
that is the uptake of dsRNA triggers that have simply been added to the medium. 
Introduction 
 
 
19 
GFP-based reporter cell lines allow the study of small RNA silencing pathways quantitatively 
by flow cytometry. Figure 3 shows the underlying principle using the example of a microRNA 
reporter. The reporter expresses GFP mRNA with specific miRNA binding sites in its 3´UTR 
(Figure 3A). Due to constitutive silencing by the endogenously expressed miRNA, reporter 
cells are only marginally green fluorescent owing to translational repression and degradation 
of the GFP message (Figure 3B). Any disturbances of the miRNA silencing pathway will 
increase GFP levels while enhanced silencing will be mirrored by lower GFP levels. Similar 
GFP-based systems are conceivable for other small RNA silencing pathways. 
 
 
Figure 3:
A) GFP-mRNA with multiple small RNA binding sites in its 3´UTR; as an example a miRNA-dependent reporter 
is depicted 
 Schematic overview of GFP-based reporter systems 
B) Manipulation of pathway efficiency is directly visible in the GFP level of cells; fluorescence levels can be 
quantified by flow cytometry 
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3.4.2 Transgenic flies 
3.4.2.1 Embryo injection and transgenic fly lines 
P-elements have colonized the Drosophila genome within 80 years and spread over wildtype 
populations world-wide. However, laboratory strains have been protected from invasion and 
are free of transposase activity necessary to mobilize P-elements. This fact has made P-
elements an invaluable tool in the generation of transgenic flies that consists of two 
components (Figure 4). A gene of interest can be flanked by P-element direct repeat sites 
required for recognition by the transposase and integration into the genome. Without the 
transposase activity, however, this element is unable to mobilize itself. A second plasmid 
encodes for the transposase enzyme activity but lacks P-element direct repeat recognition 
sites. This means that the plasmid-encoded transposase activity can mobilize and integrate 
the gene of interest into the genome but will itself be lost in subsequent cell divisions. By 
injection of both plasmids into the germline cells of an early Drosophila embryo, it is possible 
to obtain adults that will bear stably transgenic heterozygous offspring. 
 
3.4.2.2 The UAS/Gal4 expression system 
A frequently used conditional expression system in Drosophila is derived from yeast (Figure 
5). If a transgene is brought under the control of a DNA sequence recognized by the yeast 
transcription factor Gal4, called Upstream Activating Sequence (UAS), it is inactive in the fly 
due to the lack of the yeast transcription factor. This is especially helpful if expression of the 
transgene is harmful to the organism, since it allows generating stably transgenic lines. 
Expression of the gene of interest can then be turned on in a tissue-specific manner by 
mating the UAS-strain to a driver line which expresses the yeast transcription factor Gal4 
under a tissue specific promoter. Effects of transgene expression can then be studied in the 
affected tissue of the offspring. 
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Figure 4: Generation of transgenic fruit flies by P-element transformation (legend continued on p. 22) 
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(legend Figure 4 continued) 
The P element, a mobile genetic element, can move from one place in the genome to another. This movement 
(transposition) is catalyzed by transposase, which is encoded by the P element; the 3′ and 5′ ends of the P 
element are recognized by transposase and are required for transposition to occur. To produce transgenic fruit 
flies by this method, the functionally different regions of the P element are incorporated into two different 
bacterial plasmids. The donor plasmid contains three necessary elements: the transgene (orange); a marker 
gene (green) used to indicate flies in which the plasmid DNA is transposed to a recipient chromosome; and 
both ends of the P element (dark purple) — 3′ P and 5′ P — flanking the other two genes. It does not contain 
transposase. In this example, the marker is the dominant w+ allele, which confers red eye color. The red bracket 
indicates the segment of the donor plasmid that can transpose into the fly genome. The other plasmid carries 
the P element (encoding transposase) with mutations in one end, which prevent it from transposing. The two 
plasmids are co-injected into blastoderm embryos homozygous for the recessive w− allele, which confers white 
eye color. Transposase synthesized from the gene on the P-element plasmid catalyzes transposition of the 
donor plasmid DNA into the fly genome. Because transposition occurs only in germ-line cells (not in somatic 
cells), all the G0 adults that develop from injected embryos have white eyes. Mating of these flies with white-
eyed flies will yield some G1 red-eyed progeny carrying the transgene and the marker allele (w
+) in all cells. 
Figure from Lodish et al., 2000 
 
 
3.5 Small RNA silencing systems in other organisms 
Even though small RNA silencing pathways are conserved between most eukaryotes they 
differ in mechanistic details. Mammals only have a single Dicer molecule for both miRNAs 
and siRNAs (Grishok et al., 2001; Hutvagner et al., 2001; Ketting et al., 2001; Knight et al., 
2001). However, mammalian genomes encode for two dsRBPs that interact with Dicer, TRBP 
and PACT (Chendrimada et al., 2005; Haase et al., 2005; Lee et al., 2006). These highly 
conserved homologs of Drosophila Loqs and R2D2, respectively, could similarly achieve 
commitment of the single Dicer to either the miRNA or the siRNA pathway. Like Loqs, its 
homolog TRBP is expressed in several splice variants (Haase et al., 2005). C. elegans has one 
canonical Dicer protein and three Dicer-related helicase proteins (DRHs) that are involved in 
small RNA mediated gene silencing (Tabara et al., 2002; Nakamura et al., 2007). The dsRBP 
RDE-4 is a C. elegans homolog of Loqs and R2D2 (Tabara et al., 2002). 
Unlike mammals or flies, C. elegans is able to amplify and maintain an siRNA response for a 
long time and even transmit this silencing activity to the next generation (reviewed in 
Ghildiyal et al., 2009). The worm expresses 27 distinct Argonaute proteins compared with 
five in the fly. Most of these are specialized to bind secondary siRNAs that are derived from 
RNA-dependent RNA-polymerase (RdRP) activity (Aoki et al., 2007; Pak et al., 2007; Sijen et 
al., 2007). 
Plants have developed a great diversity of small RNA silencing pathways and corresponding 
proteins which may be a way of an immobile organism to counteract various biotic and 
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abiotic threats (reviewed in Ghildiyal et al., 2009). Small RNA mediated gene silencing in 
plants is characterized by the importance of transcriptional gene silencing on DNA and 
chromatin level. Indications for this epigenetic control by DNA and histone methylation were 
reported early in the field of small RNA-dependent silencing (Kooter et al., 1999; Mette et 
al., 2000). 
 
 
 
Figure 5:
Flies carrying a transgene with a UAS-promotor element are mated with a diver line, encoding for the yeast 
transcription factor Gal4. In the offspring, the gene of interest is activated. 
 The UAS-Gal4 expression system in Drosophila melanogaster 
Adapted from Alcorta et al., 1996 
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4 Specific aims of this thesis 
 
1.) Which isoform of Loqs is involved in endo-siRNA dependent silencing? Can 
involvement of different isoforms in miRNA silencing and endo-siRNA silencing 
explain how specificity can be maintained despite involvement of Loqs in both 
processes? 
 
2.) Can this particular isoform of Loqs interact with Dcr-2? If so, can the interaction 
domains be mapped more precisely? 
 
3.) How can Dcr-2 bind both to R2D2 and Loqs? Does binding of one dsRBP influence 
binding of the other? 
 
4.) What conclusion can be drawn for mechanisms of small RNA sorting in Drosophila 
melanogaster? 
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5 Materials and Methods 
5.1 Materials 
5.1.1 Laboratory hardware 
ABI PRISM 7000 qPCR cycler Applied Biosystems; Foster City, USA 
Agarose gel running chamber (H1-Set) Carl Roth GmbH; Karlsruhe, Germany 
Branson Sonifier 250 Heinemann Ultraschall Labortechnik; 
Schwäbisch-Gmünd, Germany 
FACSCalibur flow cytometer Becton, Dickinson; Franklin Lakes, USA 
Flow buddy CO2-distributer Genesee Scientific; San Diego, USA 
Fly anesthetic pad/pistol Genesee Scientific; San Diego, USA 
INTAS UV Imaging System INTAS; Göttingen, Germany 
LAS 3000 mini Western Imager Fujifilm; Tokyo, Japan   
Leica MZ7 stereomicroscope Leica Microsystems; Wetzlar, Germany 
PAGE-electrophoresis material BioRad; Hercules, USA  
Power supply for electrophoresis BioRad; Hercules, USA 
Rotanta 460R centrifuge Hettich; Tuttlingen, Germany 
Semi-dry blotter BioRad; Hercules, USA 
SpectroLinker XL1500 UV Crosslinker Spectronics Corporation; Westbury, USA 
SterilGARD cell culture workbench The Baker Company; Sanford, USA 
Super Roller Kisker; Steinfurt, Germany 
Table top centrifuge (5417R and 5415R) Eppendorf AG; Hamburg, Germany 
Tank-blotting chamber BioRad; Hercules, USA 
Thermocycler Eppendorf AG; Hamburg, Germany 
Typhoon 9400 Variable Mode Imager GE Healthcare; Freiburg, Germany 
 
5.1.2 Analysis software 
BD Cell Quest  Becton, Dickinson; Franklin Lakes, USA 
BioEdit see Hall, 1999 
Multi Gauge V3.0 Fujifilm; Tokyo, Japan 
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5.1.3 Laboratory chemicals 
Acrylamide Carl Roth GmbH; Karlsruhe, Germany 
Agarose Biozym Scientific GmbH; Oldendorf, 
Germany 
Ampicillin Carl Roth GmbH; Karlsruhe, Germany 
APS (ammonium peroxodisulfate) Carl Roth GmbH; Karlsruhe, Germany 
BactoTM Agar Becton, Dickinson; Franklin Lakes, USA 
Bradford Assay  BioRad; Hercules, USA 
BSA (bovine serum albumin) Fermentas; St. Leon-Rot, Germany 
Chloroform Merck Biosciences GmbH; Schwalbach, 
Germany 
Complete® without EDTA (=protease  Roche Diagnostics; Mannheim, Germany 
inhibitor cocktail)  
Coomassie Brilliant Blue R Sigma Aldrich; Taufkirchen, Germany 
Coomassie G250 Carl Roth GmbH; Karlsruhe, Germany 
Desoxyribonucleotides (dA/C/G/TTP) Sigma Aldrich; Taufkirchen, Germany 
DMSO (dimethyl sulfoxide) Carl Roth GmbH; Karlsruhe, Germany 
DTT (dithiothreitol) Carl Roth GmbH; Karlsruhe, Germany 
Ethanol (p.a.) Merck Biosciences GmbH; Schwalbach, 
Germany 
Ethanol (tech.) VWR; Ismaning, Germany 
FACS Flow/Clean/Rinse Becton, Dickinson; Franklin Lakes, USA 
Fetal bovine serum (FBS) Thermo Fisher Scientific; Waltham, USA 
Formamide Sigma Aldrich; Taufkirchen, Germany 
Fugene® HD transfection reagent Roche Diagnostics GmbH; Mannheim, 
Germany 
G418 sulphate (neomycin) PAA, The Cell Culture Company; Cölbe, 
Germany 
H2O HPLC quality VWR; Ismaning, Germany 
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Hepes (N-(2-Hydroxyethyl-)piperazine-N´-  Carl Roth GmbH; Karlsruhe, Germany 
(2-ethanesulfonic acid)) 
Hygromycin B Carl Roth GmbH; Karlsruhe, Germany 
IPTG Fermentas; St. Leon-Rot, Germany 
Isopropanol (p.a.) Merck Biosciences GmbH; Schwalbach, 
Germany 
Kanamycin Carl Roth GmbH; Karlsruhe, Germany 
L-Glutathione reduced Sigma Aldrich; Taufkirchen, Germany 
Methanol (p.a.) Merck Biosciences GmbH; Schwalbach, 
Germany 
Methanol (tech.)  VWR; Ismaning, Germany 
NP-40 (Igepal CA 630) Fluka BioCemika; Ulm, Germany 
Powdered milk, Rapilait Migros; Zürich, Switzerland 
Roti®Aqua Phenol/C/I Carl Roth GmbH; Karlsruhe, Germany 
Saponin Fluka BioCemika; Ulm, Germany  
SDS (sodium dodecyl sulfate) Merck Biosciences GmbH; Schwalbach, 
Germany 
Sequagel Sequencing System National Diagnostics; Atlanta, USA 
Syber Safe/Gold Invitrogen; Karlsruhe, Germany 
TEMED (N,N,N´,N´-Tetramethylethylenediamine) Carl Roth GmbH; Karlsruhe, Germany 
Triton X-100 Sigma Aldrich; Taufkirchen, Germany 
Trizol Invitrogen; Karlsruhe, Germany 
Tween 20 Carl Roth GmbH; Karlsruhe, Germany 
 
Other standard laboratory chemicals were obtained from the in-house supply system. 
 
5.1.4 Radiochemicals 
[γ 32P] ATP (SRP 501)  Hartmann Analytic; Braunschweig,  
10 mCi/ml; 6000 Ci/mmol; 250 µCi  Germany 
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5.1.5 Enzymes 
5.1.5.1 General enzymes 
DNAse I, RNAse free Fermentas; St. Leon-Rot, Germany 
Polynucleotidekinase (PNK) with Buffer A Fermentas; St. Leon-Rot, Germany 
Proteinase K Fermentas; St. Leon-Rot, Germany 
RNAse A Fermentas; St. Leon-Rot, Germany 
T4-DNA Ligase New England Biolabs; Ipswich, USA 
5.1.5.2 Polymerases 
Pfu DNA Polymerase Fermentas; St. Leon-Rot, Germany 
Phusion Hot Start DNA Polymerase Finnzymes via New England Biolabs 
Superscript II, Reverse Transcriptase  Invitrogen; Karlsruhe, Germany 
T7-polymerase laboratory stock 
Taq DNA Polymerase laboratory stock 
5.1.5.3 Restriction enzymes  
 Fermentas; St. Leon-Rot, Germany and 
New England Biolabs; Ipswich, USA 
AvrII 
BamHI 
BglII 
EcoRI 
KpnI 
NheI 
NotI 
HinP1I 
MspI 
 
5.1.6 Kits 
DyNAmo Flash SYBR Green qPCR Kit  Finnzymes via New England Biolabs 
GeneRACER Kit Invitrogen; Karlsruhe, Germany 
miScript SYBR Green PCR Kit Qiagen; Hilden, Germany 
QIAGEN Gel extraction Kit Qiagen; Hilden, Germany 
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QIAGEN miRNeasy Mini-Kit Qiagen; Hilden, Germany 
QIAGEN PCR Purification Kit Qiagen; Hilden, Germany 
QIAGEN Plasmid Midi Kit Qiagen; Hilden, Germany 
QIAGEN Plasmid Mini Kit Qiagen; Hilden, Germany 
CloneJet PCR Cloning Kit (TA-cloning) Fermentas; St. Leon-Roth, Germany 
 
5.1.7 Other materials 
cell culture materials Bio&Sell; Nürnberg, Germany 
 Sarstedt; Nümbrecht, Germany  
Cryovials  Biozym Scientific GmbH; Oldendorf, 
Germany 
ECL substrate  Thermo Fisher Scientific; Waltham, USA 
Gene Ruler DNA Ladder Mix Fermentas; St. Leon-Rot, Germany 
GFP-Trap®_A beads  Chromotek; Planegg-Martinsried, 
Germany 
Glutathione Sepharose 4 Fast Flow Amersham Biosciences via GE Healthcare 
Isopropanol freezing container Nalgene via Thermo Fisher Scientific 
NHS-Sepharose (H8280) Sigma Aldrich; Taufkirchen, Germany 
Nitrocellulose membrane (Protan BA 83) Schleicher & Schüll; Dassel, Germany 
Nylon membrane, positively charged Roche Diagnostics GmbH; Mannheim, 
Germany 
Parafilm Carl Roth GmbH; Karlsruhe, Germany 
Phosphoimager Screen Fujifilm; Tokyo, Japan 
Pistils for fly lysis Sigma Aldrich; Taufkirchen, Germany 
Polyvinylidenfluoride (PVDF) membrane Milipore; Billerica, USA 
Prestained Protein Ladder Fermentas; St. Leon-Rot, Germany 
Protein G Plus/Protein A Agarose beads (IP05)  Calbiochem via Merck 
qPCR plates Biozym Scientific GmbH; Oldendorf, 
Germany 
RestoreTM Western Blot Stripping Buffer Thermo Fisher Scientific; Waltham, USA 
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Sephadex spin column (G25) Roche Diagnostics GmbH; Mannheim, 
Germany 
Spin column for IP MoBiTec; Göttingen, Germany 
SuperSignal West Dura Extended Duration  Thermo Fisher Scientific; Waltham, USA 
Whatman 595 ½ Folded Filters Whatman GmbH; Dassel, Germany 
Blotting paper Machery-Nagel; Düren, Germany  
α-Flag affinity agarose (A2220) Sigma Aldrich; Taufkirchen, Germany 
α-myc affinity agarose (A7470) Sigma Aldrich; Taufkirchen, Germany 
 
5.1.8  Plasmids in laboratory stock 
Plasmid 
name 
description comments reference 
pGEX-6P-1 ampicillin resistance for recombinant expression of 
GST-tagged proteins 
Amersham/GE 
Healthcare 
pHShygro hygromycin 
resistance 
selection of stable cell culture lines  
pHSneo neomycin resistance selection of stable cell culture lines  
pJB17 contains 2 kb tubulin 
promotor 
excised with EcoRI/KpnI for 
cloning 
Brennecke et 
al., 2003 
pKF109 myc-Loqs-PB  Forstemann et 
al., 2005 
pKF111 myc-Loqs-PA  Forstemann et 
al., 2005 
pKF112 myc-Loqs-PB C-term.  Hartig et al., 
submitted 
pKF114 myc-Loqs-PDgenomic  Hartig et al., 
submitted 
pKF63 myc-GFP  Forstemann et 
al., 2005 
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pKF95 UAS-myc-GFP  Forstemann et 
al., 2005 
pKF201 Flag-myc-tag only also contains His6-tag and Profinity-
exact® tag 
Hartig et al., 
submitted 
pKF202 Flag-myc-Loqs-PB also contains His6-tag and Profinity-
exact® tag 
Hartig et al., 
submitted 
pKF203 Flag-myc-Loqs-PA also contains His6-tag and Profinity-
exact® tag 
Hartig et al., 
submitted 
pKF204 Flag-myc-Loqs-PB C-
term. 
also contains His6-tag and Profinity-
exact® tag 
Hartig et al., 
submitted 
pKF205 Flag-myc-Loqs-
PDgenomic 
also contains His6-tag and Profinity-
exact® tag 
Hartig et al., 
submitted 
pET-28a kanamycin 
resistance 
for recombinant expression of His6-
tagged proteins 
Novagen/Merck 
Biochemicals 
pUC18  transfection control Stratagene; La 
Jolla, USA 
pUAST  conditional expression Brand et al., 
1993 
pCasper5 cloning vector for Flag-Dcr-2 cloning Le et al., 2007 
 
 
5.1.9 Cells 
5.1.9.1 Bacterial stocks 
XL2-blue CaCl2-competent cells    Laboratory stock 
BL21 Gold (DE3; pLys S) E. coli expression strain   Stratagene; La Jolla, USA 
SoloPack Gold Competent Cells Stratagene; La Jolla, USA 
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5.1.9.2  Cell lines 
Cell line Description Comment Reference 
63N1 myc-GFP; no miRNA binding 
sites 
endo-siRNA cell culture 
reporter 
Hartig et al., 
2009 
63-6 myc-GFP; no miRNA binding 
sites 
endo-siRNA cell culture 
reporter with less pronounced 
reaction 
Förstemann, 
2007; Hartig et 
al., 2009 
67-1D myc-GFP; two perfect binding 
sites for miR-277 in GFP 3´-
UTR 
miR-277 perfect match 
reporter for Dcr-1/Loqs-PB 
dependent biogenesis and 
Dcr-2/R2D2 dependent 
loading into Ago2 
Förstemann, 
2007 
S2 B2 parental cell line laboratory stock  
  
 
5.1.10 Fly stocks 
Bloomington 
Stock # 
genotype description origin 
 w/w; P{w+, UASP-Loqs-PB}/CyO UAS-Loqs-PB Park et al., 
2007 
BL5138 y1 w*; P{w+mC=tubPGAL4} LL7/TM3, Sb1 tubulin-Gal4 driver 
line 
Bloomington 
Stock Center 
 yw/yw; 63-1/63-1; +/+ myc-GFP Forstemann 
et al., 2005 
 yw, hs-FLP/yw, hs-FLP/p{w+, loqsKO2-48}, 
FRT40A/CyO; p{w+, Loqs-L (=PB)}298-ba/TM3 
Loqs-PB rescue Park et al., 
2007 
BL7199 w*; KrIf-1/CyO; D1/TM6C, Sb1 Tb1 double-balancer Bloomington 
Stock Center 
 Loqsf0079 Loqs promotor 
transposon 
insertion 
Forstemann 
et al., 2005 
BL6326 w1118 recessive white 
mutation 
Bloomington 
Stock Center 
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5.1.11 PCR primers 
5.1.11.1 Cloning 5.1.11.1.1 Loqs / R2D2 constructs 
Loqs_myc_PB_RB1_BamHI_fw 5′-AGCGGATCCATGGAACAAAAACTTATTTCTGAAGAAGAC 
TTGGAACAAAAACTTATTTCTGAAGAAGACTTGGCCAAGAA
CACCATGGACCAGGAG-3′ 
Loqs_PB_RB1_BamHI_fw 5′-CAAGGATCCAAGAACACCATGGACCAGGAG-3′ 
Loqs_PB_RB1_BglII_rv 5′-CAAAGATCTGGCATTGCCGTCTCCTCCGCT-3′ 
Loqs_PB_RB2_BamHI_fw 5′-CAAGGATCCAATGCCACAGGCGGAGGAGAT-3′ 
Loqs_PB_RB2_BglII_rv 5′-CAAAGATCTTAACTTAAGCAGTTTTTTGCCCGTTGC-3′ 
Loqs_PB_RB3_BamHI_fw 5′-CAAGGATCCCAGAAGACTTGCTTGAAGAACAACAAG-3′ 
Loqs_PB_RB3_BglII_rv 5′-CAAAGATCTAGTTGGCTGCACCCCCTACTT-3′ 
Loqs_PB_RB3_NotI_rv 5′-CAAAGCGGCCGCTGGCTGCACCCCCTACTT-3′ 
Loqs_PA_RB2_BglII_rv 5′-CAAAGATCTTTCGCCCTCCAACTCGCCGCAG-3′ 
Loqs_PA_RB2_stop_Not_rv_new 5′-CAAAGCGGCCGCCTATTCGCCCTCCAACTCGCCGCAG-3′ 
Loqs_PB_RB2_NotI_rv 5′-CAAAGCGGCCGCTAACTTAAGCAGTTTTTTGCCCGT 
TGC-3′ 
Loqs_PB_RB2_stop_NotI_rv 5′-CAAAGCGGCCGCCTATAACTTAAGCAGTTTTTTGCCC 
GT-3′ 
BamHI_LoqsPC_fw 5′-CAAGGATCCAACGAATCTGTAAAGCACCT-3′ 
LoqsPC_end_NotI_rv 5′-CAAAGCGGCCGCCTACTGCGGGGCTGTAAATAAG-3′ 
BamHI_LoqsPD_fw 5′-CAAGGATCCGTGAGTATCATTCAAGACATC-3′ 
LoqsPD_end_NotI_rv 5′-CAAAGCGGCCGCTTAGATCTTGATGAACTC-3′ 
BamHI_myc_LoqsPDspec_fw 5′-AGCGGATCCATGGAACAAAAACTTATTTCTGAAGAAGAC 
TTGGAACAAAAACTTATTTCTGAAGAAGACTTGGCCGTGAG
TATCATTCAAGACATC-3′ 
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R2d2_myc_RB1_BamHI_fw 5′-AGCGGATCCATGGAACAAAAACTTATTTCTGAAGAAGAC 
TTGGAACAAAAACTTATTTCTGAAGAAGACTTGGCCCTTGA
ACTCATGGATAACAAG-3′ 
R2d2_RB1_BamHI_fw 5′-CAAGGATCCCTTGAACTCATGGATAACAAG-3′ 
R2D2_RB1_BglII_rv 5′-CAAAGATCTGTTGAGGTTAGTCAGTTCCTC-3′ 
R2d2_RB2_BamHI_fw 5′-CAAGGATCCCGGGACATGGTGAAGGAGCTG-3′ 
R2d2_RB2_BglII_rv 5′-CAAAGATCTTTTCAGGGTAGGATAGAAGTTCTTGAA-3′ 
R2_stop_Not_rv 5′-CAAAGCGGCCGCCTATTTCAGGGTAGGATAGAAGTT 
CTT-3′ 
R2d2_Rc_BamHI_fw 5′-CAAGGATCCAAGGAGGCCATTGAGGCCATC-3′ 
R2d2_Rc_BglII_rv 5′-CAAAGATCTATGTTATACGCATTAAATCAA-3′ 
R2d2_Rc_NotI_rv 5′-CAAAGCGGCCGCTTATACGCATTAAATCAA-3′ 
 
 
5.1.11.1.2 Flag-myc-Dcr-2 constructs 
Nhe_tub3UTR_fw 5′-CAAGCTAGCATTCGAATCGGAAATCAATCGAATTC-3′ 
tub3UTR_AvrII_rv 5′-CAACCTAGGAGACTTGTGAACAAAATTGGATCCG-3′ 
 
NotI_Dcr2_AUG_fw 5′-CAAGCGGCCGCATGGAAGATGTGGAAATCAAGCCT 
CGC-3′ 
NotI_Dcr2_AUG_Flag_fw 5′-CAAGCGGCCGCATGGATTATAAAGATGATGATGATAAA 
GAAGATGTGGAAATCAAGCCTCGC-3′ 
Dcr2_stop_NheI_rv 5′-CAAGCTAGCTTAGGCGTCGCATTTGCTTAGCTGCTG-3′ 
D_hel_Flag_Dcr2_fw 5′-CAAGCGGCCGCATGGATTATAAAGATGATGATGATAAA 
CAGGACGATATTGACCCTTTTACCA-3′ 
D_RBD_Dcr2_stop_NheI_rv  5′-CAAGCTAGCTTAGAAAATTACCTCCCAAGTACGTTGG 
AG-3′ 
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5.1.11.1.3 GFP-fusion constructs 
BamHI_myc_GFP_fw 5′-AGCGGATCCATGGAACAAAAACTTATTTCTGAAGAAGA 
CTTGGAACAAAAACTTATTTCTGAAGAAGACTTGGCCGTGA
GCAAGGGCGAGGAGCTG-3′ 
BglII_GFP_ORF_rv 5′-CAAAGATCTCTTGTACAGCTCGTCCATG-3′ 
 
 
5.1.11.1.4 T7-primers for RNAi 
T7prom_Loqs 5´UTR_fw 5′-CGTAATACGACTCACTATAGGGCAACCACAAATATCAGT-3′ 
T7prom_Loqs 5´UTR_rv 5′-CGTAATACGACTCACTATAGGTTGCACGGTTTTCGGGAG-3′ 
T7prom_Loqs 3´UTR_fw 5′-CGTAATACGACTCACTATAGGGTGCAGCCAACTGAATAG 
CA-3′ 
T7prom_Loqs 3´UTR_rv 5′-CGTAATACGACTCACTATAGGCCTTCGCAAACTAGCACGT 
AG-3′ 
T7prom_R2D2 3´UTR_fw 5′-CGTAATACGACTCACTATAGGATTCAACTATTCTAGCTTA-3′ 
T7prom_R2D2 3´UTR_rv 5′-CGTAATACGACTCACTATAGGCTTTGATTACTAGCATTC 
CT-3′ 
T7prom_GFP_ORF_fw 5′-CGTAATACGACTCACTATAGGATGGTGAGCAAGGGCGAG 
GAGCTG-3′ 
T7prom_GFP_ORF_rv 5′-CGTAATACGACTCACTATAGGTTACTTGTACAGCTCGTCCA 
TG-3′ 
T7prom_LoqsPC_fw 5′-CGTAATACGACTCACTATAGGAACGAATCTGTAAAGCAC 
CT-3′ 
T7prom_LoqsPC_rv 5′-CGTAATACGACTCACTATAGGCTGTAAATAAGAGCGCAA 
AG-3′ 
T7prom_Dcr1_new_fw 5′-CGTAATACGACTCACTATAGGCCAGGATCAACCGCAGTA 
TT-3′ 
T7prom_Dcr1_new_rv 5′-CGTAATACGACTCACTATAGGGTATCGTGGCGTGAGGA 
AGT-3′ 
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T7prom_LoqsPB+PC_fw 5′-CGTAATACGACTCACTATAGGCCCCGCAGTAGTGAAAA 
TTA-3′ 
T7prom_LoqsPB+PC_rv 5′-CGTAATACGACTCACTATAGGCTGTAACTTAAGCAGTTTT 
TTGCC-3′ 
T7prom_HP1_ORF_fw 5′-CGTAATACGACTCACTATAGGATGGGCAAGAAAATCGA 
CAA-3′ 
T7prom_HP1_ORF_rv 5′-CGTAATACGACTCACTATAGGACCATTTCTGCTTGGTC 
CAC-3′ 
T7prom_LoqsPD_fw 5′-CGTAATACGACTCACTATGTGAGTATCATTCAAGACATC 
GATC-3′ 
T7prom_LoqsPD_rv 5′-CGTAATACGACTCACTATAGGTAAGGTGTAAGCATTATGT 
TAATT-3′ 
T7prom_dsRed_ORF_rv 5′-CGTAATACGACTCACTATAGGTGGTGTAGTCCTCGTTG 
TGG-3′ 
T7prom_dsRed_ORF_rv_short 5′-CGTAATACGACTCACTATAGGCCGTCCTCGAAGTTCAT 
CAC-3′ 
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5.1.11.2 Sequencing 5.1.11.2.1 Loqs sequencing primer 
Seq_L1_rv 5′-GATATCTTCTCCTTCTTGAGCTTCACATGG-3′  
Seq_L1-L2_fw 5′-CAGGACGATCGAAGAAGGAGGCCAAG-3′  
Seq_L1-L2_rv 5′-TGCCCTTGCCCATCTCGCGGTA-3′  
Seq_L2_L3_fw 5′-CATCGATTCGGGCAAAATCAGCGACAG-3′  
Seq_Loqs_L2-L3_rv 5′-GAACTGGTTCTCCGTGGCGATTTC-3′  
Seq_Loqs_L3_fw 5′-GGCAGCGGACCAACAG-3′  
 
5.1.11.2.2 R2D2 sequencing primer 
Seq_R2D2_R1_rv 5′-CGGGAATAAAACTGTATGTTGGTAG-3′  
Seq_R2D2_R1-R2_fw 5′-CGGCATACACGGCTTGATGAAG-3′  
Seq_R2D2_R1-R2_rv 5′-CCACGGAGCAACAGGCCACGAAT-3′  
Seq_R2D2_R2-R3_fw 5′-CGTAGACCATACAGGCATGCGG-3′  
Seq_R2D2_R2-R3_rv 5′-GTGTTATCTTTAAAGAGCTCATTACGTC-3′  
Seq_R2D2_R3_fw 5′-GCGTCGAGCTTAATTGTGCATTC-3′  
 
5.1.11.2.3 Flag-Dcr-2 sequencing primer 
pCasper5_seq_fw 5′-TGGTACATCAAATACCCTTGGATCG-3′  
pCasper5_seq_rv 5′-GTGCGAGTGAAAGGAATAGTATTCTG-3′  
 
5.1.11.3 qPCR  
qPCR loqs fw 2 5′-AATGCCGTCAGTGGTAGTCC-3′  
qPCR Loqs rv 2 5′-CGTTTCGCTGACGAACTTTA-3′  
qPCR Probe B (CG4068B) 5′-TTGACTCCAACAAGTTCGCTCC-3′ 
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5.1.11.4 Test-PCR 
Test_iso_PD_rv 5′-AGCATGGGACTGCATTCAA-3′  
Loqs_all_fw 5′-CAAAATCAGCGACAGCATCTGCGG-3′  
Loqs_all_rv_long 5′-AACTGGTTCTCCGTGGCGATTTCG-3′  
GFP 2 s 5′-AGAACGGCATCAAGGTGAAC-3′ 
GFP 2 as 5′-TGCTCAGGTAGTGGTTGTCG-3′ 
 
5.1.11.5 RACE 
3´RACE exon3 fw = 
Loqs_PB_RB2_BamHI_fw 
5´-CAAGGATCCAATGCCACAGGCGGAGGAGAT-3´ 
Cloned AMV RT Module 5′-GCTGTCAACGATACGCTACGTAACGGCATGACAG 
TG(T)18-3′  
  
3´primer 5′-GCTGTCAACGATACGCTACGTAACG-3′  
3´nested primer 5′-CGCTACGTAACGGCATGACAGTG-3′  
 
 
5.1.11.6 Mapping P-element insertions in transgenic flies 5.1.11.6.1 Sequencing primer for wht1/lac1 
Sp1_seq_mapping 5´PCR 5′-ACACAACCTTTCCTCTCAACAA-3′  
Spep1_seq_mapping 3´PCR 5′-GACACTCAGAATACTATTC-3′ 
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5.1.11.6.2 Verification of mapped insertion site 
UAS-Loqs-PD line „B“: 3R insertion site 217147 
3R:2171431..2171458; Forward: 5′-CACATGCCGCTGCCAGTTACGCCATTTC-3′  
3R:2171468..2171485; Reverse:  5′-TCCCGGGGCAGATGGGAC-3′  
 
UAS-Loqs-PC line „E“: 3L insertion site 5241560 
3L:5241514..5241540; Forward:  5′-GTCTCGTCGGGTCGAGCAACGAAGTTC-3′  
3L:5241559..5241587; Reverse: 5′-CTCTAGACTCTGAATCTGAAACTGAAGTC-3′  
 
UAS-Loqs-PD line „D“: 2L insertion site 5999610 
2L:5999562..5999586; Forward:  5′-CAAACACAGTTTCTTATCGGCGGAG-3′  
2L:5999644..5999672; Reverse:  5′-CCTATGACCGAACTGATTTTGAATCTAATG-3′  
 
UAS-Loqs-PD line „H“: 3L insertion site 20488501 
3L:20488438..20488468; Forward:  5′-CCTGTCAATTCTAGTATATTCCAATTGCTAC-3′  
3L:20488535..20488561; Reverse:  5′-ACCAACTCGATTCGGTTAATTTACGCT-3′  
 
UAS-Loqs-PC line „M“: 2R insertion site 8519550 
2R:8519501..8519524; Forward: 5′-CGGTAGATCTCAAAGTTCAGGCGC-3′  
2R:8519574..8519599; Reverse:  5′-CTCGGCCCTTAATCCATCTTTAAACC-3′  
 
5.1.11.7 Sequencing primer for pUASP-trangenic flies 
pUASP basal Promotor 5′-ATTCAGTGCACGTTTGCTTG-3′ 
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5.1.12  Media 
5.1.12.1 Bacterial stocks 
All E. coli strains were cultivated in LB-medium or in SOC-medium following transformation. 
Agarose plates were obtained from in-house supply. 
 
SOB-medium     0.5% (w/v) yeast extract  
2% (w/v) Tryptone  
10 mM NaCl  
2.5 mM KCl  
10 mM MgCl2  
10 mM MgSO4 
pH 7 
 
SOC-medium    SOB-medium 
     20 mM glucose 
 
LB-medium    1% (w/v) Tryptone 
     0.5% (w/v) yeast extract 
     1% (w/v) NaCl 
     pH 7.2 
 
Antibiotics added to medium after autoclaving: 
100 µg/ml ampicillin (100 mg/ml stock) 
10 µg/ml kanamycin (10 mg/ml stock) 
25 µg/ml chloramphenicol (34 mg/ml stock) 
 
5.1.12.2 Cell culture 
Cell culture medium and additives for Drosophila Schneider cells was obtained from Bio&Sell 
(Nürnberg, Germany) and supplemented with 10% temperature-inactivated Fetal Bovine 
Serum (FBS; Thermo Fisher; Waltham, USA). 
Materials and Methods 
 
 
41 
For selection purposes 1.2 mg/ml G418 (neomycin) or 300 µg/ml hygromycin were added to 
the medium. 
 
5.1.13 Fly food  
Standard fly food was obtained from in-house supply: 
5.8% corn meal 
5.5% molasses 
2.4% yeast extract 
 
5.1.14 Antibodies 
5.1.14.1 Primary antibodies 
antibody organism dilution reference/ catalog # 
α-beta-tubulin mouse 
(monoclonal) 
1:1000 DSHB, E7 
α-Dcr-1 rabbit 
(polyclonal) 
1:1000 Förstemann, 2007 
α-Dcr-2 rabbit 
(polyclonal) 
1:1000 Abcam, ab4732-100 
α-Dcr-2 mouse 
(monoclonal) 
1:1000 Dcr-2 8-59; Miyoshi et al., 2009 
α-Flag mouse  
(monoclonal) 
1:2000 Sigma, F1804 
α-GFP mouse  
(monoclonal) 
1:4000 Santa Cruz Biotechnology, B-2; 
sc-9996 
α-GST mouse 
(monoclonal) 
1:1000 GE Healthcare, 27-4577-01 
α-Loqs mouse 
(monoclonal) 
1:1000-1:4000 Hartig et al., 2009; Miyoshi et al., 
2009 
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α-Loqs-PB C-
term. 
rabbit 
(polyclonal) 
1:1000 Abcam, ab 24237 
α-myc  mouse 
(monoclonal) 
1:1000 Sigma, M4439 
α-R2D2 rabbit 
(polyclonal) 
1:5000 Abcam, ab14750 
 
Rabbit IgG was purchased from Sigma (I5006). 
 
5.1.14.2 Secondary antibodies 
Antibody Dilution Origin 
Goat Anti-Mouse IgG (H+L) 
HRP-coupled  
1:100 000 Pierce (Thermo Scientific)  
31160 
Goat Anti-Rabbit IgG (H+L) 
HRP-coupled 
1:100 000 Pierce (Thermo Scientific)  
31210 
 
 
5.1.15 Stock solutions and commonly used buffers 
Acrylamide solution (Rotiphorese Gel 30) Acrylamide : Bisacrylamide = 37.5 : 1 
  
Alternative IP-buffer  Lysis buffer with 0.4% Triton X-100 
 
Buffer A for fly DNA extraction 100 mM Tris/HCl, pH 7.5 
100 mM EDTA 
100 mM NaCl 
0.5% SDS 
 
Church buffer 1% (w/v) bovine serum albumine 
 1 mM EDTA 
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 0.5 M phosphate buffer 
 7% (w/v) SDS 
 pH 7.2 
 
Colloidal Coomassie staining solution 50 g/l aluminum sulfate 
 2% (v/v) H3PO4 (conc.) 
 10% (v/v) 100% ethanol 
 0.5% (v/v) Coomassie G250 stock solution 
 
Coomassie G250 stock solution 0.5 g/l Coomassie G250 in 100% 
methanol 
Coomassie staining solution 45% (v/v) methanol 
 10% acetic acid 
 0.25% (w/v) Coomassie Brilliant Blue 
  
Coomassie destain 45% (v/v) methanol 
 10% acetic acid 
 
DNA loading buffer (6x) 0.25% (w/v) bromophenol blue 
0.25% (w/v) xylene cyanol 
 30% (w/v) glycerol 
 
Formamide loading dye (2x) 80% (w/v) formamide 
 10 mM EDTA, pH 8 
 1 mg/ml xylene cyanol 
 1 mg/ml bromophenol blue 
 
GST-purification binding/washing buffer 1xPBS 
 0.5% (w/v) Saponin 
 1x Complete® without EDTA (=protease 
inhibitor cocktail) 
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GST-purification elution buffer 50 mM Tris/HCl 
 10 mM Glutathione 
 0.1% Saponin 
 
Laemmli SDS loading buffer (2x) 100 mM Tris/HCl, pH 6.8 
 4% (w/v) SDS 
 20% (v/v) glycerol 
0.2% (w/v) bromophenol blue 
 200 mM freshly added DTT 
 
LiCl/KOAc Solution 1 part 5 M KOAc stock : 2.5 parts 6 M LiCl 
stock 
 
Lysis buffer for protein extraction 100 mM KOAc  
30 mM Hepes 
 2 mM MgCl2 
 1 mM DTT 
 1% (v/v) Triton X-100 
 2x Complete® without EDTA (=protease 
inhibitor cocktail) 
 
Lysis buffer with high MgCl2 20 mM Tris/Cl, pH 8 
 20 mM MgCl2  
 0.5% NP-40  
 2x Complete® without EDTA (=protease 
inhibitor cocktail) 
 
PBS (10x) 137 mM NaCl 
 2.7 mM KCl 
 10 mM Na2HPO4 
 2 mM KH2PO4, pH 7.4 
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PBS-T PBS supplemented with 0.05% Tween-20 
 
SDS-running buffer (5x) 125 mM Tris/HCl, pH 7.5 
 1.25 M glycine 
 5% SDS 
 
SSC (20x) 3 M NaCl 
 0.3 M sodium citrate 
 
TAE (50x) 2 M Tris-base 
 5.71% acetic acid 
 100 mM EDTA 
 
TBE (10x) 0.9 M Tris base 
 0.9 M boric acid 
 0.5 M EDTA (pH 8) 
 
TBS (10x) 50 mM Tris 
 150 mM NaCl 
 pH 7.4 
 
TBS-T TBS supplemented with 0.02% Tween-20 
 
Western blotting stock (10x) 250 mM Tris/HCl, pH 7.5 
 1.92 M glycine 
  
Western blotting buffer (1x) 10% Western blotting stock (10x) 
 20% methanol 
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5.2 Methods 
5.2.1 Molecular cloning 
5.2.1.1 Primer design for cloning of dsRBDs 
Loqs and R2D2 sequences were analyzed for evolutionary conserved dsRBD motifs with 
BLAST software (www.blast.ncbi.nlm.nih.gov; see Appendix 6 and Appendix 7). Primers were 
designed which annealed to the linker sequences and introduced appropriate restriction 
sites. Oligonucleotides were ordered from Thermo Fisher Scientific (Waltham, USA) and 
Eurofins/MWG (Ebersberg, Germany). 
5.2.1.2 Amplification of DNA sequences by Polymerase Chain Reaction (PCR) 
For molecular cloning purposes the standard reaction mix was as follows: 
10x Taq-buffer (-MgCl2, +(NH4)2SO4) 5 μl 
dNTP-mix (10 mM each)  1 μl 
25 mM MgSO4
   3 μl  (final conc. 1.5 mM) 
100 nM primer fw   0.1 μl 
100 nM primer rv   0.1 μl 
template DNA    2 μl   
Taq polymerase   0.4 μl 
Pfu polymerase   0.1 µl 
H2O     
     50 μl 
38.3 μl 
 
Reaction components were acquired from Fermentas (St. Leon-Rot, Germany), Taq 
polymerase was taken from our own laboratory stock. PCR reactions were carried out on an 
automated thermal cycler (Eppendorf; Hamburg, Germany). 
The following standard protocol for gradient PCR was used to determine the appropriate 
annealing temperatures. Conditions were then adjusted accordingly: 
3 min 94°C (initial denaturation) 
34 cycles: 
1 min 94°C (denaturation) 
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1 min 50-65°C (primer annealing) 
1 min 72°C (extension) 
 
5 min 72°C (final extension) 
Hold 4°C 
 
PCR products were separated by agarose gel electrophoresis, excised and purified by 
QIAGEN Gel Extraction Kit or directly treated with the QIAGEN PCR Purification Kit (Qiagen; 
Hilden, Germany). 
5.2.1.3 Agarose gel electrophoresis 
Appropriate for the length of nucleotides to be separated 0.5% – 4% agarose gels were 
prepared with 1x TAE buffer and stained with 1x SyberSafe (Invitrogen; Karlsruhe, Germany). 
Gels were run at 55V for 30 min and photographed in an Intas UV Imaging System. If higher 
sensitivity was required gels were re-stained in 1x SyberGold (Invitrogen; Karlsruhe, 
Germany) for 30 min. 
5.2.1.4 Specific digestion of DNA by restriction endonucleases 
Endonucleolytic digestion of DNA was carried out with restriction endonucleases acquired 
from Fermentas (St. Leon-Rot, Germany) and New England Biolabs (Ipswich, USA) according 
to manufacturers´ recommendations. Usually, reactions were incubated for 2 hours at 37°C. 
5.2.1.5 Ligation of vector with insert DNA 
Digested and purified insert and vector were combined according to the following formula in 
a molar ratio of 1 to 3: mass (vector) ∗ length bp (vector) ∗ 3length bp (insert) = required mass (insert) 
≥ 200 ng vector  
+ required amount of insert 
+ 2 μl T4-buffer (10x) 
+ 1 μl T4-DNA Ligase 
20 μl 
+ x μl H2O 
Optimally samples were ligated over night at 18°C and used for bacterial transformation. 
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5.2.1.6 Bacterial transformation 
Transformation of competent bacteria was carried out by standard heat shock procedures. 
Briefly, 50 µl XL2-blue CaCl2-competent cells were thawed on ice. 1-4 µl of ligation sample 
were added and the mixture was incubated on ice for 30 min, subjected to a 1 min heat 
shock at 42°C and returned to ice. 1 ml SOC-medium was added and cells were allowed to 
grow for 1 h in a 37°C shaking incubator. Cells were then streaked out on agarose plates with 
appropriate antibiotics for selection of transformants. 
5.2.1.7 Test for correct transformants by colony-PCR 
Individual colonies were tested for correct integration of the insert by colony-PCR with 
suitable primer pairs. A standard PCR reaction mix was inoculated with a single colony, 
which was subsequently streaked onto a fresh plate and labeled for later recognition. 
Standard amplification was carried out with 10 min initial denaturing for cell lysis of bacteria. 
5.2.1.8 Preparation of plasmid DNA 
Plasmid DNA was prepared from over-night cultures of 5 ml or 30 ml LB-medium, 
respectively, supplemented with appropriate antibiotics (usually 100 µg/ml ampicillin). 
QIAGEN Mini or Midi Kits (Qiagen; Hilden, Germany) were used according to the 
manufacturer´s protocols. 
5.2.1.9 DNA sequencing 
Sequencing was carried out by Eurofins/MWG (Ebersberg, Germany) according to the 
provider´s specifications. Sequence analysis and alignments were performed with BioEdit 
software (Hall, 1999) and openly available online tools. 
5.2.1.10 3´-RACE PCR analysis of the loqs-RD variant 
RNA from S2-cells was prepared with the miRNeasy® mini-kit (Qiagen; Hilden, Germany). 1 
μg of total RNA was reverse transcribed (Superscript II, Invitrogen; Karlsruhe, Germany) 
using the oligo(dT) primer from the GeneRACER Kit (Invitrogen; Karlsruhe, Germany) 5′-GCT 
GTC AAC GAT ACG CTA CGT AAC GGC ATG ACA GTG (T)18-3′. PCR was performed with a 
primer at the end of loqs exon 3 (5´-CAA GGA TCC AAT GCC ACA GGC GGA GGA GAT-3´) and 
the 3’-end reverse primer from the GeneRACER kit (5´-GCT GTC AAC GAT ACG CTA CGT AAC 
G-3´) using a 5:1 mix of Taq and Pfu (Fermentas; St. Leon-Rot, Germany) polymerases and a 
1:20 diluted cDNA template at 55°C annealing temperature. PCR products were TA-cloned 
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using the CloneJet PCR cloning kit (Fermentas; St. Leon-Rot, Germany) and sequenced 
(Eurofins/MWG; Ebersberg, Germany). 
 
5.2.2 Methods of Drosophila S2 cell culture 
5.2.2.1 Maintenance 
Drosophila Schneider 2 (S2) cells were cultured in Schneider’s medium (Bio&Sell, Nürnberg, 
Germany) supplemented with 10% fetal calf serum (Thermo Fisher Scientific; Waltham, USA) 
in 10 cm cell culture dishes. Cultures were split 2-3 times a week into fresh medium. 
 
5.2.2.2 Depletion of individual genes by RNAi in cell culture 5.2.2.2.1 Production of dsRNA 
RNA interference by simply adding dsRNA to cell culture medium (soaking) was performed 
essentially as described (Shah et al., 2008). Briefly, gene specific primers for target genes 
were designed to introduce flanking T7-promotor fragments (see Materials 5.1.11.1.4) and 
amplified using standard PCR. The PCR products were precipitated with ethanol, the pellet 
was dissolved in 1/10 of the original volume and used directly for over-night in-vitro 
transcription at 37°C with the following specifications: 
 
10 μl 10x T7-buffer 
10 μl  re-dissolved DNA 
0.5 μl  1 M DTT  
5 μl  100 mM ATP  
5 μl  100 mM CTP 
5 μl  100 mM UTP 
8 μl  100 mM GTP 
54.5 μl H2O 
100 μl 
2 μl       T7-polymerase 
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After in-vitro transcription 1 µl of DNAseI was added per 100 µl of reaction and incubated for 
30 min at 37 °C. White precipitate was pelleted and RNA was precipitated from supernatant 
with 1x volume of isopropanol and washed with 70% ethanol. The dried pellet was dissolved 
in 100 µl of H2O. For proper strand annealing MgCl2 was added to a final concentration of 5 
mM, the sample was heated to 95°C for 3 min and allowed to slowly cool down to room 
temperature. Concentration of dsRNA was estimated from an agarose gel in comparison to a 
DNA Ladder Mix (Fermentas; St. Leon-Rot, Germany). 
5.2.2.2.2 Soaking 
Cells were seeded at 0.5x106 cells/ml and 20 μg/ml dsRNA were added to the medium. On 
day 2, the cells were split 1:5 into a fresh culture dish and the dsRNA treatment was 
repeated. On day 5 or 6, GFP fluorescence was quantified in a Becton Dickinson FACSCalibur 
flow cytometer.  
5.2.2.2.3 Transfection 
Transfections of S2 cells were carried out essentially as described in Shah et al., 2008. For 
each well of a 24-well cell culture dish 50 ng of the vector of interest in 50 µl medium 
(without serum) and 4 µl of Fugene Transfection Reagent (Roche Diagnostics; Mannheim, 
Germany) in 46 µl of medium (without serum) were mixed and incubated for 1 hour. Cells 
were added to the transfection mix at 0.5x106 cells/ml medium (+10% FBS), split on day 3 
after transfection and analyzed on day 5 or 6. 
5.2.2.2.4 Flow cytometric analysis of GFP levels 
GFP fluorescence levels were quantified using a FACSCalibur flow cytometer (Becton 
Dickinson; Franklin Lakes, USA). 100 µl of cell culture were added to 300 µl of FACS-flow. 
10,000 cells were measured per sample (settings FL-1 290V Log scale). FACS profiles were 
depicted as cell counts over a logarithmic scale for fluorescence intensity. Analysis was 
carried out with CellQuest software (Becton Dickinson; Franklin Lakes, USA). Non-fluorescent 
GFP-reporter cells were excluded from the analysis and the mean fluorescence value for 
each sample was determined (Note: Stable cell-lines in non-selective medium may not be 
derived from a single clone and contain a minority of contaminating non-fluorescent cells). 
Measurements were carried out in technical triplicates to calculate mean and standard 
deviation. 
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5.2.2.3 Selection of clonal cell lines 
To create cell lines that stably express a transgene the expression plasmid of interest was co-
transfected with an antibiotic resistance plasmid into cells at 5-10 x 105 cells/ml. For native 
S2 cells 10 ng pHSneo (for neomycin resistance) and for secondary transfections of stable 
reporter lines 10 ng pHShygro (for hygromycin resistance) were used together with 200 ng of 
the vector of interest. After 3 days, cells were split 1:5 into G418 or hygromycin containing 
medium, respectively. The concentration was 1.2 mg/ml of G418 for neomycin resistance 
and 300 µg/ml of hygromycin. Cells were split 1:5 once a week for 4 weeks to obtain stable 
cell lines. For clonal selection serial dilution steps in a 96-well plate were made and colonies 
derived from a single cell were picked. 
5.2.2.4 Storage of cells in liquid nitrogen 
Cell stocks were frozen by adding 500 µl cells to 100 µl Dimethylsulfoxide (DMSO) diluted in 
400 µl cell culture medium (+10% FBS) in a Cryovial (Biozym; Oldendorf, Germany). Cryovials 
were slowly (1°C per hour) cooled to -80°C in an isopropanol freezing container 
(Nalgene/Thermo Fisher) and transferred into liquid nitrogen for long-term storage. 
 
5.2.3 Protein analysis 
5.2.3.1 Protein extraction 
Cells were harvested (2500 x g, 5 min) and washed twice in PBS. The pellet was resuspended 
in lysis buffer (30 mM Hepes, 100 mM KOAc, 2 mM MgCl2, 1 mM fresh DTT, 1% (v/v) Triton 
X-100, 2x protease inhibitor cocktail (Complete® without EDTA, Roche Diagnostics)) and 
frozen in liquid nitrogen. Samples were thawed on ice and cell debris was pelleted in a 
refrigerated microcentrifuge at 15,000 x g (Eppendorf; Hamburg, Germany). Protein 
concentrations were determined by Bradford Assay (BioRad; Hercules, USA).  
Fly protein was extracted by grinding flies in lysis buffer using a pistil (Sigma Aldrich; 
Taufkirchen, Germany) suitable for 1.5 ml reaction tubes and subsequent freeze-thaw lysis 
analogous to S2 cells. 
For extraction of HP-1 protein (Figure 20B), lysis buffer with high MgCl2 conditions was used 
as indicated [Tris/Cl 20 mM pH 8; MgCl2 20 mM; 0.5% NP40 + 2x protease inhibitor cocktail 
(Complete® without EDTA, Roche Diagnostics)]. 
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5.2.3.2 Co-immunoprecipitation 
Protein G Plus/Protein A Agarose beads (IP05, Calbiochem) were washed three times in 1 ml 
Lysis buffer and agitated for 30 min at 4°C with the respective antibody. Beads were then 
washed four times and incubated with 1-5 mg of total protein in Lysis buffer at 4°C for 1 h on 
an overhead-rotator. For α-myc immunoprecipitation in Figure 13A, B, C 1 mg total protein 
was incubated with 50 μl α-myc affinity agarose (A7470, Sigma; washed three times in 1 ml 
of Lysis buffer) for 2 h at 4°C on an overhead-rotator. For α-Flag immunoprecipitation, α-Flag 
affinity agarose (A2220, Sigma), washed three times in 1 ml of Lysis buffer, was used.  For IP 
experiments in Figure 15B, C and Figure 19D a Triton X-100 concentration of 0.4% (v/v) was 
emloyed. GFP-fusion constructs were precipitated using GFP-Trap®_A beads (Chromotek; 
Planegg-Martinsried, Germany). Flow-through and beads were separated by spin columns 
(MoBiTec; Göttingen, Germany) and washed four times with 500 μl lysis buffer. Bound 
proteins were eluted by applying 15 μl 1x Laemmli SDS sample buffer and heating to 95°C for 
5 minutes.  
5.2.3.3 Immunoblotting for detection of proteins 
Western blotting was performed as previously described (Förstemann, 2007). In short, 
proteins were separated on 8-12% polyacrylamide gels (150 V; 1h) in a BioRad 
electrophoresis tank. Proteins were transferred to a polyvinylidenfluoride (PVDF; Milipore; 
Billerica, USA) membrane by tank blotting (100 V; 1-1.5h). After blocking in 5% milk for 1 h 
membranes were incubated under constant rolling in 50 ml tubes with 5 ml of primary 
antibody solution over night at 4°C. Antibodies and dilutions are indicated in the Materials 
section 5.1.14.1. For all washing, blocking and incubation steps for rabbit antibodies PBS-T 
(0.05% Tween) was used, for mouse antibodies TBS-T (0.02% Tween) was employed. After 
primary antibody binding blotting membranes were washed three times 10 min in buffer and 
incubated with appropriate secondary antibodies for 2 h at room temperature. After 
analogous washing, Enhanced Chemiluminescence (ECL) substrate (Thermo Fisher Scientific; 
Waltham, USA) was applied and the signal was measured in an LAS3000 mini Western 
Imager System (Fujifilm; Tokyo, Japan). Multi Gauge software (Fujifilm; Tokyo, Japan) was 
used for relative quantification of protein band intensities. Western blots were stripped with 
10 ml of Restore Stripping Solution (Thermo Fisher Scientific; Waltham, USA) for 30 min at 
37°C and another 30 min at room temperature, washed extensively in water and buffer and 
blocked for new primary antibody incubation. 
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5.2.3.4 α-Loqs-PD-specific antibody production 
Loqs-PD-specific peptide was synthesized, coupled to KLH (keyhole limpet hemocyanin) as a 
carrier protein and used to immunize rabbits (Davids Biotechnologie; Rgensburg, Germany). 
Affinity purification was performed as described (Harlow et al., 1988) using Loqs-PD peptide 
coupled to NHS-Sepharose (Sigma, H8280). 
5.2.3.5 Dot blot 
8-10 µg of total protein extracts were spotted on a nitrocellulose membrane (Schleicher & 
Schuell; Dassel, Germany) and left to dry. Immunoblotting was performed as described 
above. 
 
5.2.4 RNA analysis 
5.2.4.1 RNA extraction 
RNA was extracted either with Trizol (Invitrogen; Karlsruhe, Germany) according to the 
manufacturer´s instructions or using the QIAGEN miRNeasy Kit (Quiagen; Hilden, Germany) 
and quantified using spectrophotometry. 
5.2.4.2 Northern Blotting 
1-5 µg of RNA were separated on a 20% Sequagel Acrylamide/Urea gel (National Diagnostics; 
Atlanta, USA) at 250V for 1.5 hours. RNA was then transferred to a positively charged Nylon 
membrane (Roche Diagnostics; Mannheim, Germany) by semi-dry blotting for 1h at 20V. 
Membranes were transferred to hybridizing tubes and incubated in Church Buffer for at least 
1h in a hybridization oven under constant rotation. Probes for detection of bantam miRNA 
and 2S rRNA were as described (Forstemann et al., 2005). A DNA antisense probe for the 
detection of CG4068 B endo-siRNA (Okamura et al., 2008b) was used.  
 
 
Probe for Northern Blotting Sequence 
Probe B (CG4068 B) DNA as probe 5´-GGAGCGAACTTGTTGGAGTCAA-3´ 
bantam 2´OMe as probe 5´-AATCAGCTTTCAAAATGATCTCA-3´ 
miR-277 2´OMe as probe 5´-TGTCGTACCAGATAGTGCATTTA-3´ 
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Probes were labeled by incubating 9 µl H2O, 2 µl 10x PNK buffer, 2 µl 5 mM probe 
oligonucleotide (=10 pmol), 1 µl PNK (Fermentas) and 6 µl [γ 32P] ATP for 1h at 37°C. 
Unbound radioactive nucleotides were removed using a Sephadex G-25 spin column (Roche 
Diagnostics; Mannheim, Germany). Labeled oligonucleotide anti-sense probes were added 
to 5 ml of Church Buffer for over-night hybridization. Prehybridization and hybridization 
were carried out at 37°C for DNA-probes or 65°C for 2´OMe-probes. Membranes were 
washed three times for ≥  1h in 2x SSC + 0,1% SDS and exposed to Phosphoimager Screens 
(Fujifilm; Tokyo, Japan) for up to 1 week. Screens were scanned using a Typhoon scanner 
(Amersham Biosciences) and band intensities were quantified using Multi Gauge software 
(Fujifilm; Tokyo, Japan). Membranes were immersed in 1% SDS heated to boiling in a 
conventional microwave and allowed to sit there for 5 min before they could be reused for 
prehybridization.  
 
5.2.4.3 Analysis of mRNA levels by Polymerase Chain Reaction 5.2.4.3.1 Semi-quantitative method  
1 µg total RNA extract was used for cDNA production with the Superscript II Reverse 
Transcriptase (Invitrogen; Karlsruhe, Germany). cDNA was diluted and used for PCR 
amplification with primers for the first dsRBD common to all loqs isoforms 
(Loqs_PB_RB1_BamHI_fw; Loqs_PB_RB1_BglII_rv). The following Phusion-polymerase PCR 
Mix was used: 
 
4 µl Phusion HF buffer (5x) 
0.4 µl 10 mM dNTP Mix 
0.1 µl primer fw 
0.1 µl primer rv 
1 µl template cDNA 
20µl 
0.2 µl Phusion Hot Start Polymerase 
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PCR amplification was limited to 25 cycles and adapted for optimal conditions of the Phusion 
polymerase: 
30 sec 98°C 
 
24 cycles: 
10 sec 98°C 
30 sec 65°C 
1 min 72°C 
 
5 min 72°C 
Hold 4°C 
 
Reaction products were separated on a 1.5% agarose gel and band intensities were 
quantified with Multi Gauge software (Fujifilm; Tokyo, Japan). 
 
5.2.4.3.2 Real-time quantitative PCR (RT-qPCR)  
1 µg of total RNA extract was reverse transcribed according to the Qiagen miScript protocol: 
 
4 µl miScript RT buffer (5x) 
0.3-0.7 µl total RNA 
14.3-14.7 µl H2O 
20 µl 
1 µl miScript enzyme mix 
 
Samples were incubated at 37°C for 60 min and then inactivated at 95°C for 5 min. After 
adding 100 µl of water to make a final volume of 120 µl, 1:10, 1:100 and 1:1000 dilutions 
(post-RT dilutions) were made. The qPCR reaction mix was as follows: 
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Reaction mixes for 14 reactions (for 1 row of 96-well plate): 
70 µl Quantitect SyBr-green mix (2x) 
35 µl H2O 
14 µl miScript universal primer (5 µM) 
7 µl miScript specific primers (10 µM)  
 
9 µl of reaction mix and 1 µl of RT-reaction per well was amplified in an ABI PRISM 7000 
qPCR cycler (Applied Biosystems; Foster City, USA) using the following conditions: 
 
15 min 94°C 
 
40 cycles: 
20 sec 94°C 
30 sec 55°C 
30 sec 70°C 
 
Cycle of Threshold values (CT-values) usually determined via the auto-CT function and 
manually adjusted if necessary. The 2S-1 primer from the miScript kit was used as a control. 
 
5.2.4.3.3 ∆∆ CT-Method 
Expression levels were analyzed using the ∆∆ CT-Method (Schmittgen et al., 2008). 
 
5.2.5 Drosophila melanogaster methods 
5.2.5.1 Maintenance and handling 
Flies were kept on standard fly food (see Materials 5.1.13) at 25°C and transferred to new 
food every 2-3 weeks. For phenotype selection flies were anesthetized with CO2 and sorted 
on a CO2-emitting pad (Genesee Scientific; San Diego, USA) using a Leica MZ7 
stereomicroscope (Leica Microsystems; Wetzlar, Germany). 
To slow proliferation by reducing metabolic rates flies were kept at 18°C for up to one week 
if necessary. 
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5.2.5.2 Transgenic flies 5.2.5.2.1 Obtaining transgenic lines 
The myc-Loqs-PD and -PC constructs described elsewhere (see Materials 5.1.11.1; pEH37 
and pEH38, respectively, see Results 6.17, Table 5) were sub-cloned into pUAST vector 
(Brand et al., 1993). The constructs, listed in Results 6.17 Table 3, were sequenced, tested in 
cell culture and sent for injection into w1118 fly embryos (Rainbow Transgenic Flies; Newbury 
Park, USA). Transgenic offspring, marked by red eye color, were twice crossed with w1118 flies 
to reduce the risk of secondary mutations. Siblings were then mated to produce 
homozygous stable lines (see Results 6.17 Table 4). 
5.2.5.2.2 Mapping of P-element insertions by inverse PCR 
The protocol for the mapping of P-element insertions was applied according to the Berkeley 
Drosophila Genome Project. In short, DNA was prepared from 30 anesthetized flies by 
freezing at -80°C and subsequent mechanical lysis in Buffer A. LiCl/KOAc-solution was added, 
debris was pelleted and supernatant was precipitated with isopropanol. The genomic fly 
DNA pellet was washed with 70% ethanol, dried and dissolved in H20. To create appropriate 
fragment sizes for inverse PCR, genomic DNA was digested with HinP1I or MspI. The 
fragments were circularized by ligation at low DNA concentration. Standard PCR with Sp1 
and Spep1 primers indicated above (see Materials 5.1.11.6.1) was carried out, amplification 
products were separated on a 1.5% agarose gel. Bands were excised, sequenced and 
mapped to the Drosophila genome. Insertion sites in genomic DNA samples of transgenic 
lines were verified by PCR with newly designed genomic primers flanking the putative P-
element (see Materials 5.1.11.6.2). 
5.2.5.2.3 Crossing 
To obtain Loqs-PD (and Loqs-PC) rescue flies virgins of a tubulin-Gal4 driver line, Loqs-PB 
rescue flies and homozygous UAS-Loqs-PD (or Loqs-PC) transgenic flies carrying the P-
element insertion on the third chromosome were each crossed to Kr/Cyo; D/TM6, Sb, Tb 
double balancer males, to obtain offspring with balanced 2nd (CyO) and 3rd (TM6, Tb, Sb) 
autosomes. F1 offspring from the Loqs-PB rescue flies was selected for D/TM6, Sb, Tb 
phenotypes to recover the loqsKO background. F1 virgins from the tub-Gal4 cross and the 
UAS-Loqs-PD (or Loqs-PC) cross were both mated with balanced loqsKO males and F2 siblings 
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were crossed to obtain homozygous loqsKO flies with a tub-Gal4/UAS-Loqs-PD (or Loqs-PC) 
phenotype. 
 
5.2.6 Recombinant expression and purification of GST- or His6-tagged Loqs isoforms 
5.2.6.1 Recombinant expression 
First attempts to recombinantly express Loqs isoforms in small scale were made by sub-
cloning Loqs-PB in bacterial expression vectors pGex-6P-1 or pET-28a (see Materials 5.1.8 
and Appendix 2; pEH 52). Loqs-PB was PCR amplified with Loqs_PB_RB1_BamHI_fw and 
Loqs_PB_RB3_NotI_rv, BamHI/NotI digested and then ligated into pGex. An analogous 
construct for pPET-Loqs-PA construct (lacking the last codon of the ORF before the stop 
codon) was made by Milijana Mirkovic-Hösle in our laboratory. 
For recombinant expression the BL21 E. coli expression strain (carrying the extra plasmid 
pLysS encoding for lysozyme and a chloramphenicol resistance) was transformed. Briefly, 5 
ml of a 50 ml primary overnight culture of BL21 cells growing in LB-medium + ampicillin (or 
kanamycin) + chloramphenicol + 1% glucose at 37°C were used to inoculate 100 ml LB-
medium supplemented with appropriate antibiotics and culture was grown to an optical 
density OD600 of 0.6. Expression was induced with 0.1 mM Isopropyl-β-D-
thiogalactopyranosid (IPTG) and cells were harvested after 7h. Cell pellets were re-
suspended in Lysis-buffer (+1% Triton X-100, + Complete® without EDTA, Roche Diagnostics) 
and frozen in liquid nitrogen. Samples were thawed on ice and sonified to reduce viscosity 
and improve solubility of proteins: 
 
Sonifier settings: 
Output control: 5-6 
Duty cycle 20-30 
1 min sonify, 30 sec on ice, 1 min sonify 
 
Debris was pelleted and 50 µg of total protein extract were run on a 10% polyacrylamide gel. 
Gel was stained with colloidal Coomassie. 
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5.2.6.2 Affinity purification of recombinant proteins 
250 µl Glutathione Sepharose 4 Fast Flow (GE Healthcare; Freiburg, Germany) was washed 
three times with wash buffer (1x PBS; 0.5% Saponin; 1x Complete® without EDTA), 
resuspended in 500 µl washing buffer and loaded into a spin column (MoBiTec; Göttingen, 
Germany). 5 µl of sonified and filtered protein extract was applied twice to the column (FT1 
and 2). Column was washed three times with 5 ml wash buffer (wash1-3) and then eluted 
with glutathione elution buffer in 6 steps á 100 µl (E1-6). Equivalent amounts were 
separated on a 10% polyacrylamide gel. Gel was stained with colloidal Coomassie. 
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6 Results 
6.1 A novel isoform of loqs 
The observation that endo-siRNA mediated silencing depends on loqs in combination with 
dcr-2 was a surprise because it suggested that a hybrid complex with components of the 
canonical miRNA and siRNA biogenesis pathways exists. However, this interpretation may 
have been an oversimplification because the loqs gene can give rise to at least three 
different mRNAs, each coding for a protein with distinct properties (Figure 6A; Forstemann 
et al., 2005; Jiang et al., 2005; Saito et al., 2005). Only one isoform, called Loqs-PB, is an 
essential partner of Dcr-1 in the biogenesis of miRNAs (Jiang et al., 2005; Park et al., 2007). 
Loqs-PA, which lacks 46 amino acids compared to Loqs-PB, also associates with Dcr-1 but 
does not suffice for miRNA silencing. A shift in the reading frame due to alternative splicing 
leads to a new stop codon in the Loqs-PC isoform. Instead of the third dsRBD the Loqs-PC 
protein is characterized by 54 specific amino acids. However, there was a possibility that not 
all isoforms of Loqs had been annotated yet. Therefore, I performed 3’-RACE experiments to 
detect novel splice variants from both genomic DNA and a genomic expression construct for 
Loqs-PC (Figure 6A). I recovered a new mRNA variant of loqs (loqs-RD), where an alternative 
polyadenylation in the third intron leads to a novel protein isoform that lacks the third 
dsRBD of Loqs-PA/-PB and contains 22 amino acids of new protein sequence (Figure 6A and 
B). Polyadenylation (poly-A) signals in Drosophila and humans are well conserved (Retelska 
et al., 2006) and consist of a defined polyadenylation signal located 10-30 bases upstream of 
the mRNA cleavage site and a less conserved U-rich sequence located within the first 30 
nucleotides downstream of the cleavage site. Poly-A prediction yielded several possible poly-
A motifs adequately spaced from the experimentally inferred site for Loqs-PD (see Appendix 
5). Together with a T-rich stretch downstream in the genome (Figure 6B) this corroborated 
the experimental data. Sequencing of clones from genomic expression constructs confirmed 
the common poly-A signal for loqs-RA, -RB and -RC (Figure 6A). With Loqs-PB functioning in 
miRNA biogenesis, I hypothesized that one of the other Loqs isoforms might specifically act 
in endo-siRNA dependent silencing. In order to determine which of the four splice-variants 
of Loqs is involved in the endo-siRNA pathway, I needed a tool to manipulate them 
individually. 
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Figure 6:
A) Schematic diagram of the four loqs mRNA and protein variants currently known. In the mRNA exons are 
represented by horizontal bars, introns by thin lines. Start codons are indicated in green, stop codons in 
red. The dsRBD-motifs are depicted in the cartoon drawings of the protein isoforms (diagram analogous to 
Forstemann et al., 2005). The novel amino acid sequence of Loqs-PD is indicated. The genomic expression 
construct encodes for both loqs-RD and -RC, but expresses almost exclusively Loqs-PD (see 
 A novel isoform of the dsRBP Loquacious 
Figure 7C) 
B) 3´-RACE PCR for detection of the loqs-RD isoform; top strand of DNA represents Drosophila melanogaster 
genomic sequence, bottom strand represents cloned 3´-RACE product; the appended poly-A tail is colored 
in green; the amino acid sequence of Loqs-PD is indicated in red, the exon sequence common to all 
isoforms is shaded in blue 
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6.2 Isoform-specific knock-down 
Isoform-specific knock-downs are possible if the corresponding mRNA contains a stretch of 
unique sequence that is amenable to RNAi. In the case of the loqs gene, it is possible to 
target the loqs-RC and loqs-RD RNA individually, the loqs-RB RNA together with the loqs-RC 
RNA, loqs-RA, loqs-RB and loqs-RC together via the common sequence towards the 3’-end 
and finally all four loqs isoforms simultaneously with dsRNA directed against the amino-
terminus of Loqs (Figure 7A).  
Detection of endogenous Loqs protein isoforms on immunoblots has revealed three bands of 
distinct sizes, which had been assumed to correspond to Loqs-PB, Loqs-PA and Loqs-PC 
(Forstemann et al., 2005). With the help of Loqs-PD-specific RNAi I could show that the 
smallest of these bands predominantly contains the new Loqs-PD isoform (Figure 7B). 
Difficulties to recover loqs-RC clones in my 3´-RACE experiments indicated that loqs-RC 
mRNA is only detectable in low levels in S2 cells. Therefore I tested whether it is expressed at 
all from the genomic construct encoding for both Loqs-PC and the novel Loqs-PD isoform. 
The genomic Loqs-PC/-PD expression construct produces two protein bands previously 
assumed to represent myc-tagged Loqs-PC and untagged Loqs-PC, translated from the 
endogenous start codon situated downstream of the myc-sequence. When cells were 
simultaneously transfected with the genomic expression construct and RNAi triggers, no 
protein bands could be detected after loqs-RD knock-down (Figure 7C). A control dsRNA, on 
the other hand, did not affect expression, indicating that the genomic construct (henceforth 
abbreviated Loqs-PDgenomic) almost exclusively expresses Loqs-PD. This indicates that the 
original detection of Loqs-PC might be a cloning artifact and that the isoform plays only a 
minor role in vivo. However, for reasons of completeness I included Loqs-PC in subsequent 
experiments. Immunoblotting confirmed that on protein level, the Loqs isoform-specific 
RNAi was efficient and specific (Figure 7B). The loqs-ORF dsRNA was slightly more successful 
in Loqs-PD depletion than the loqs-5´UTR dsRNA, while neither Loqs-PB nor -PA bands 
remained detectable. Alternative polyadenylation of the Loqs-PD isoform was substantiated 
by exclusive targeting of Loqs-PB, -PA (and -PC) by the dsRNA derived from the 3´UTR of 
these isoforms. 
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Figure 7:
A) Schematic diagram of the four loqs mRNA variants; the regions from which dsRNA was derived to trigger 
isoform-specific RNAi are indicated below the mRNA variants; note that loqs-RD does not share the same 
3´UTR with loqs-RA/-RB/-RC 
 Loqs isoform-specific RNAi and verification on protein level 
B) Effect of isoform-specific RNAi treatment in Drosophila S2 cells; dsRNA against dsRed served as a control; 
the Western blot was probed with α-Loqs monoclonal antibody to confirm depletion of specific Loqs 
protein isoforms; α-tubulin served as a loading control (legend continued on p. 64) 
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(legend Figure 7 continued) 
C) The genomic expression construct for Loqs-PD almost exclusively expresses Loqs-PD and not Loqs-PC; 5d 
after RNAi treatment against Loqs-PD or a dsRed control, S2 cells were split 1:5 and transfected with the 
genomic Loqs-PD expression construct or a pUC18 control; protein extract was prepared 4d after 
transfection; α-Loqs Western detected expression from the genomic construct only after control RNAi 
(Note that expression of endogenous Loqs isoforms is below the detection limit in this Western blot so that 
endogenous Loqs-PC expression cannot completely be ruled out); α-tubulin Western served as a control 
 
In addition to the protein level of individual isoforms I tested for depletion of the 
corresponding mRNA by isoform-specific PCR. After isoform-specific RNAi treatment total 
RNA was extracted from S2 cells and cDNA was produced. With a primer pair spanning from 
the third to the last exon (indicated by arrows in Figure 8A) I could distinguish three bands 
amplified from cDNA of loqs-RA, -RB and -RC isoforms and a minor contamination with 
genomic DNA (Figure 8B). Note that the shortest protein isoform, Loqs-PC, corresponds to 
the largest band in the mRNA assay due to the extended fourth exon (Figure 8A). Targeting 
by the RNAi triggers proved to be equally efficient and selective on RNA as on protein level. 
The loqs-RD cDNA was similarly detected with a primer pair within the loqs-RD-specific 
sequence (Figure 8A, C; amplicon indicated by green bar). Treatment of S2 cells with the 
RNAi trigger directed against the 3´UTR of Loqs-PA, -PB and -PC did not affect cDNA levels of 
loqs-RD while targeting the second exon, common to all splice variants (loqs-ORF), depleted 
the PD-specific amplicon. However, the PCR analysis did not allow a quantification of overall 
Loqs levels. It was possible that depletion of one transcript variant would relatively enrich 
the other ones, making interpretation of isoform-specific RNAi data difficult. To test this I 
used both a semi-quantitative and a quantitative PCR (qPCR) approach to determine total 
loqs cDNA levels prepared from S2 cells after isoform-specific RNAi (Figure 8D). For the 
semiquantitative method equal amounts of cDNA were used as a template for PCR 
amplification with a primer pair flanking the first dsRBD common to all isoforms 
(Loqs_PB_RB1_BamHI_fw; Loqs_PB_RB1_BglII_rv; see Materials and Methods 5.1.11.1.1). 
Amplification was stopped within the exponential phase, products were separated on an 
agarose gel and band intensities were quantified. Results were comparable to SyberGreen-
based qPCR with a specially designed primer pair: loqs-RC depletion, consistent with its low 
expression level, caused no reduction of total loqs levels compared to an RNAi control 
(Figure 8D). If isoform-specific RNAi is not compensated by increased transcription of the re- 
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Figure 8: Loqs isoform-specific RNAi and verification on RNA level (legend continued on p. 66) 
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(legend Figure 8 continued) 
A) Schematic diagram of the four loqs mRNA variants; arrows indicate the primer pair used for amplification 
of loqs-RA/-RB/-RC from cDNA; the PD-specific amplicon is marked by a green horizontal bar below the 
loqs-RD sequence 
B) Effect of isoform-specific RNAi treatment on mRNA levels; total RNA of S2 cells was extracted and cDNA 
was amplified with the primer pair for loqs-RA/-RB/-RC detection (compare arrows in A); PCR products 
were separated on a 1.5% agarose gel and stained with SyberSafe; main bands of a 1 kb DNA marker mix 
are indicated 
C) Effect of isoform-specific RNAi treatment on mRNA level of loqs-RD; total RNA of S2 cells was extracted; 
samples were either reverse transcribed (RT +) or not (RT -) and then amplified with the primer pair for 
loqs-RD detection (compare green bar in A); loqs-3´UTR RNAi did not deplete the loqs-RD mRNA; PCR 
products were separated on a 4% agarose gel and stained with SyberSafe; main bands of a 1 kb DNA 
marker mix are indicated; amplification of a ca. 100 bp GFP fragment served as a control for cDNA quality 
D) Effect of isoform-specific RNAi on total loqs RNA level; 
Left panel: semi-quantitative amplification of cDNA from S2 cells with the L1_fw/L1_rv primer pair for all 
four loqs-isoforms; after 25 PCR cycles products were separated on an agarose gel, stained with SyberSafe 
and band intensities were quantified with MultiGauge software (Fujifilm) relative to an actin control; RNAi 
triggers are indicated below the bars; horizontal red line indicates no change compared to a dsRed RNAi 
control 
Right panel: qPCR from total cDNA preparations of S2 cells; qPCR primers for total loqs were used; 
expression was normalized to a 2S control; horizontal red line indicates no change compared to a dsRed 
RNAi control; values are represented as mean ± SD (n=3). 
 
maining isoforms, then additional RNAi against Loqs-PB should lead to more pronounced 
depletion of total loqs. Indeed, qPCR data showed significantly reduced loqs expression after 
loqs-RB+RC treatment (Figure 8D, second panel). Both methods demonstrated that, 
consistent with findings on protein level, more total loqs cDNA remained after treatment 
with the 5´UTR trigger than with the loqs-ORF dsRNA (Figure 8D).  
Together, my isoform-specific RNAi constructs are selective and deplete targeted mRNAs 
and corresponding proteins effectively, without interfering with the expression of remaining 
isoforms. 
 
6.3 A cell culture reporter system for endo-siRNA silencing activity 
In order to study the endo-siRNA pathway in cell culture with an easily visible and 
quantifiable readout I re-examined the GFP reporter cell lines in our laboratory stock. The 
reasoning was that some of the canonical features of transposable elements, such as 
multicopy insertion and the formation of repetitive regions, are shared by transgenes that 
have integrated into the host cell genome after transfection and selection of stable cell 
culture lines. Indeed, Ago2-dependent repression of a stably integrated GFP expression 
plasmid in Drosophila cells has been described (Saito et al., 2005).  
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Several GFP-based reporter cell lines were derived from S2 cells transfected with a plasmid 
(pKF63; see Appendix 3) encoding an Enhanced Green Fluorescent Protein (EGFP) transgene 
under the control of a two kilobase ubiquitin promotor and a downstream SV40 
polyadenylation signal (Figure 9A). The additional ampicillin resistance gene allows for 
bacterial selection. The pKF63 plasmid was co-transfected with an antibiotic resistance 
vector (pHSneo for G418 neomycin resistance) to allow selection of stable, green fluorescent 
cells. Stable cells were diluted to isolate clonal lines, each derived from a single cell (Figure 
9B). In our cell culture stock we had two clonal lines prepared by Klaus Förstemann with 
comparatively low (63-6) and intermediate (63N1) levels of GFP fluorescence. The 
hypothesis was that in both lines endo-siRNAs from the high-copy GFP transgene would 
cause a certain degree of silencing of GFP mRNAs. This would lead to visible changes in 
fluorescence levels when the efficacy of endo-siRNA silencing changed. 
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Figure 9:
A) 10.8 kb pKF63 expression construct (Forstemann et al., 2005); a 2 kb ubiquitin promoter drives expression 
of enhanced GFP (EGFP); the SV40 poly-A signal was added downstream of the GFP into the Multiple 
Cloning Site (MCS); ampicillin resistance gene for bacterial selection; restriction enzymes used for cloning 
are indicated  
 The endo-siRNA cell culture reporter 
B) The endo-siRNA reporter system is based on transfection of a GFP expression construct together with an 
antibiotic resistance plasmid (pHSneo) to allow for selection of stable transformants, followed by selection 
of stable, single-cell derived clones; the two cell lines analyzed in this thesis are indicated below the 
cartoon drawing of the 96-well plate 
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I tested whether the 63N1 cell line could serve as a cell culture reporter for endo-siRNA 
silencing by measuring the GFP levels after RNAi against small RNA silencing components 
(Figure 10A). From the three RNaseIII-enzymes Drosha, Dcr-1 and Dcr-2, only the latter 
appeared to be involved in repression of GFP. Depletion of the cytoplasmic dsRBD-protein 
Loqs also resulted in a de-repression of GFP, while depletion of its homolog R2D2 appeared 
to increase repression. Finally, Ago2 is the main effector protein mediating this response, 
although depletion of Ago1 also resulted in a slight de-repression (Figure 7A). These are 
precisely the genetic requirements of the endo-siRNA pathway in Drosophila (Czech et al., 
2008; Kawamura et al., 2008; Okamura et al., 2008b). With the endo-siRNA cell culture 
reporter system and the newly established isoform-specific RNAi I had the tools to 
determine the roles of individual Loqs isoforms in endo-siRNA dependent silencing. 
 
6.4 Loqs-PD is essential for silencing high-copy transgenes  
Employing isoform-specific knock-downs in the 63N1 cell line I saw that GFP fluorescence did 
not change upon depletion of loqs-RC alone, while targeting loqs-RA+RB+RC (compare loqs-
3´UTR) even caused hyper-repression of the reporter (Figure 10B). In contrast, specific 
targeting of loqs-RD as well as targeting loqs-RD and loqs-RC together led to an even 
stronger de-repression than knock-down of all loqs variants. Thus, Loqs-PD appears to be 
required for repetitive-element-derived endo-siRNA silencing in our artificial reporter.  
If Loqs-PD is not only necessary but sufficient for endo-siRNA silencing, it should be able to 
rescue the effect of RNAi against all endogenous isoforms. Endo-siRNA reporter cells were 
treated with loqs-5´UTR dsRNA and transfected with expression constructs for myc-tagged 
Loqs-PB, -PA or the genomic Loqs-PD construct, none of which is targeted by the RNAi 
trigger against endogenous loqs. Only Loqs-PD expression could revert the de-repression of 
the reporter caused by RNAi (Figure 10C). However, Western blotting showed only a 20-35% 
reduction of endogenous Loqs so that over-expression alone could account for the observed 
effect on the endo-siRNA cell culture reporter (compare below).  
To optimize the readout of the reporter I roughly determined the kinetics of RNAi against 
loqs isoforms (Figure 10D). The amplitude of the reporter reaction is dependent on the 
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amount of Loqs-PD protein. De-repressive effect of loqs-ORF and hyper-repressive effect of 
loqs-RB+RC treatment increased continually during the five day assay. All RNAi experiments 
were therefore assayed after a 5-6 day interval. 
 
 
Figure 10: Loqs-PD is essential for endo-siRNA dependent silencing of stably integrated transgenes (legend 
continued on p. 71) 
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(legend Figure 10 continued) 
A) Individual components of small RNA silencing pathways were depleted via RNA interference to define the 
genetic requirements for GFP repression in the 63N1 cell culture reporter; RNAi triggers are indicated 
below the bars; the control dsRNA was directed against DsRed; values are represented as mean ± SD (n=3); 
the horizontal red line marks no change compared to the control 
B) Effects of isoform-specific RNAi experiments on the GFP-expression in the 63N1 cell culture reporter; RNAi 
triggers are indicated below the bars; values represent the mean ± SD (n=3); the horizontal red line marks 
no change compared to the control 
C) Loqs-PD is sufficient to rescue knock-down of endogenous Loqs; the endo-siRNA reporter cell line was 
treated with RNAi against the 5´UTR of all endogenous loqs isoforms and transfected with plasmids for 
expression of myc-tagged Loqs-PA, -PB and the genomic expression construct for myc-Loqs-PD; values 
represent the mean ± SD (n=3); the horizontal red line marks no change compared to the mock-transfected 
control; table shows efficiency of endogenous Loqs depletion on protein level: Western blots from protein 
extracts were probed with α-Loqs antibody and band intensities of individual isoforms were quantified 
using MultiGauge software (Fujifilm) and normalized to a tubulin loading control. Depletion efficiency of 
endogenous Loqs isoforms was determined by comparing the loqs-5´UTR sample to a mock control. 
D) Kinetics of endo-siRNA reporter reaction after isoform-specific RNAi treatment; RNAi triggers are indicated 
below the bars; the horizontal red line marks no change compared to dsRed control; a single experiment is 
shown 
 
6.5 Loqs-PD is essential for biogenesis of hairpin-derived endo-siRNAs 
In order to test whether Loqs-PD is required for naturally occurring endo-siRNAs as well, I 
depleted individual Loqs protein isoforms in S2 cells and then measured the levels of an 
endo-siRNA derived from the long hairpin-forming gene CG4068 by Northern blotting (Czech 
et al., 2008; Kawamura et al., 2008; Okamura et al., 2008b). Only depletion of the loqs-RD 
transcript correlated with a reduced production of the CG4068 B endo-siRNA (Figure 11A), 
while the biogenesis of the bantam miRNA was not impaired when loqs-RD was targeted. 
Depletion of all other isoforms (loqs-3´UTR) might even enhance endo-siRNA biogenesis 
(Figure 11A, B). Knock-down of another factor associated with endo-siRNA silencing, Dcr-2, 
similarly reduced biogenesis of the CG4068 B endo-siRNA, indicating that Dcr-2 and Loqs-PD 
are equally important in the process (Figure 11B). As expected, depletion of the Loqs-PB 
isoform (compare loqs-5´UTR, loqs-ORF and loqs-3´UTR) led to accumulation of pre-bantam, 
indicating impaired miRNA biogenesis (Figure 11A). Similarly, depletion of Dcr-1, the 
RNAseIII enzyme for miRNA biogenesis, affected biogenesis of both bantam and miR-277 
(Figure 11B). CG4068 B levels, on the other hand, appeared increased, comparable to loqs-
3´UTR treatment. Ago1 depletion only decreased the stability of mature bantam, since both 
endo-siRNAs and miR-277 are preferentially loaded into Ago2 RISC complexes (Figure 11B; 
Förstemann, 2007; Czech et al., 2008; Kawamura et al., 2008). Northern blot data were 
verified by qPCR with primers for CG4068 (Figure 11C). While both total Loqs and Dcr-2 
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depletion reduced CG4068 expression levels by more than 50%, loqs-3´UTR RNAi indeed 
caused higher expression levels of the hairpin-derived endo-siRNA. This suggests that 
efficiency of endo-siRNA silencing is directly correlated with the level of Loqs-PD, while other 
isoforms may have an inhibitory effect. 
 
 
Figure 11:
A) Northern blot after Loqs isoform-specific RNAi in Drosophila S2 cells; RNAi triggers are indicated; dsRed 
RNAi served as a control; probes against the hairpin-derived endo-siRNA (called CG4068 B in Okamura et 
al., 2008b) and the bantam miRNA were used; pre-bantam marks the accumulation of un-diced precursor; 
2S rRNA served as a loading control 
 Loqs-PD is essential for biogenesis of hairpin-derived endo-siRNAs 
B) Northern blot after RNAi against components of small RNA silencing pathways in Drosophila S2 cells; RNAi 
triggers are indicated; dsRed RNAi served as a control; probes against the CG4068 B as well as bantam and 
miR-277 miRNAs were used; pre-miRNA marks the accumulation of un-diced precursor; 2S rRNA served as 
a loading control 
C) qPCR analysis of CG4968 B expression after depletion of small RNA silencing components; qPCR primers for 
CG4068 B were used; expression is normalized to a 2S-1 control; horizontal red line indicates no change 
compared to a dsRed RNAi control; values are represented as mean ± SD (n=3) 
 
Results 
 
 
73 
6.6 Loqs-PD-specific antibody 
The Loqs-PD-specific sequence not only makes the loqs-RD mRNA amenable to isoform-
specific RNAi, but can act as an epitope for antibody recognition. I ordered immunization of 
rabbits with the 22 amino acid peptide that is unique to the Loqs-PD isoform. The specificity 
of the affinity-purified antibodies was confirmed in Western blotting after isoform-specific 
RNAi of endogenous loqs (Figure 12A, first panel). The antibody also detected overexpressed 
and recombinant Loqs-PD (Figure 12A, second panel) and could recognize the PD-specific 
domain in a fusion protein with GFP (Figure 12B). Results were comparable for antibody 
samples from two different rabbits (data not shown) and both samples could be used for co-
immunoprecipitation experiments as well. 
 
 
Figure 12:
A) The PD-specific antibody detects overexpressed and endogenous Loqs-PD 
 Test of affinity-purified PD-specific antibody for specificity 
Left panel: Western blot from S2 cell extract after isoform-specific RNAi; RNAi against dsRed served as a 
control 
Right panel: Western blot from S2 cell extract after transfection with a myc-tagged loqs-PD expression 
construct as well as purified recombinant Loqs-PD protein; the asterisk marks protein degradation 
B) Western blot from S2 cells transfected with myc-tagged GFP-fusion constructs; Loqs-PD-specific antibody 
can detect GFP-PDspec chimaeras; α-myc Western served as a control for expression 
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6.7 Loqs-PD interacts with Dcr-2 in cell culture and flies 
In order for Loqs-PD to act in the biogenesis of endo-siRNAs, it must partner with Dcr-2. Co-
immunoprecipitation of Loqs with Dcr-2 has been described previously (Czech et al., 2008) 
but the antibody employed recognized all Loqs protein isoforms. With the help of cDNA 
constructs coding for only one of the splice variants, I could distinguish Loqs-PA, -PB and -PD 
in transfected S2-cells and determine the potential of each isoform to interact with Dcr-2 by 
co-immunoprecipitation. Epitope-tagged Loqs-PD, just like tagged R2D2, was able to 
associate with Dcr-2 but not with Dcr-1, though the extent of Dcr-2 association varied 
between experiments (Figure 13A-C). This is consistent with the previous observation that 
on the level of the endogenous protein, the smallest Loqs isoform (identified as Loqs-PD in 
this thesis) does not co-immunoprecipitate with Dcr-1 (Forstemann et al., 2005). In contrast, 
tagged Loqs-PB and Loqs-PA can associate with Dcr-1, but also to some extent with Dcr-2. 
Since only Loqs-PD is required for endo-siRNA generation, it appears that the Dcr-2/Loqs-PD 
complex is exclusively responsible for endo-siRNA generation. 
To exclude the possibility that Loqs-PD/Dcr-2 binding is due to an overexpression artifact, I 
used the PD-specific antibody to precipitate endogenous Loqs-PD in untreated S2 cells. This 
resulted in significant co-precipitation of endogenous Dcr-2, indicating strong interaction of 
Loqs-PD and Dcr-2 at endogenous levels (Figure 13D).  
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Figure 13: Dcr-2 preferentially interacts with Loqs-PD (legend continued on p. 76) 
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(legend Figure 13 continued) 
A-C) α-myc co-immunoprecipitation of endogenous Dcr-1 and Dcr-2 from S2 cells expressing myc-tagged Loqs 
isoforms and R2D2. Three independent experiments are shown. Although the extent of association varied, 
Loqs-PD associates preferentially with Dcr-2 (compare red arrow). While some association between Loqs-
PA/-PB and Dcr-2 may also occur, these two isoforms preferentially associate with Dcr-1; R2D2 served as a 
positive control for Dcr-2 interaction; α-myc Western served as a control for co-immunoprecipitation; inp. 
= input; bd. = bound 
D) Co-immunoprecipitation of endogenous Dcr-2 with endogenous Loqs-PD from Drosophila S2 cell extract; α-
Loqs-PD specific antibody was used for IP; rabbit immunoglobulin G (IgG) served as a control; inp. = input; 
bd. = bound 
 
6.8 The PD-specific C-terminus is sufficient for Dcr-2 binding and essential 
for endo-siRNA function 
Since Loqs-PB binding to Dcr-1 is mediated via the C-terminus containing the third dsRBD 
(Forstemann et al., 2005; Ye et al., 2007), I wondered whether the Loqs-PD-specific C-
terminus is sufficient to interact with Dcr-2. I fused the unique sequences of Loqs-PD as well 
as Loqs-PC to GFP and performed anti-GFP immunoprecipitations. A small amount of Dcr-2 
co-precipitated reproducibly in case of the GFP-PDspec fusion (Figure 14A), demonstrating 
that the PD-specific part can be sufficient for interaction with Dcr-2. Nonetheless, this 
interaction is weaker than the one observed with full-length Loqs-PD (Figure 13).  
Since the PD-specific sequence was sufficient for Dcr-2 interaction, I tested whether it was 
required for endo-siRNA dependent silencing. I transfected the endo-siRNA cell culture 
reporter with loqs-PA, -PB and -PC expression vectors. Overexpression of the isoforms not 
known to be involved in endo-siRNA silencing caused an increase in GFP expression (Figure 
14B). Transfection with a version of loqs truncated at the start of the PD-specific amino acids 
resulted in comparable impairment of endo-siRNA silencing, suggesting that this protein is 
non-functional in the endo-siRNA pathway (Figure 14B). Re-addition of the Loqs-PD-specific 
sequence to the truncated Loqs variant to reconstitute Loqs-PD (L1L2+PDspec containing 
two ligation-dependent extra amino acids, glycine and lysine) completely reverted the 
dominant-negative effect (Figure 14B). Taken together, my results indicate that the different 
isoforms of Loqs can compete for binding to Dcr-2 and that the C-terminus of Loqs-PD is 
required for endo-siRNA silencing.  
Initial studies analyzing the genetic requirements for endo-siRNA silencing found no 
necessity for r2d2, a paralog of loqs (Czech et al., 2008; Zhou et al., 2009). R2D2 contains two 
dsRBDs and interacts with Dcr-2 via its C-terminal part (Liu et al., 2003; Ye et al., 2007). I 
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exploited the similar domain architecture of Loqs and R2D2 by swapping either the PD-
specific sequence (PDspec) or the R2D2 C-terminus (RC-term) between the Loqs and R2D2 
scaffolds consisting of the first two dsRBDs (L1L2 and R1R2, respectively; compare schematic 
drawing in Figure 14C). Overexpression of the wild-type proteins had no effect (R2D2) or 
caused slight hyper-repression (Loqs-PD) of the endo-siRNA reporter. In contrast, expression 
of an R1R2+PDspec chimaera resulted in increased GFP expression, indicating that endo-
siRNA mediated silencing had been impaired (Figure 14C, black bars). Apparently, the 
R1R2+PDspec construct is a dominant negative protein that may be able to sequester endo-
siRNA pathway components such as Dcr-2 but cannot functionally substitute Loqs-PD. The 
truncated form of Loqs (L1L2) led to a two-fold de-repression of the endo-siRNA reporter 
(Figure 14C, black bars). Interestingly, an L1L2+RC-term chimaera impaired endo-siRNA 
silencing to a lesser extent, indicating that the Dcr-2 binding element from R2D2 can partially 
substitute the Loqs-PD-specific sequence. 
I observed a distinct reaction to the overexpressed proteins with a miRNA reporter system, 
where the GFP mRNA contains two perfect binding sites for miR-277 (Figure 14C, white 
bars). This reporter is silenced by Ago2-loaded miR-277, a process which depends on the 
Dcr-2/R2D2 RISC loading complex (Förstemann, 2007). In these cells the R1R2+PDspec 
construct is functional, presumably because the PD-specific sequence can substitute the 
native C-terminus and mediate association with Dcr-2. On the other hand, Loqs-PD 
overexpression impairs miR-277 dependent GFP-silencing, indicating that Loqs-PD cannot 
substitute R2D2 in the miR-277 programmed RISC loading complex (Figure 14C, white bars). 
I tried to express myc-tagged Loqs-PD-specific sequence alone for potential interaction 
studies and reporter assays. However, neither Western blotting nor dot blotting allowed 
detection of the isolated PD-specific sequence (Figure 14D). Since the sequencing data for 
the expression construct verified correct cloning, this may indicate degradation of the 
peptide. 
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Figure 14: Dcr-2 interacts with the C-terminal 22 amino acids specific to Loqs-PD (legend continued on p. 79) 
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(legend Figure 14 continued) 
A) Western blot after co-immunoprecipitation of endogenous Dcr-2 with GFP-fusion constructs in S2-cells; 
blot was stripped and re-probed for α-GFP to confirm expression and immunoprecipitation; inp. = input; 
bd. = bound 
B) Effect of Loqs isoform overexpression on GFP expression levels of the endo-siRNA cell culture reporter 
(Loqs-PA, -PB and -PC contained an N-terminal myc-tag); protein isoforms are depicted on the right 
(dsRBDs are represented by brown symbols; Loqs-PC-specific sequence is colored in blue, Loqs-PD-specific 
sequence in red); measurement values represent the mean ± SD (n=3) and were normalized to a pUC18 
transfected control (red line) 
C) Effect of third domain swaps between Loqs (L1L2) and R2D2 (R1R2) scaffolds on GFP expression levels of 
the endo-siRNA cell culture reporter (black bars) and the miR-277 perfect match reporter (white bars; 
Förstemann, 2007); protein isoforms are depicted on the right (dsRBDs are represented by brown symbols 
for Loqs, green symbols for R2D2; Loqs-PD-specific sequence is colored in red, the R2D2 C-terminus is 
colored in green); measurement values represent the mean ± SD (n=3) and were normalized to a pUC18 
transfected control (red line) 
D) Test for expression of myc-tagged PD-specific sequence; 
Left panel: α-myc Western blot of 63N1 cell extract transfected with expression constructs for myc-tagged 
PD-specific sequence or Loqs-PD C-terminus; no band for the PD-specific peptide could be detected; 
endogenous myc-GFP from 63N1 cells served as a loading control; molecular weight marker indicated on 
the left 
Right panel: Dot blot for expression of myc-PD-spec; S2 cells were transfected with 50 ng or 500 ng of myc-
tagged Loqs-PA/-PB or PD-spec peptide; pUC18 and mock transfection served as controls; protein extracts 
were spotted on a nitrocellulose membrane and probed for expression with α-myc antibody 
 
 
6.9 Loqs-PD interacts with the N-terminal helicase domain of Dcr-2 during 
endo-siRNA biogenesis 
My results suggest that the 22 amino acids unique to Loqs-PD convey its binding capacity for 
Dcr-2 and an essential part of its functionality during endo-siRNA silencing. I therefore 
proceeded to characterize the corresponding interaction domain in Dcr-2. Dcr-2 contains 
two N-terminal helicase domains, a Domain of Unknown Function (DUF) and a central PAZ 
domain. Two endonucleolytic RNAseIII domains and a dsRBD are situated at the C-terminus 
(Figure 15A). Recently, an EM-model proposed an L-shaped arrangement for human Dicer 
with the catalytic domain residing in the long branch (Lau et al., 2009; Wang et al., 2009). 
The N-terminal DExH/D helicase domain of human Dicer, situated in the short branch of the 
structure, mediates binding to the mammalian Loqs homologue TRBP (Haase et al., 2005; 
Lau et al., 2009; Wang et al., 2009). I therefore tested if Drosophila Dcr-2 also interacts 
through its N-terminal helicase domain with Loqs-PD by co-expressing Flag-tagged Dcr-2 
with GFP+PDspec/+PCspec fusions in S2 cells. Full-length Dcr-2 efficiently co-precipitated 
with the GFP+PDspec fusion proteins, corroborating the observations for endogenous Dcr-2 
(Figure 15B). When I substituted the full-length Flag-Dcr-2 with a construct lacking the N-
terminal helicase region (∆1-551 = ∆hel; compare arrow in Figure 15A), GFP+PDspec failed to 
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enrich Δhel-Flag-Dcr-2 in comparison to the input and showed only marginally higher levels 
than background binding observed for myc-GFP alone (Figure 15A). Similarly, both Loqs-PD 
and R2D2 recovery were almost completely lost when Δhel-Flag-Dcr-2 was 
immunoprecipitated (Figure 15C). Taken together, the helicase domain of Dcr-2 is required 
for interaction with both Loqs-PD and R2D2. Note that co-expression of either R2D2 or Loqs-
PD appears to stabilize Dcr-2; mutual in vivo stabilization has been reported previously for 
both the R2D2/Dcr-2 pair (Liu et al., 2003) and for the Loqs-PB/Dcr-1 complex (Forstemann 
et al., 2005; Liu et al., 2007). 
Further co-immunoprecipitation experiments confirmed a clear functional distinction 
between the Loqs-PB C-terminus, which encompasses the third dsRBD and thus mediates 
the interaction with Dcr-1 (Forstemann et al., 2005; Ye et al., 2007) and the Loqs-PD-specific 
C-terminus. Figure 15D shows that the Loqs-PD C-terminus can neither interact with the full-
length Flag-Dcr-2, nor with the overexpressed ∆hel-Flag-Dcr-2. Interaction of both R2D2 and 
Loqs-PD with Flag-Dcr-2 but not ∆hel-Flag-Dcr-2 was confirmed (Figure 15D). 
I tested whether a Δhel-Flag-Dcr-2 protein had a dominant-negative effect on endo-siRNA 
biogenesis by transfecting the endo-siRNA cell culture reporter with either the full-length 
form of Flag-Dcr-2 or the Δhel-Flag-Dcr-2 construct. Transfection of truncated Dcr-2 resulted 
in an approximately twofold increase in reporter fluorescence (Figure 16A). Simultaneous 
overexpression of Loqs-PD could not counteract this dominant-negative effect, whereas 
RNAi against R2D2 reduced the effect of Δhel-Flag-Dcr-2 overexpression (Figure 16B). This is 
consistent with an antagonistic relation between R2D2 and Loqs-PD. 
miR-277 is processed by the typical miRNA biogenesis factors Dcr-1 and Loqs, but loaded 
mainly into Ago2 complexes by the canonical siRNA RLC consisting of Dcr-2 and R2D2 
(Förstemann, 2007). Figure 16B and C show the effects of Flag-Dcr2 and ∆hel-Flag-Dcr-2 in 
the miR-277 perfect match reporter cell line. Unlike the endo-siRNA reporter, the miR-277 
perfect match reporter does not show a significant difference between overexpression of 
full-length or truncated Flag-Dcr-2. This is consistent with previously published results, 
showing that a point mutation in the helicase region of Dcr-2, which prevented dicing but 
not loading, did not have an effect on the miR-277 perfect match reporter system 
(Förstemann, 2007). 
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Figure 15: Loqs-PD interacts with the N-terminal helicase domain of Dcr-2 for endo-siRNA silencing (legend 
continued on p. 82) 
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(legend Figure 15 continued) 
A) Domain architecture of Drosophila Dcr-2; blue ovals mark the two DExH/D helicase motifs that are deleted 
in the ∆hel-Flag-Dcr-2 protein; the arrow indicates the position of the forward primer used for cloning the 
truncated version; DUF = Domain of Unknown Function (probably a double-stranded RNA binding motif); 
PAZ = “Piwi, Aubergine, Zwille” domain, binds small RNA precursor; RNAse = two RNAseIII type 
endonycleolytic domains for cleavage of siRNA precursors; dsRBD = double-stranded RNA binding domain 
B) Co-immunoprecipitation from Drosophila S2 cell extract co-expressing GFP-fusion proteins together with 
either Flag-Dcr-2 or Δhel-Flag-Dcr2; the GFP proteins in this experiment also contained an N-terminal myc-
tag that was used for detection, but GFP-trap beads were used for immunoprecipitation; due to the high 
amount of immunoprecipitated proteins, some bands in the α-myc Western appear “hollow” because of 
ECL substrate depletion 
C) Co-immunoprecipitation from Drosophila S2 cell extract co-expressing myc-tagged Loqs-PD, R2D2 or a 
pUC18 control together with either Flag-Dcr-2 or Δhel-Flag-Dcr-2; α-Flag agarose was used for IP; myc-GFP 
served as a control 
D) Co-immunoprecipitation from Drosophila S2 cell extract co-expressing myc-tagged Loqs isoforms, the Loqs-
PB C-terminus, R2D2 or a pUC18 control together with either Flag-Dcr-2 or Δhel-Flag-Dcr-2; α-myc 
antibody was used for IP; α-Flag antibody was used for Western 
 
 
 
(Legend Figure 16; see next page) 
(A-B) Effect on 63N1 endo-siRNA cell culture reporter, (C-D) effect on miR-277 perfect match reporter 
A) Effect of Flag-Dcr-2 (black bars) and Δhel-Flag-Dcr-2 (white bars) overexpression on GFP fluorescence of 
the endo-siRNA cell culture reporter; Dcr-2 construct expression was combined with Loqs-PD co-
expression or an untransfected control 
B) Effect of Flag-Dcr-2 (black bars) and Δhel-Flag-Dcr-2 (white bars) overexpression on GFP fluorescence of 
the endo-siRNA cell culture reporter; Dcr-2 construct expression was combined with RNAi against either 
mRNAs of Loqs-PD, R2D2 or a control (dsRed) 
C) Effect of Flag-Dcr-2 (black bars) and Δhel-Flag-Dcr-2 (white bars) overexpression on GFP fluorescence of 
the miR-277 perfect match cell culture reporter; Dcr-2 construct expression was combined with Loqs-PD 
co-expression or an untransfected control 
D) Effect of Flag-Dcr-2 (black bars) and Δhel-Flag-Dcr-2 (white bars) overexpression on GFP fluorescence of 
the miR-277 perfect match cell culture reporter; Dcr-2 construct expression was combined with RNAi 
against either mRNAs of Loqs-PD, R2D2 or a control (dsRed) 
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Figure 16: Effect of ∆hel-Flag-Dcr-2 overexpression on endo-siRNA and miR-277 perfect match reporter cell 
lines (legend continued on p. 82) 
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6.10 R2D2 acts as an antagonist of Loqs-PD in endo-siRNA silencing 
A possible explanation for the antagonistic behavior of Loqs and R2D2 is competition for 
binding to Dcr-2, thereby committing the enzyme to either the endo-siRNA or the exo-siRNA 
pathway. Reduced co-precipitation of both Loqs-PD and R2D2 with the Δhel-Flag-Dcr-2 
construct (Figure 15C) substantiates this hypothesis as both proteins seem to interact with 
the helicase region of Dcr-2 (Ye et al., 2007; Lim do et al., 2008). Binding of Loqs-PD and 
R2D2 should be mutually exclusive if the same binding site is used; alternatively, Loqs-PD 
and R2D2 could simultaneously bind Dcr-2 but induce different conformations.  
A recent finding by the Siomi lab (Miyoshi et al., 2010) reports a small amount of R2D2 
association together with the Loqs-PD/Dcr-2 complex. I co-expressed a Flag-myc-tagged 
version of the genomic Loqs-PD construct (compare Figure 6A) together with myc-tagged 
Loqs isoforms or R2D2 in S2 cells. Upon α-Flag IP I recovered a minor amount of myc-R2D2 
associated with Flag-myc-Loqs-PD (Figure 17A, first panel). To reduce the effects of 
overexpression, I used the PD-specific antibody to precipitate endogenous Loqs-PD. 
Association of overexpressed R2D2 with endogenous Loqs-PD was barely detectable (Figure 
17A, second panel). Co-precipitation of endogenous R2D2 after PD-specific IP was difficult to 
analyze, since R2D2 and the antibody light chain migrated closely together (Figure 17B). As 
the amount of R2D2 that co-precipitated with Loqs-PD was sub-stoichiometric even when 
overexpressed, I favor the hypothesis that binding of Loqs-PD and R2D2 to Dcr-2 is mutually 
exclusive. 
To test whether the competition between Loqs-PD and R2D2 can be observed at the level of 
endo-siRNA biogenesis, I treated S2 cells with RNAi against combinations of Loqs isoforms 
together with R2D2. Subsequently, I isolated RNA and probed Northern blots for the long 
hairpin-derived endo-siRNA CG4068 B, as well as bantam and miR-277. As indicated before 
(Figure 11A, B), I observed impaired endo-siRNA biogenesis of CG4068 B after treatment 
with the loqs-ORF RNAi construct against all Loqs isoforms and – even more pronounced – 
with dsRNA against Loqs-PD specifically (Figure 17C). Simultaneous knock-down of R2D2 led 
to higher levels of mature endo-siRNA in all combinations. The simplest explanation for this 
effect is that depletion of R2D2 allows more efficient processing of the long hairpin endo-
siRNA precursor by the Loqs-PD/Dcr-2 complex.  
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Figure 17: R2D2 minimally associates with Dcr-2 and Loqs-PD and acts as an inhibitor of Loqs-PD in endo-
siRNA silencing (legend continued on p. 86) 
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(legend Figure 17 continued) 
A) Top panel: Co-immunoprecipitation from Drosophila S2 cell extract co-expressing myc-Loqs isoforms or 
R2D2 together with Flag-myc-Loqs-PC/-PD; α-Flag antibody was used for IP; myc-GFP served as a control; 
note that Flag-myc-Loqs-PD migrates at the same height as myc-Loqs-PB 
Bottom panel: Co-immunoprecipitation from Drosophila S2 cell extract prepared after transfection of myc-
tagged Loqs isoforms or myc-tagged R2D2; α-Loqs-PD-specific antibody was used to immunoprecipitate 
endogenous Loqs-PD; myc-GFP served as a control 
l.c. = antibody light-chain 
B) Co-immunoprecipitation from Drosophila S2 cell extract expressing myc-Loqs isoforms; α-myc antibody 
was used for IP; myc-GFP served as a control; endogenous R2D2 was detected with polyclonal α-R2D2 
antibody; red arrow and red square indicate faint band of possible R2D2 co-precipitation above the 
antibody light-chain band in the Loqs-PD bound fraction 
C) Northern blot from Drosophila S2 cell extract after RNAi treatment with combinations of Loqs isoforms and 
R2D2; DsRed dsRNA served as a control for RNAi; a DNA probe against the long hairpin-derived endo-siRNA 
CG4068 B and 2´-OMe oligonucleotide probes against bantam miRNA and miR-277 were used; 2S rRNA 
served as a control for loading 
D) Effect of RNAi treatment with combinations of Loqs isoforms and R2D2 on GFP expression of the endo-
siRNA cell culture reporter; double-stranded RNA directed against DsRed served as a control, RNAi triggers 
are indicated below the bars; measurement values represent the mean ± SD (n=3) and were normalized to 
a DsRed/DsRed control (red line); asterisk: p<0.005 (two-tailed t-Test, unequal variance) 
 
I then tested whether enhanced biogenesis of endo-siRNAs led to improved endo-siRNA 
silencing in the 63N1 cell culture reporter. Figure 17D shows that this is indeed the case, 
indicating that my observation is true for long hairpin- as well as transgene-derived endo-
siRNAs. RNAi against R2D2 had no significant effect on the reporter if Loqs-PD levels were 
unaltered (RNAi against the 3’UTR or DsRed control). However, simultaneous R2D2 depletion 
could reduce the impairment of endo-siRNA silencing caused by Loqs-PD depletion (RNAi 
against all Loqs isoforms or Loqs-PD), indicating that the ratio of Loqs-PD and R2D2 in the 
cell can influence the efficiency of endo-siRNA silencing.  
 
6.11 The role of Loqs-PD in exo-siRNA silencing 
My experiments indicate that R2D2 is not required for endo-siRNA dependent silencing in S2 
cells but rather acts as a competitor of Loqs-PD. This is consistent with previous cell culture 
studies (Czech et al., 2008; Ghildiyal et al., 2008; Kawamura et al., 2008; Okamura et al., 
2008a; Okamura et al., 2008b; Zhou et al., 2009) but inconsistent with results from a recent 
study conducted in mutant fly tissue (Marques et al., 2010). They propose, that Loqs-PD is 
necessary for processing of both exo-siRNAs and endo-siRNAs and that a common Dicer-
2/R2D2 RLC exists to funnel precursors into Ago2 RISCs. Given the obvious discrepancy for 
the R2D2 role in endo-siRNA silencing between flies and S2 cells, I looked for evidence of 
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Loqs-PD involvement in exo-siRNA biogenesis in cell culture. S2 cells were treated with RNAi 
triggers against small RNA silencing components. To visualize exo-siRNA silencing efficiency 
cells were then soaked with dsRNA against GFP or a control and transfected with the pKF63 
expression construct for myc-GFP (Figure 18A). Priming of Ago2 RISCs with dsGFP will 
decrease in efficiency, if the first knock-down depletes an essential component for exo-
siRNA silencing. This will result in higher GFP levels after pKF63 transfection. GFP levels were 
efficiently repressed to 3% in dsGFP treated cells compared to the control, if non-essential 
components were targeted in the first step (Figure 18B; compare luciferase RNAi). Depletion 
of the canonical exo-siRNA pathway components Dcr-2 and Ago2 reduced the efficiency of 
exo-siRNA silencing, resulting in a GFP fluorescence of 25% or 35% compared to the control. 
This indicates that the assay can be used for exo-siRNA silencing analysis. Of the two dsRBDs, 
r2d2 RNAi impaired exo-siRNA silencing (10% compared to control), although the effect was 
not as pronounced as for dcr-2 or ago2. Loqs-PD depletion, on the other hand, slightly but 
significantly enhanced silencing of GFP (p < 0.005). Taken together the reporter suggests 
that R2D2 enhances exo-siRNA silencing while Loqs-PD is not required and may even act as 
an inhibitor of R2D2 function.  
Previously, a non-canonical RNA-dependent RNA-polymerase (RdRP) was observed by 
biochemical evidence in Drosophila and recently identified as D-elp-1, a subunit of the PolII 
elongator complex (Lipardi et al., 2001; Lipardi et al., 2009). RdRP activity in other organisms 
is known to produce secondary siRNAs (Simmer et al., 2002; Pak et al., 2007; Sijen et al., 
2007). However, no other study has so far observed any evidence for secondary siRNAs or 
spreading of siRNA responses in Drosophila melanogaster. Therefore I included RNAi against 
D-elp-1 in the experiment but could not observe a significant decrease of siRNA silencing 
efficiency after depletion of D-elp-1. Thus, I could not confirm any RdRP-like activity of D-elp-
1 in my reporter system. However, efficiency of RNAi against D-elp-1 cannot be tested in 
Western blotting, since there is no commercially available antibody for D-elp-1 detection. 
Efficiency of RNAi against D-elp-1 might be assessed on the mRNA level by quantitative PCR.  
 
Results 
 
 
88 
 
 
Figure 18:
A) Flow diagram for exo-siRNA silencing assay; S2 cells were treated twice by RNAi against small RNA silencing 
factors; Ago2 RISCs were then primed with RNAi triggers against gfp or a luciferase control and transfected 
with an expression plasmid for GFP (pKF63); GFP levels were measured by flow cytometry 
 Loqs-PD is not necessary for exo-siRNA dependent silencing 
B) Effect of R2D2 and Loqs-PD on the exo-siRNA silencing assay; RNAi triggers are indicated below the bars; 
GFP fluorescence relative to a control treated with dsRNA against luciferase in the 2nd step of RNAi; the red 
bar marks GFP levels if the exo-siRNA silencing system is unaltered; ** p<0.005, * p<0.02 (two-tailed t-Test, 
unequal variance) 
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6.12 Multimerization and competition of Loqs isoforms for Dcr-2 binding 
As shown in Figure 14B, overexpression of other Loqs isoforms leads to impaired endo-siRNA 
silencing. By transfecting endo-siRNA reporter cells with increasing amounts of Loqs 
isoforms or only the Loqs-PB C-terminus (encompassing the third dsRBD of Loqs-PB), I tested 
for a correlation between the amount of transfected expression plasmid and an increase in 
GFP-expression (Figure 19A). The expression of the Loqs-PB C-terminus, which is responsible 
for Dcr-1 interaction, did not have a significant influence on the reporter, nor did Loqs-PD. In 
contrast, I saw a strong correlation between the quantity of transfected Loqs-PA or -PB with 
impaired endo-siRNA silencing. The effect of Loqs-PC was considerably weaker; this may 
however be due to lower expression levels of the construct (see Appendix 4). The de-
repression of the reporter was not influenced by the epitope tag, since transfection with 
Flag-myc-tagged constructs caused a comparable effect in the endo-siRNA cell culture 
reporter (Figure 19B). Moderate overexpression levels of Loqs-PD here even lead to 
hyperrepession of GFP levels. Could the dominant-negative effect be explained by 
multimerization of overexpressed Loqs isoforms together with endogenous Loqs-PD and the 
formation of dsRBP complexes unsuitable for silencing? I overexpressed Flag-myc-Loqs-PB 
together with myc-tagged Loqs isoforms or R2D2 and analyzed the bound fraction after α-
Flag-IP (Figure 19C, left panel). While recovery of Loqs-PA/-PB/-PC was high, Loqs-PD 
associated only to a moderate extent with Loqs-PB, and R2D2 was not detected in the bound 
fraction at all. The result indicates that overexpressed Loqs isoforms can oligomerize, but 
that R2D2 does not form a complex with Loqs-PB. Analogous co-immunoprecipitation from 
cells expressing the Flag-myc-Loqs-PDgenomic construct yielded a barely detectable amount of 
R2D2 in the bound fraction, as well as considerable Loqs-PA and -PC recovery (Figure 19C, 
right panel; Loqs-PB association was not quantifiable, since myc-Loqs-PB and Flag-myc-Loqs-
PD migrate together).  
To further analyze the association of myc-tagged Loqs variants with Loqs-PD I used the Loqs-
PD-specific antibody to precipitate endogenous Loqs-PD (see Figure 17A, bottom panel). The 
result confirmed the finding that an interaction of Loqs-PD with all other isoforms as well as 
R2D2 in Drosophila S2 cells is at least possible. However, these interactions may have been 
forced by overexpression and might be indirect. I therefore tested for oligomerization of 
Loqs-PD and other Loqs-isoforms at endogenous levels by immunoprecipitation with our 
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Loqs-PD specific antibody, followed by Western blotting with α-Loqs monoclonal antibody. 
This did not reveal any significant recovery of Loqs-PB or Loqs-PA associated with Loqs-PD 
(Figure 19D, α-Dcr-1 IP was used as a control to mark Loqs-PB precipitation). Taken together, 
my experiments indicate that endogenous Loqs-PD does not form complexes with other 
Loqs isoforms to a significant extent but can be induced to do so upon overexpression. 
If overexpression of other isoforms impairs endo-siRNA silencing on the level of Loqs-
PD/Dcr-2 association, then endo-siRNA biogenesis should be disturbed. Loqs-PD 
overexpression from both cDNA- and genomic DNA-derived expression constructs did not 
change the levels of the long hairpin-derived endo-siRNA CG4068 B. Expression of full-length 
myc-Loqs-PB/-PA or Loqs-PC (either full-length or reconstituted L1L2+PCspec) led to a 
reduction of mature CG4068 B (Figure 19E). In accordance with my reporter cell experiments 
(Figure 14B, C) truncated Loqs, lacking only the PD-specific amino acid sequence (L1L2), 
caused the same impairment of long hairpin endo-siRNA biogenesis as the Loqs-PC isoform 
(Figure 19E). In summary, multimerization induced by overexpression of individual Loqs 
isoforms perturbs the balance of the other, endogenous dsRBD-proteins and impairs the 
function of the small RNA silencing system.  
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Figure 19: Multimerization and competition of Loqs isoforms for Dcr-2 binding (legend continued on p. 92) 
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(legend Figure 19 continued) 
A) Correlation of GFP fluorescence increase in the endo-siRNA cell culture reporter with the amount of 
transfected plasmid; the transfected myc-tagged construct is indicated below the bars; cells were 
transfected with 10 ng, 25 ng, 50 ng, 75 ng and 100 ng of the respective expression plasmid; the values 
were normalized to a pUC18 control (red line); Loqs-PB C-term. = expression construct for the 3rd  dsRBD of 
Loqs-PB 
B) Effect of Flag-myc-tagged Loqs-isoforms on the endo-siRNA cell culture reporter; transfected plasmids are 
indicated below the bars; mock-transfection (red horizontal line) and an expression construct for the Flag-
tag only served as controls; measurement values represent the mean ± SD (n=3) 
C) Left panel: α-myc Western blot after immunoprecipitation of Flag-myc-Loqs-PB from Drosophila S2 cell 
extracts co-expressing myc-Loqs isoforms or myc-R2D2; α-Flag antibody was used for IP; myc-GFP served 
as a control; 
Right panel: α-myc Western blot after immunoprecipitation of Flag-myc-Loqs-PD from Drosophila S2 cell 
extracts co-expressing myc-Loqs isoforms or myc-R2D2; α-Flag antibody was used for IP; myc-GFP served 
as a control; note that Flag-myc-Loqs-PD co-migrates with myc-Loqs-PB during SDS-PAGE; 
bottom panels show a longer exposure to detect faint R2D2 bands; red arrow indicates co-precipitated 
R2D2 
D) Detection of endogenous Loqs protein from S2-cell extract after immunoprecipitation with α-Dcr-1, α-
Loqs-PB C-terminus and α-Loqs-PD; rb IgG and α-R2D2 served as controls; α-Loqs monoclonal antibody was 
used for detection of endogenous Loqs isoforms 
E) Northern blot from Drosophila S2 cell extract overexpressing Loqs isoforms; transfection with pUC18 
served as a control; L1L2 = Loqs truncation lacking the PD-specific amino acid sequence, L1L2+PCspec = 
reconstituted Loqs-PC; myc-loqs-PD (genomic) = expression construct derived from genomic DNA; DNA 
probes against the long hairpin-derived endo-siRNA CG4068 B (Okamura et al., 2008c) and against bantam 
miRNA were used; 2S rRNA served as a control for loading 
 
6.13 Transcriptional vs. post-transcriptional gene silencing 
Endogenous RNA targets of the endo-siRNA pathway become more abundant upon 
depletion of Dcr-2 or Ago2. The simplest interpretation of these results is that endo-siRNAs, 
like exo-siRNAs, induce the post-transcriptional degradation of mRNAs, and this capacity has 
indeed been demonstrated (Chung et al., 2008; Czech et al., 2008; Ghildiyal et al., 2008; 
Kawamura et al., 2008; Okamura et al., 2008b). However, a transcriptional component of 
silencing may be present as well. Transcriptional silencing by chromatin remodeling has 
previously been reported in the yeast S. pombe, mammals and plants (Girard et al., 2008). I 
treated endo-siRNA reporter cells with dsRNA against heterochromatin protein 1 (HP-1) and 
probed for efficient depletion by Western blotting with a HP-1 specific antibody (Figure 20B). 
Since HP-1 is chromatin-associated I used extraction buffers with low and high MgCl2 
conditions but could not detect a significant difference in the extraction efficiency. Even 
after efficient RNAi, however, I could observe no effect on the 63N1 reporter cell line (Figure 
20A). 
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p68/Lip is the Drosophila homolog of the mammalian RNA helicase P68 and was described to 
function in RNA export and rapid removal of transcripts from sites that need chromatin 
remodeling for transcriptional silencing (Buszczak et al., 2006). p68/Lip can be found in a 
complex with Ago2 and is required for efficient RNAi (Ishizuka et al., 2002), hinting at a 
possible transcriptional element of silencing. It can be found in a complex with dFMR1, the 
Drosophila homolog of the human Fragile X Mental Retardation Protein 1 (Ishizuka et al., 
2002). RNAi against FMR1 led to a slight repression of GFP levels (Figure 20A), p68/Lip to a 
slight increase (Figure 20C; 63N1 cell line). Taken together, I could detect no significant 
dependence of endo-siRNA silencing on transcriptional components. 
 
6.14 Comparison between two clonal cell lines: 63-6 and 63N1 
The 63N1 cell line has mounted a bona fide endo-siRNA response against the integrated 
transgene, but the extent to which this occurs varies between clones: As indicated before, 
our laboratory cell culture stock comprises several GFP expressing cell lines derived 
independently from the same stock of parental S2 cells and transfected with the same 
expression plasmid. In a previous publication, the cell line (called 63-6) showed only 
marginal response to depletion of Dcr-2, Loqs and Ago2 (Förstemann, 2007). I re-examined 
this cell line and could corroborate that there is a minor, but significant increase in GFP-
levels upon depletion of Dcr-2 (1.2-fold, ± 0.03, p<0.01; Figure 20C). The level of GFP 
fluorescence is generally higher in the 63N1 cells. This suggests that one potential difference 
between the two cell lines is the number of plasmid copies that have integrated in the 
genome. However, the 63-6 cell line reacted with a strong increase of GFP levels to p68/Lip 
RNAi while the 63N1 line only shows a slight reaction (Figure 20C).  
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Figure 20:
A) Effect of RNAi against factors associated with transcriptional gene silencing in the endo-siRNA cell culture 
reporter; horizontal red line indicates no change compared to a dsRed RNAi control; measurement values 
represent the mean ± SD (n=3) 
 Endo-siRNAs: Transcriptional versus post-transcriptional silencing? 
B) α-HP-1 Western blot to verify efficient depletion of HP-1; α-tubulin Western served as a loading control; 
extraction buffers with normal and high MgCl2 conditions (see Materials 5.1.15) were used 
C) Comparison of RNAi effects in two GFP-expressing cell lines, 63-6 and 63N1; they represent two 
independently derived clones from the same parental cells using the same expression plasmid; RNAi 
triggers are indicated below the bars; measurement values represent the mean ± SD (n=3) normalized 
against a dsRed RNAi control 
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6.15 Loqs-PD associates with Dcr-2 in vivo 
To test whether the role of Loqs-PD for endo-siRNA silencing could be substantiated in vivo I 
created transgenic flies expressing myc-tagged isoforms under the control of the UAS/Gal4-
system. Therefore I sub-cloned myc-tagged Loqs isoforms into pUAST-plasmids and tested 
the constructs in the 63N1 endo-siRNA cell culture reporter. Only upon co-transfection of a 
tubulin-Gal4 driver did the reporter respond with de-repression of GFP fluorescence to both 
pUAST-PC and -PD constructs (Figure 21, left panel). Conditional GFP-expression in S2 cells 
demonstrated functionality of the tubulin-Gal4 driver plasmid (Figure 21A, right panel). I 
confirmed expression in cell culture by Western blotting: Loqs-PC showed only moderate 
expression while Loqs-PD was highly expressed (Figure 21B). The high expression level of 
Loqs-PD may account for the observed de-repression of the 63N1 reporter and is consistent 
with the previously indicated correlation of transfected plasmid and reporter fluorescence 
(Figure 19A). Expression of UAST-Loqs-PA in Western blotting (Figure 21C) and the 63N1 cell 
culture reporter (data not shown) was similarly checked. Loqs-PC and -PD plasmids were 
sent for embryo injection and several homozygous fly lines were recovered (see Results 6.17, 
Table 4). Together with an analogous construct for Loqs-PB (Park et al., 2007), the flies were 
crossed to a tubulin-Gal4 driver-line. Western blotting again detected expression of Loqs-PB, 
-PC and -PD in the resulting offspring flies (Figure 21D), with Loqs-PD being most 
prominently expressed. Co-immunoprecipitation experiments with protein extracts from 
these offspring flies confirmed that myc-tagged Loqs-PD – but not Loqs-PB or -PC – interacts 
with Dcr-2 (Figure 21E). 
 
Results 
 
 
96 
 
 
Figure 21: Expression of Loqs-isoforms under the control of the UAS/Gal4 system (legend continued on p. 97) 
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(legend Figure 21 continued) 
A) Left panel: Effect of UAST-myc-Loqs-PA/-PC/-PD expression constructs co-transfected with (+) or without  
(-) a tubulin-Gal4 driver plasmid into 63N1 cell culture reporter cells  
Right panel: Test of the driver-plasmid by conditional expression of a UAS-myc-GFP plasmid in S2 cells 
Results of a single experiment are shown 
B) Western blot to confirm expression of UAST-myc-Loqs-PC and -PD in 63N1 cell culture cells (+); samples 
without co-expression of Gal4 served as a control (-); α-loqs Western shows degradation products of highly 
expressed UAS-myc-Loqs-PD; myc-GFP expression of the 63N1 cell line was not significantly altered by 
transgene expression 
C) Western blot to confirm expression of UAST-myc-Loqs-PA in 63N1 cell culture cells (+); samples without co-
expression of Gal4 served as a control (-); two different UAST-myc-Loqs-PA clones were transfected; myc-
GFP expression of the 63N1 cell line was not significantly altered by transgene expression; induced UAS-
myc-GFP expression in S2 cells confirmed functionality of the system 
D) Western blot for expression of UAST-myc-Loqs-PC and -PD in transgenic flies; several homozygous 
transgenic lines were crossed with a tubulin-Gal4 driver line and offspring were assayed for transgene 
expression; a previously published UASP-myc-Loqs-PB expression construct (Park et al., 2007) served as a 
control; α-loqs Western shows degradation products of highly expressed UAST-myc-Loqs-PD 
E) Co-immunoprecipitation of endogenous Dcr-2 with myc-tagged Loqs isoforms from transgenic Drosophila 
fly extract; the blot was re-probed with α-myc antibodies to verify successful immunoprecipitation of the 
Loqs proteins; the smaller size bands in the myc-Loqs-PB lane likely represent degradation products; myc-
GFP expressing flies were used as a non-specific control 
 
 
6.16 Loqs-PD is essential for endo-siRNA biogenesis in vivo 
The next step was to analyze the role of Loqs-PD for living animals. A transposon insertion 
mutant of Loqs (loqsf0079; Forstemann et al., 2005) shows reduced expression of all Loqs 
protein isoforms and can be used to approximate the effect of a complete Loqs knock-out 
allele. As could be anticipated, both endo-siRNA and miRNA biogeneses were disrupted in 
loqsf0079 flies (Figure 22B). It has been described previously that Loqs-PB expression in a 
LoqsKO background was sufficient to rescue miRNA biogenesis (Park et al., 2007). However, it 
did not suffice to reconstitute processing of the long hairpin-derived endo-siRNA CG4068 B 
(Figure 22B). In contrast, flies expressing additional Loqs-PD had even higher levels of 
mature endo-siRNA CG4068 B than the wildtype (OrR), while bantam biogenesis was 
unaffected (Figure 22B). Loqs-PC expression did not significantly affect biogenesis of the 
analyzed small RNAs (data not shown).  
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Figure 22: Transgenic flies expressing only the Loqs-PD isoform (legend continued on p. 99) 
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(legend Figure 22 continued) 
A) Mating scheme for recovery of Loqs-PD rescue flies with abbreviated phenotypes (see Materials and 
Methods 5.1.10 and 5.2.5.2.3); virgins of a tubulin-Gal4 driver line (cross 1; marked in red), the Loqs-PB 
rescue line (cross 2; marked in blue) and homozygous UAST-Loqs-PD transgenic flies (cross 3; marked in 
yellow) were mated with male double-balancer flies; offspring from cross 1 and 3 were both mated with F1 
males from cross 2, yielding F2 flies (marked in violet and green); the third generation should produce 
homozygous LoqsKO flies with an active tub-Gal4/UAST-Loqs-PD expression system 
B) Northern blot from Drosophila transgenic fly extract; loqs-PB rescue flies (Park et al., 2007) and Loqs-PD 
expressing offspring from a tubulin-Gal4/UAST-Loqs-PD cross were used; loqsf0079 flies (Forstemann et al., 
2005) have reduced (5-fold in somatic tissue and up to 40-fold in ovaries) Loqs expression levels due to a 
BiggyBac transposon insertion 57 nucleotides upstream of the loqs transcription start site; a DNA probe 
against the long hairpin-derived endo-siRNA CG4068 B and 2´-OMe oligonucleotide probes against bantam 
miRNA and miR-277 were used; 2S rRNA served as a control for loading 
C) Schematic overview over possible offspring in the F3 generation (see A); only relevant chromosomes 2 and 
3 are depicted; upper panel shows possible combinations of phenotypes, lower panel the corresponding 
visible phenotypic markers in the adult fly; crosses mark non-viable individuals with homozygous balancer 
chromosomes; red rectangles mark intended features of F3 offspring 
w+ = gene for red eye color (intensity is additive); CyO = “Curly of Oyster”, curly wings; TM6, Sb, Tb = TM6 
balancer chromosome with Sb (stubble = short thoracic bristles) and Tb (tubby = segmentation phenotype with 
short larval form) as phenotypic markers; “<” represents male Y-chromosome 
 
In a subsequent step I made crosses to obtain a Loqs-PD rescue strain (Figure 22A), that is 
flies expressing only Loqs-PD in a LoqsKO background analogous to the existing Loqs-PB 
rescue strain (Park et al., 2007). According to Mendelian laws there is a 1/16 probability for 
correct F3 offspring (Figure 22C). Since balancer chromosomes carry recessive lethal 
mutations, individuals with homozygous balancer chromosomes are non-viable. Therefore 
1/9 of surviving offspring should have the intended genotype (Figure 22C). Table 2 indicates, 
however, that no PD-rescue flies carrying a homozygous LoqsKO could be recovered. It has 
been reported (Park et al., 2007) that only a small percentage of homozygous LoqsKO flies 
survive past pupal stage, due to a developmental defect caused by lack of miRNAs. Adult 
flies are unhealthy and die shortly after eclosion (Park et al., 2007). Loqs-PB expression in 
the Loqs-PB rescue flies reconstitutes the miRNA system and normalizes survival rate. No 
viable Loqs-PD rescue flies suggest that Loqs-PD cannot substitute for Loqs-PB in miRNA 
biogenesis.  
Table 2:
Red rectangle marks correct phenotype of Loqs-PD rescue flies; note that no homozygous LoqsKO flies could be 
recovered, even though there is a 1/3 probability; ratio of heterozygous LoqsKO flies essentially as expected 
 Cross to obtain flies expressing Loqs-PD in a LoqsKO background; F3 offspring 
phenotype  
offspring 
non-CyO 
non-sb 
non-CyO 
sb 
CyO  
non-sb 
CyO 
sb 
# offspring 0 0 156 252 
experimental ratio / / 1,00 1,62 
expected ratio 1 2 2 4 
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6.17 Future perspective 
The next step will be to design a cross that will yield viable offspring of Loqs-PD rescue flies, 
potentially in a tissue-specific expression system and to extend the experiment to Loqs-PA 
and Loqs-PC rescue flies. Table 3 lists the UAS/Gal4 expression plasmids, Table 4 shows the 
potential homozygous fly stocks now available. 
 
Table 3
Plasmid 
: pUAST expression plasmids for myc-tagged Loqs-PA/-PC/-PD 
abbreviation stock number 
pUAST+myc-Loqs-PC pEH 47 113 
pUAST+myc-Loqs-PD pEH 48 114 
pUAST+myc-Loqs-PA pEH 51 126 
 
 
Table 4:
Stock number 318 was used in cross to obtain Loqs-PD rescue flies (see 
 Overview over UAS-myc-Loqs-PC and -PD transgenic flies 
 
Figure 22A); eye phenotype marks intensity of transgene expression, no remark indicates eye color similar to 
wildtye flies; mapped and verified stocks are indicated 
Original name Eye phenotype New Name Mapped 
location 
Stock 
number 
E PC M 
17;38+37 
dark red UAS-Loqs-PC 
1 
3L; 5241560 300 
K PC M 73  UAS-Loqs-PC 
2 
 302 
PC 11;3+11  UAS-Loqs-PC 
3 
 303 
PC V 12;4+12  UAS-Loqs-PC 
4 
 304 
PC V 73;32+36 m red; f dark orange UAS-Loqs-PC 
5 
 305 
PC 50;17+23 m red; f dark orange UAS-Loqs-PC 
6 
 306 
PC 63;35+31 m dark red; f red UAS-Loqs-PC 
7 
 307 
PC V 3;50  UAS-Loqs-PC 
8 
 308 
PC M 28;45 light red UAS-Loqs-PC 
9 
 309 
PC M 55; 
46+39 
varying eye color (red-
orange) 
UAS-Loqs-PC 
10 
 310 
PC V 4; 1+10  UAS-Loqs-PC 
11 
 311 
PC V 51; 17+38  UAS-Loqs-PC 
12 
 312 
M PC   UAS-Loqs-PC 
13 
2R; 8519550 330 
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(Table 4 continued) 
Original name Eye phenotype New Name Mapped 
location 
Stock 
number 
B PD M 68   UAS-Loqs-PD 
1 
3R; 217147 313 
A PD V 68  UAS-Loqs-PD 
2 
 314 
C PD V 68 dark red UAS-Loqs-PD 
3 
 315 
D PD M 5   UAS-Loqs-PD 
4 
2L; 5999610 316 
G PD V 30  UAS-Loqs-PD 
5 
 317 
H PD 53 light red UAS-Loqs-PD 
6 
3L; 20488501 318 
I PD M 68  UAS-Loqs-PD 
7 
 319 
PD V 27;12+3  UAS-Loqs-PD 
8 
 320 
PD V 30;4+13  UAS-Loqs-PD 
9 
 321 
PD V 35;5+14 dark red UAS-Loqs-PD 
10 
 322 
PD V 38;15+17  UAS-Loqs-PD 
11 
 323 
PD V 54;23  UAS-Loqs-PD 
12 
 324 
PD V 69;26 dark red UAS-Loqs-PD 
13 
 325 
PD V 78;27 light red UAS-Loqs-PD 
14 
 326 
PD V 49;16+8 orange UAS-Loqs-PD 
15 
 327 
PD M 5; 40+37 dark red UAS-Loqs-PD 
16 
 328 
PD V 68; 25+31  UAS-Loqs-PD 
17 
 329 
 
To further study the complex interplay of small RNA silencing pathways in cell culture, I 
designed domain-swapped constructs listed in Table 5. Stable cell lines derived from these 
constructs are shown in Appendix 9. Together they will be a helpful tool in the functional 
analysis of the dsRBDs of Loqs and R2D2.  
GFP-fusion constructs for Loqs-PC- and Loqs-PD-specific C-termini are listed in Table 6, Dcr-2 
expression constructs in Table 7. 
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Table 5:
dsRBD elements of Loqs are shaded in orange, dsRBD elements of R2D2 in green; Loqs-PDspec C-terminus is 
marked in red, Loqs-PCspec C-terminus in blue; “isoform dsRBD 2” indicates, if 46 aa sequence of Loqs-PB was 
included or not (PA); PCR-derived point mutations as well as subsequent amino acid exchange are indicated for 
a subset of constructs [nucleotide position refers to loqs or r2d2 genomic regions (see 
http://flybase.org/reports/FBgn0032515.html) for comparability]; ligation-dependent addition of two amino 
acids (glycine and lysine) is indicated by a “+” 
 Overview over domain-swapped Loqs/R2D2 constructs 
epitope-
tag 
dsRBD 
1 
Liga-
tion 
dsRBD 
2 
Liga-
tion 
dsRBD 
3/ C-
term. 
isoform 
dsRBD 2 
comments 
abbre-
viation 
Stock 
# 
  R1   R2 + L3     pEH 1 64 
  L1 + R2   RC-term     pEH 2 65 
  L1   L2 + RC-term PB   pEH 4 68 
  R1 + L2   L3 PB 
nt 892 AG (aa TA) 
nt 1374 TC (aa LP) pEH 5 
69 
myc R1   R2   RC-term     pEH 7 71 
myc L1   L2   L3 PA 
 
pEH 8 73 
myc R1   R2 + L3   nt 517 AG (aa EG) pEH 10 75 
  R1 + L2 + RC-term PA   pEH 12 76 
  L1   L2   L3 PB   pEH 16 80 
myc L1   L2   L3 PB nt 1031 TC (aa FL) pEH17 81 
  R2   R3   RC-term     pEH 18 82 
myc L1   L2   / PA 
nt 813 CT (aa PL) nt 
1178 GA (aa GS) 
nt 1191 GA (aa GE) 
pEH 19 
84 
  L1   L2   / PA 
nt 813 CT (aa PL) nt 
1178 GA (aa GS) 
nt 1191 GA (aa GE) 
pEH 22 
87 
myc L1   L2   L3 PA nt 851 GC (aa GR) pEH 24 89 
  L1   L2   L3 PA nt 851 GC (aa GR) pEH 25 90 
myc L1   L2 + RC-term PA 
nt 851 GC (aa GR) 
nt 1172 AG (aa IV) pEH 30 
95 
myc L1   L2 + RC-term PB nt 937 TC (aa IT) pEH 31 96 
  L1   L2   / PA truncated Loqs pEH 33 99 
  L1   L2 + PCspec PA reconstituted PC pEH 34 100 
  L1   L2   PCspec   PC isoform pEH 35 101 
myc L1   L2   PDspec   PD isoform pEH 37 103 
myc L1   L2   PCspec   PC isoform pEH 38 104 
  L1   L2   PDspec   PD isoform pEH 39 105 
myc         PDspec   PDspec only pEH 40 106 
  R1   R2 + PCspec     pEH 41 107 
  R1   R2   /   truncated R2D2 pEH 42 108 
  L1   L2 + PDspec PA reconstituted PD pEH 44 110 
  R1   R2 + PDspec     pEH 45 111 
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Table 6:
Loqs-PDspec C-terminus is marked in red, Loqs-PCspec C-terminus in blue; ligation-dependent addition of two 
amino acids (glycine and lysine) is indicated by a “+” 
 Overview over GFP-fusion proteins 
epitope-tag fusion protein Ligation C-terminus abbreviation Stock # 
 
GFP + PCspec pEH 43 109 
 
GFP + PDspec pEH 46 112 
myc GFP + PDspec pEH 49 115 
myc GFP + PCspec pEH 50 116 
 
 
Table 7:
For Dcr-2 ∆dsRBD see 
 Overview over Flag-Dcr-2 expression proteins 
Appendix 8 
epitope-tag fusion protein abbreviation Stock # 
Flag Dcr-2 full-length pEH 53 128 
Flag Dcr-2 ∆hel pEH 54 129 
Flag Dcr-2 ∆dsRBD pEH 55 130 
 
 
 
However, a definite answer about the affinity of individual dsRBDs can only be obtained by 
in vitro studies with recombinantly expressed and purified proteins. I started to optimize 
conditions for expression and affinity purification of GST- or His6-tagged Loqs and R2D2. 
Initial promising expression and GST-agarose purification of GST-Loqs-PA, recombinantly 
expressed in the BL21 E. coli strain, is shown in Figure 23A and B, respectively. This project is 
now continued and expanded in the lab by Stephanie Fesser. 
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Figure 23:
A) Recombinant expression of pGEX-Loqs-PA 4h and 7h after induction with 0.1 mM IPTG in BL21 E. coli cells; 
empty pGEX-6P-1 served as a control; 50 µl of soluble fraction (S) and an equivalent amount of insoluble 
pellet (P), boiled in Laemmli SDS loading dye, were separated on a 10% polyacrylamide gel. Gel was stained 
with colloidal Coomassie. 
 Recombinant expression of GST-Loqs-PA and affinity purification 
B) Affinity purification of recombinant GST-Loqs-PA over a Glutathione Sepharose column. 10 µl of total 
protein extract (input), flow through (FT 1+2) and wash fractions (wash 1-3) and 22.5 µl of elution fractions 
(E 1-6) were loaded onto a 10% polyacrylamide gel. Gel was stained with colloidal Coomassie. 
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7 Discussion 
The results presented in this thesis extend and refine our understanding of a small-RNA 
mediated host defense system against selfish genetic elements in somatic cells. I have 
identified a novel isoform of the Dicer-partner Loquacious, thus explaining how endo-siRNA 
and miRNA biogenesis pathways are kept distinct. I could demonstrate in this study that 
interaction of the PD-specific amino acids of Loqs-PD with the N-terminal helicase domain of 
Dcr-2 is essential for the biogenesis of long hairpin- and high-copy transgene-derived endo-
siRNAs. I could further show that R2D2 acts as an antagonist of Loqs-PD in endo-siRNA 
biogenesis and Loqs-PD antagonizes R2D2 in exo-siRNA mediated silencing. My results 
indicate that the relative level of Loqs-PD in comparison to the other Loqs isoforms is critical 
for optimal efficiency of endo-siRNA biogenesis and function. Furthermore, the 
establishment of a GFP-based reporter system for endo-siRNA silencing demonstrates that 
the endo-siRNA response can be initiated de novo. 
 
7.1 Distinct Loqs isoforms separate the biogenesis routes for endo-siRNAs 
and miRNAs 
The discovery of a new Loqs protein isoform as a central player in endo-siRNA biogenesis 
sheds light onto the question of how a single gene - loqs - can participate in the recognition 
of pre-miRNA structures together with Dcr-1 (Forstemann et al., 2005; Jiang et al., 2005; 
Saito et al., 2005) and dsRNA together with Dcr-2 (Czech et al., 2008; Okamura et al., 2008b). 
The isoform-specific knock-down experiments in this thesis demonstrate that all three 
currently known Drosophila small RNA biogenesis pathways in somatic cells are defined by a 
distinct set of required factors and can be genetically separated: Dcr-1 and Loqs-PB for 
miRNAs (including miRtrons; see Figure 1), R2D2 for siRNAs – even those derived from 
transgenic hairpin constructs (Forstemann et al., 2005) – and Loqs-PD for endo-siRNAs 
(Figure 24A). It should be noted, however, that this exclusively linear model is to some 
extent an oversimplification. Certain miRNAs can become incorporated into Ago2-complexes 
(Förstemann, 2007; Seitz et al., 2008), Loqs and Dcr-1 play a minor but detectable role in 
transgenic RNAi (Lee et al., 2004; Forstemann et al., 2005) and endo-siRNAs can persist to a 
certain extent in the absence of ago2 or loqs (Czech et al., 2008; Okamura et al., 2008b).  
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The current results are, however, insufficient to decide whether Loqs-PD is required for the 
processing of endo-siRNA precursors or for the Ago2-loading step, or for both. From the 
perspective of the Loqs protein isoforms, we now know that Loqs-PB participates in miRNA 
biogenesis and Loqs-PD participates in endo-siRNA biogenesis. If isoform-specific regulation 
of small RNA silencing pathways proves to be a general mechanism, this will leave the open 
question for the substrates of the Loqs-PA isoform. 
 
7.2 Antagonism of small RNA biogenesis pathways 
All studies concerned with endo-siRNA silencing in Drosophila unanimously found a 
dependence on Ago2 and Dcr-2 (Chung et al., 2008; Czech et al., 2008; Ghildiyal et al., 2008; 
Kawamura et al., 2008; Zhou et al., 2009). The surprising finding was the requirement of 
Loqs instead of the canonical RNAi factor R2D2. R2D2 had no influence on the biogenesis of 
endo-siRNAs and could not rescue long hairpin-derived endo-siRNA biogenesis. Yet, a recent 
study reported impaired endo-siRNA silencing in r2d2 mutant fly tissue (Marques et al., 
2010). This was attributed to defective loading of endo-siRNAs by a common RISC loading 
complex (RLC) for endo- and exo-siRNAs consisting of Dcr-2 and R2D2. In addition, they 
proposed that Loqs-PD was involved not only in endo-siRNA biogenesis but also in exo-siRNA 
biogenesis. My results suggest a major difference between flies and S2 cells. This is most 
obvious in the GFP-based endo-siRNA reporter system, which reacts with hyper-repression 
to depletion of R2D2 alone or in combination with Loqs isoforms, demonstrating the 
inhibitory effect of R2D2 on endo-siRNA silencing in S2 cells. My RNAi reporter assay, on the 
other hand, shows an antagonistic effect of Loqs-PD on siRNA-mediated silencing. These 
results are in direct contrast to the previous study in mutant flies. However, these 
differences between cell culture and whole animals do not necessarily contradict each other. 
S2 cells are an immortalized embryonic cell line (Schneider, 1972) and it is therefore not 
surprising that some of their properties can differ from those of living animals. On the other 
hand, they are a useful tool to analyze endo-siRNA responses: There is an enrichment of 
transposable elements in their genome (Finnegan et al., 1978; Potter et al., 1979; Di Franco 
et al., 1992; Maisonhaute et al., 2007) that probably requires a strong endo-siRNA response 
to maintain genomic stability. One could speculate that this causes the high level of Loqs-PD 
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expression in S2 cells, while Loqs-PD levels in adult flies are much lower and vary in different 
tissues (Forstemann et al., 2005; Miyoshi et al., 2010).  
This discrepancy between results in flies and in cell culture points out the need for further in 
vivo studies of the endo-siRNA system. This is especially important since all experiments in 
flies have so far indiscriminately depleted all isoforms, which may account in part for the 
difference to Loqs-PD-specific RNAi in cell culture. Generation of flies expressing only the 
Loqs-PD isoform will allow detailed functional and biochemical studies of effects on adult 
flies. However, lack of miRNA regulation due to loss of Loqs-PB in Loqs-PD rescue flies 
severely impairs embryogenesis and causes sterility of surviving offspring, similar to the 
LoqsKO fly (Park et al., 2007). But since overexpression of Loqs-PD in flies with wildtype loqs 
background enhances endo-siRNA biogenesis, a functional distinction between Loqs-PB 
dependent miRNA biogenesis and Loqs-PD dependent endo-siRNA biogenesis in the adult 
Drosophila fly is already obvious. 
 
My thesis demonstrates that endo- and exo-siRNA pathways in Drosophila compete with 
each other for Dcr-2 through their specific dsRBPs, Loqs-PD and R2D2, respectively (Figure 
24B). My co-immunoprecipitation experiments indicate that there is only a minimal amount 
of Loqs-PD associated with R2D2. Given the much stronger interaction of Loqs-PD with other 
Loqs isoforms this is likely to represent an overexpression artifact rather than a ternary 
complex of Loqs-PD, R2D2 and Dcr-2 as reported before (Miyoshi et al., 2010). My co-
immunoprecipitation data for truncated Dcr-2 in addition with published data for interaction 
of R2D2 with the helicase domain of Dcr-2 (Ye et al., 2007; Lim do et al., 2008) rather suggest 
that Loqs-PD and R2D2 compete for Dcr-2 binding, for example via a shared interaction site 
located in the N-terminal DExH/D helicase domain. A parallel phenomenon has been 
reported for competition of Loqs-PA and -PB in miRNA biogenesis (Liu et al., 2007). There, 
the authors proposed that the two isoforms compete for binding to Dcr-1 and induce 
different conformations (Liu et al., 2007). Possibly the Loqs-PB induced conformation 
increases Dcr-1 affinity for miRNA precursors thus enhancing dicing efficiency (Jiang et al., 
2005). One could speculate that Loqs-PD and R2D2 may similarly favor different 
conformations of Dcr-2, enabling the protein to preferentially act in either endo- or exo-
siRNA silencing. 
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Figure 24: Small RNA biogenesis pathways (legend continued on p. 109) 
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(legend Figure 24 continued) 
A) All somatic small RNA biogenesis pathways can be distinguished by at least one specific component. The 
model represents important biogenesis steps for miRNAs, endo-siRNAs and siRNAs. Pathway-specific 
components are labeled in red. For the Loqs isoforms and R2D2, the individual dsRBDs are numbered to 
make the differences more obvious. While a RISC-loading complex (RLC) has been discovered for siRNAs 
(Pham et al., 2004; Tomari et al., 2004), analogous complexes for endo-siRNAs and miRNAs have yet to be 
identified (indicated by question marks). 
B) Loqs-PD and R2D2 both bind to the N-terminal helicase domain of Dcr-2, analogous to the situation of 
human Dicer and TRBP/PACT. Despite the similar architecture, the two Drosophila complexes are 
functionally distinct: My results support the notion that the Dcr-2/R2D2 complex serves as an antagonist of 
endo-siRNA biogenesis and vice versa. 
 
In C. elegans the specialized ERI endo-siRNA pathway was defined by mutations that 
enhance exo-siRNA silencing (Kennedy et al., 2004; Duchaine et al., 2006). This phenomenon 
was similarly attributed to relaxed competition for limiting common silencing components 
(Duchaine et al., 2006; Yigit et al., 2006). 
The protein partners of human Dicer, TRBP and PACT, are related dsRBD proteins (Patel et 
al., 1998; Duarte et al., 2000) and – like Loqs-PD and R2D2 – have antagonistic effects on 
Dicer: TRBP stimulates miRNA dicing and stabilizes Dicer, while PACT inhibits miRNA 
processing (Ma et al., 2008). In addition to their function in RNAi, the two proteins are 
involved in the antagonistic regulation of the dsRNA-activated Protein Kinase (PKR). Whereas 
TRBP inhibits PKR function both by direct dsRBD-mediated binding of PKR and sequestering 
of dsRNA (Park et al., 1994; Daher et al., 2001), PACT binds to PKR through its dsRBDs 1 and 
2 and activates the enzyme via the C-terminus (Huang et al., 2002; Gupta et al., 2003). 
Interestingly, TRBP interacts with the same residues of PKR but its C-terminal dsRBD has an 
inhibitory effect (Gupta et al., 2003). Thus, the modulation of enzyme activity by alternative 
dsRBD protein partners may be a conserved strategy even between otherwise unrelated 
protein complexes. 
 
7.3 Competition between Loqs isoforms 
I have demonstrated in this study that overexpression of isoforms not involved in endo-
siRNA silencing inhibits endo-siRNA biogenesis and subsequently impairs silencing of the 
reporter GFP-transgene. In addition, I could show that depletion of all other Loqs isoforms 
except for Loqs-PD enhances the efficiency of endo-siRNA mediated silencing, indicating that 
competition also exists at endogenous levels. The mechanistic basis for this competition may 
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be the sequestering of Dcr-2 via low-affinity binding by Loqs-PB/-PA. This hypothesis is 
supported by co-immunoprecipitation experiments that indicated a possible interaction of 
overexpressed Loqs-PA and -PB with Dcr-2. My thesis demonstrates that the Loqs-PD-
specific sequence can be sufficient for Dcr-2 binding and is essential for endo-siRNA 
production. Secondary interactions of the first two dsRBDs of Loqs with either an RNA 
substrate or Dcr-2 directly may also contribute to binding and thus explain low-affinity 
interactions between Dcr-2 and Loqs-PB/-PA. A similar competition phenomenon has been 
observed for Dcr-1: Both Loqs-PB and Loqs-PA readily interact with Dcr-1 in vitro, but when 
presented together Dcr-1 prefers binding to Loqs-PB (Ye et al., 2007). Interestingly, the 46 
additional amino acids in Loqs-PB are placed at the same position within Loqs (counting from 
the N-terminus) as the 22 amino acids specific to Loqs-PD (Table 8). Loqs-PA and Loqs-PC are 
similarly characterized by distinct sequences at this position.  
 
Table 8:
22 amino acid Loqs-PD-specific sequence and 46 amino acid sequence lacking in Loqs-PA are indicated; in the 
Loqs-PA isoform only the common C-terminus encompassing the third dsRBD can be found; the Loqs-PC-
specific sequence is listed for completeness, even though endogenous expression cannot be verified on protein 
level; “-“ marks stop codon in the corresponding mRNA 
 Isoform specific amino acid sequences situated at the same position from the N-terminus of the 
protein 
Loqs-PD isoform: Loqs-PDspec (22 amino acids) 
VSIIQDIDRYEQVSKDFEFIKI- 
Loqs-PB isoform: Sequence shared by Loqs-PB and -PC but not -PA (46 amino acids) 
PRSSENYYGELKDISVPTLTTQHSNKVSQFHKTLKNATGKKLLKLQ 
Loqs-PA isoform: Common C-terminus of Loqs-PB and Loqs-PA (including 3rd dsRBD) (82 
amino acids) 
KTCLKNNKIDYIKLLGEIATENQFEVTYVDIEEKTFSGQFQCLVQLSTLPVGVCHGSGPTAADAQRHAAQN
ALEYLKIMTKK- 
Loqs-PC isoform: Loqs-PCspec (43 amino acids) 
NESVKHLFHTKVICFNSPLACVISNVCEMQWRKETKNFALLFT 
 
Since different dsRBDs within one protein can have distinct functions (reviewed in Doyle et 
al., 2002), it will be necessary to attribute roles to the first two dsRBDs in both Loqs and 
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R2D2 as well. Interestingly, all Loqs isoforms share the first two dsRBDs. This suggests that 
despite the involvement of Loqs isoforms in different small RNA silencing pathways they may 
require conserved functions. However, one could speculate that a different Dicer-partner 
could stimulate a conformational change in the double-stranded RNA binding domain 
protein, which would increase versatility. NMR studies of dsRBP/Dicer interaction will help in 
this analysis of individual domains complemented by a functional approach based on my 
domain-swapped dsRBD chimaeras. By transfecting different small RNA reporter systems 
with different combinations of Loqs and R2D2 dsRBDs it will be possible to elucidate 
conserved and unique roles of individual domains. 
The ratio of individual Loqs isoforms is not uniform in different fly tissues or cell culture cells 
(Forstemann et al., 2005; Miyoshi et al., 2010). This suggests that their expression can be 
regulated individually. Since Loqs-PB is essential for the miRNA pathway and Loqs-PD has to 
respond to the threat of transposons, it seems likely that the endo-siRNA factor could be 
regulated by a separate mechanism. Loqs-PD not only has a unique C-terminus but also a 
3´UTR that is not shared by any of the other isoforms. RNAi against this alternatively poly-
adenylated transcript mirrors a possible endogenous mechanism to regulate the stability of 
loqs-RD independently from the other isoforms. Since the 3´UTR of an mRNA can contain 
possible binding sites for regulatory factors (Shalgi et al., 2005; Xie et al., 2005), the cell 
would be able to adapt the abundance of Loqs isoforms for miRNA and endo-siRNA silencing 
independently and according to the cell´s condition.  
 
7.4 A conserved interaction scheme between Dicer and dsRBD proteins 
The single Dicer enzyme found in humans can interact with TRBP and PACT, both of which 
are dsRBD proteins and homologs of Drosophila loqs and r2d2 (Gatignol et al., 1991; 
Chendrimada et al., 2005; Haase et al., 2005; Lee et al., 2006). This interaction could be 
mapped to 69 amino acids at the C-terminal end of TRBP and 165 amino acids in the N-
terminal domain of Dicer (Daniels et al., 2009). Thus, the positions of the interacting 
domains are conserved not only between Drosophila Dcr-1 and Dcr-2, but also in vertebrate 
Dicer enzymes. In C. elegans, RDE-4, interacts with Dcr-1 as well as another helicase domain 
containing protein, Drh-1 (Tabara et al., 2002). While the Dicer-interacting domain of RDE-4 
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has not been mapped, the C-terminal third dsRBD mediates dimerization of RDE-4. The 
dimer binds long double-stranded RNA cooperatively and shows a length-dependent 
decrease in binding affinity between a 650 nt fragment of dsRNA and a mature siRNA in 
vitro. This decrease is exacerbated by deletion of the C-terminus, starting at the end of the 
second dsRBD (Parker et al., 2008). Truncated RDE-4 does not form homodimers any more 
and cannot sustain the production of siRNAs in vitro (Parker et al., 2006).  
In this study I report the formation of homomultimers between Loqs-PB as well as 
heteromultimers between Loqs-PB and Loqs-PA. Heteromultimers between Loqs-PD and 
Loqs-PB were much less abundant or undetectable at endogenous levels. This finding is 
consistent with a conserved role of the third dsRBD in mediating dimerization of the dsRBD 
proteins. Whether such a dimerization is possible while retaining the association with Dicer 
or whether the dimers only form in the population of free dsRBD proteins remains to be 
elucidated. In the context of PKR activation, TRBP and PACT form an inactive heterodimer 
which cannot stimulate PKR activity (Laraki et al., 2008; Daher et al., 2009). Thus, the 
multimerization may serve a regulatory purpose. It is interesting to note that there is a splice 
variant of human TRBP lacking the third dsRBD, thus resembling Loqs-PD (Haase et al., 2005). 
Does this also represent a functionally distinct isoform with a modified protein-protein 
interaction profile? 
Deletion analysis indicated that both the 22 amino acid Loqs-PD-specific sequence and the 
Dcr-2 helicase domain are necessary for endo-siRNA function. However, I could not observe 
any impairment of miR-277 perfect match reporter silencing, when I transfected the 
reporter with a truncated Flag-Dcr-2 construct, lacking the helicase domain. Since miR-277 is 
diced by Loqs-PB/Dcr-1 and then loaded into Ago2 by the Dcr-2/R2D2 RLC, this suggests that 
the helicase domain is not required for Dcr-2/R2D2-dependent loading. This is consistent 
with previously published data about the uncoupling of the dicing and the loading step in 
dcr-2G31R mutant flies. This allele carries a point mutation that abolishes the nuclease 
function of Dcr-2 (Förstemann, 2007) but leaves the loading capacity unimpaired. The 
deletion of the helicase region may therefore similarly not interfere with Dcr-2-dependent 
loading of miR-277 into Ago2. 
Another conserved theme in dsRBP/Dicer interaction is a possible mutual stabilization 
between the binding partners (Liu et al., 2003; Forstemann et al., 2005; Förstemann, 2007; 
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Liu et al., 2007). Especially destabilization of R2D2 after Dcr-2 depletion is pronounced (Liu et 
al., 2003; Förstemann, 2007) and may contribute to maintaining a balance between 
competing pathways (see next paragraph). 
 
7.5 Affinity versus abundance: Stability of the siRNA system and a model 
for siRNA precursor recognition 
My results suggest a direct correlation between the relative level of Loqs-PD compared to 
competing dsRBPs and the efficiency of the endo-siRNA response. The competition between 
Loqs isoforms is directly obvious from the isoform-specific RNAi experiments in the 63N1 
reporter system: Loqs-PD-specific depletion has a more pronounced effect on the reporter 
than depletion of all isoforms. The RNAi trigger against the 5´UTR of loqs is less efficient in 
depleting the Loqs-PD isoform than the loqs-ORF RNAi construct. This is directly mirrored by 
the reporter response. The flexibility of the system is immediately apparent in my co-
immunoprecipitation data as well, where overexpression can induce less favorable 
interactions between Dicer proteins and Loqs isoforms. This suggests that affinities and 
concentrations of binding partners are in equilibrium under steady-state conditions in the 
cell. Furthermore I could show that R2D2 depletion in the endo-siRNA reporter causes 
hyper-repression of the GFP level and double knock-down experiments suggested that the 
ratio of R2D2 and Loqs-PD is essential for the balance between endo- and exo-siRNA 
pathways. This equilibrium, however, is precarious given that siRNAs from endogenous loci 
are far less abundant, namely by approximately two orders of magnitude (Okamura et al., 
2008a). When a cell is faced with a viral infection, it is flooded with double-stranded RNA of 
viral origin. There are two possible measures to prevent the siRNA system of a cell from 
saturation and to maintain transposon surveillance even during viral infections: First, Loqs-
PD affinity for Dcr-2 should be higher than R2D2 affinity for Dcr-2. This would avoid the 
complete sequestering of Dcr-2 by exo-siRNA factors. Second, since the substrate of the 
endo-siRNA pathway, namely long double-stranded RNA derived from endogenous loci, does 
not differ in structure from double-stranded RNA from viral origin, the Dcr-2/Loqs-PD and 
the Dcr-2/R2D2 complexes should have distinct chemical properties. A possible hypothesis 
would be that the Dcr-2/R2D2 heterodimer has a lower affinity that requires a higher 
abundance of double-stranded RNA substrate, while the Dcr2/Loqs-PD complex has a high 
affinity allowing substrate binding at lower double-stranded RNA concentrations (K. 
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Förstemann, personal communication). Recombinant expression of Dicer and dsRBPs as well 
as Loqs/R2D2-chimaeras will allow measuring of binding constants between pathway 
components. Additionally, affinity for RNA substrate of individual proteins can be 
determined in vitro. Taken together, recombinantly expressed proteins may aid to attribute 
function to individual domains and help understand pathway specificity of small RNAs. 
 
7.6 Comparison between two reporter cell lines: 63N1 and 63-6 
Transient transfection of cell culture cells has several drawbacks: First, transfection reagents 
are usually harmful for a cell. Second, expression levels of individual cells vary widely 
depending on the number of plasmids in the cytoplasm. Third, expression declines soon 
after transfection as the number of plasmids in a single cell decreases during proliferation.  
Formation of clonal cell lines stably expressing a transgene has the advantage that the entire 
population of cells has a uniform expression level. However, the number of transgenes 
integrated in the genome can vary between individual cell lines. Both the 63-6 and the 63N1 
cell lines were derived from transfection of S2 cells with a GFP-expression plasmid, however 
from different single cell clones. While the 63N1 cell line shows a strong response to 
depletion of endo-siRNA factors like Ago2, Dcr-2 and Loqs, the increase in GFP levels of the 
63-6 cell line is much less pronounced. The most straightforward explanation for this is a 
difference in the copy number of integrated GFP-genes in the genome of the two lines. 
Quantitative PCR of genomic DNA performed by a fellow PhD-student in the laboratory, 
Stephanie Esslinger, indeed showed an approximately 40-times higher copy number in the 
63N1 genome than in the 63-6 genome (Hartig et al., 2009). The more efficient endo-siRNA 
response to the higher number of transgenes implies that the cell can sense the copy-
number of repetitive genetic elements. A possible explanation for this sensitivity is the 
pervasive transcription of intergenic regions in Drosophila and other species (reviewed in 
Kapranov et al., 2007). Possible transcription events in antisense orientation would produce 
complementary strands for mRNA derived from selfish genetic elements or transgenes and 
allow processing of endo-siRNAs from these loci. This hypothesis would explain the different 
amplitudes of reporter reaction in the 63N1 and the 63-6 cell lines based on different copy-
numbers of GFP transgenes integrated in the genome.  
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However, there must be additional genetic differences between the two cell lines. This is 
obvious by the distinct reactions of the 63N1 and the 63-6 cell lines to depletion of p68/Lip. 
What causes this pronounced de-repression of GFP levels in the 63-6 line and whether there 
is a transcriptional component involved in silencing p68/Lip in 63-6 cells, remains unclear 
(see next paragraph). 
 
7.7 Transcriptional versus post-transcriptional gene silencing 
The 63N1 endo-siRNA cell culture reporter cell line did not show any significant response to 
depletion of putative transcriptional silencing factors. FMR1, p68/Lip and HP-1 are involved 
in chromatin remodeling and silencing of gene expression by tight packaging of DNA into 
heterochromatin. This suggests that the endo-siRNA response is primarily caused by post-
transcriptional cleavage of the target. This is consistent with the efficient endonuclease 
activity of Ago2 (Förstemann, 2007). Post-transcriptional target cleavage has indeed been 
reported before in vitro (Kawamura et al., 2008; Okamura et al., 2008b) and in vivo (Czech et 
al., 2008). With the help of a nascent RNA labeling and purification strategy a fellow PhD 
student in our laboratory, Stephanie Esslinger, could show that endo-siRNAs directed against 
a transgene construct predominantly affect the degradation rate of the corresponding 
transcripts and do not impose transcriptional regulation. Taken together our findings suggest 
that a post-transcriptional mechanism is sufficient to explain most – if not all – of the 
repression mediated by endo-siRNAs. 
Compacted heterochromatin, on the other hand, could also have a global effect on the rate 
of transcriptional noise and pervasive transcription. Depletion of heterochromatin factors 
could cause decondensation of DNA thus increasing the level of possible antisense 
transcripts. This in turn would lead to a more pronounced endo-siRNA response. However, I 
could not detect this effect using the endo-siRNA cell culture reporter.  
 
7.8 Is there an RdRP-like activity in Drosophila? 
The RNA-dependent RNA polymerase (RdRP)-mediated generation of secondary siRNAs in 
the yeast S. pombe, in C. elegans, and in plants increases and elongates the RNAi response 
(reviewed in Ghildiyal et al., 2009). In principle, target mRNA serves as a template for the 
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RNA polymerase. Secondary siRNAs can then in turn be loaded into RISC complexes. Since 
the secondary siRNAs are not identical with the primary siRNA but templated by novel target 
sequence, the silencing effectively “spreads” along the genome (Sijen et al., 2001). This 
phenomenon makes isoform-specific RNAi in C. elegans difficult or impossible. No obvious 
RdRP activity could be found in flies or mammals (Zamore et al., 2000; Nykanen et al., 2001; 
Martinez et al., 2002; Haley et al., 2003; Roignant et al., 2003; Tomari et al., 2004). In 
addition, genome analysis found no apparent gene encoding for a canonical RdRP in 
Drosophila. Deep-sequencing data showed no endo-siRNA sequences crossing an exon-exon 
junction, which is inconsistent with a potential RdRP activity (Hartig et al., 2009). However, 
an RdRP-like activity has been described in Drosophila, essentially by the group of Bruce 
Paterson (Lipardi et al., 2001). Recently, the same group biochemically attributed the non-
canonical RdRP-activity to D-elp-1, a subunit of the PolII elongator complex (Lipardi et al., 
2009). My GFP-based reporter system for siRNA silencing was analogous to the one used in 
the Paterson group, but I could not corroborate the RdRP-like activity of D-elp-1. If the D-elp-
1 showed similar properties as RdRPs in C. elegans, one would suppose that isoform-specific 
RNAi – as employed in this thesis and reported before (Roignant et al., 2003) – would not be 
possible. The majority of the evidence thus indicates that an RdRP-like activity does only play 
a minor role in Drosophila, if at all. 
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8 Abbreviations 
 
+  in chimaeric constructs: ligation-dependent addition of two codons 
(glycine and lysine) 
µg microgram 
63N1 endo-siRNA cell culture reporter cell line 
Ago Argonaute protein 
Amp ampicillin 
APS ammonium peroxodisulfate 
ATP adenosine triphosphate 
bd. bound IP fraction 
BLAST Basic Local Alignment Search Tool 
bp base pair(s) 
BSA bovine serum albumine 
cDNA complementary DNA 
CG4068 hairpin forming endo-siRNA precursor gene 
co-IP co-immunoprecipitation 
C-term   protein C-terminus 
CT-value  cycle of threshold value in qPCR 
d   day(s) 
D. melanogaster Drosophila melanogaster 
dcr dicer gene 
Dcr Dicer protein 
DExH/D superfamily II helicase family member that works on RNA 
DMSO dimethyl sulfoxide 
DNA  desoxy-ribonucleic acid 
dNTP desoxy-nucleotide-tri-phosphate 
ds double-stranded 
dsRBD double-stranded RNA binding domain 
dsRBP double-stranded RNA binding domain protein 
dsRNA double-stranded RNA 
DTT dithiothreitol 
Abbreviations 
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DUF Domain of Unknown Function 
ECL Enhanced Chemiluminescence 
E. coli Escherichia coli 
EGFP Enhanced Green Fluorescent protein 
EM electron microscopy 
endo- endogenous 
endo-siRNA endogenous small interfering RNA 
exo- exogenous 
exo-siRNA exogenous small-interfering RNA 
FACS Fluorescence Activated Cell Sorting 
FBS Fetal Bovine Serum 
FMR1 Fragile Mental Retardation Protein 1 
GFP Green Fluorescent Protein 
GST glutathione S-transferase 
h hour(s) 
hel helicase domain 
HP-1 Heterochomatin Protein 1 
HRP Horseradish Peroxidase 
Hygro hygromycin 
IgG immunoglobulin protein G 
inp. input  
IP immunoprecipitation 
IPTG  Isopropyl-β-D-thiogalactopyranosid  
Kana kanamycin 
KLH Keyhole limpet hemocyanin 
KO knock-out 
L double-stranded RNA binding domain of Loquacious 
l.c. antibody light-chain 
loqs loquacious gene 
Loqs Loquacious protein 
Luc luciferase 
MCS Multiple Cloning Site 
Abbreviations 
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mg milligram 
miR micro RNA 
miRNA micro RNA 
ml milliliter 
mRNA messenger RNA 
Neo neomycin 
ng nanogram 
nt nucleotide(s) 
N-term protein N-terminus 
NTP nucleotide-tri-phosphate 
OD optical density 
ORF open reading frame 
OrR Oregon R fly wildtype strain 
p.a. pro analysi 
PA/PB/PC/PD protein isoform A/B/C/D 
PACT protein act
PAGE Polyacrylamide Gel Electrophoresis 
ivator of interferon-induced double-stranded RNA-
dependent protein kinase  
PAZ Piwi-Argonaute-Zwille domain of Dicer and Argonaute proteins 
PKR interferon-induced double-stranded RNA-dependent protein kinase  
PCR Polymerase Chain Reaction 
PCspec Loqs-PC-specific sequence 
PDspec Loqs-PD-specific sequence 
piRNA Piwi-interacting RNA 
PNK  polynucleotide kinase 
Pol II DNA polymerase II 
Poly-A poly-adenylation 
PVDF  Polyvinylidenfluoride 
qPCR quantitative Polymerase Chain Reaction 
R double-stranded RNA binding domain of R2D2 
R2D2 protein name derived from: 2 dsRBD-containing protein interacting 
with Dcr-2 
Abbreviations 
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RA/RB/RC/RD loqs isoform A/B/C/D mRNA 
RACE rapid amplification of cDNA ends 
rb rabbit 
RdRP RNA-dependent RNA-Polymerase 
rel. relative 
RISC RNA induced silencing complex 
RLC RISC loading complex 
RNA ribonucleic acid 
RNAi RNA interference 
RNaseIII endoribonuclease class III 
rRNA ribosomal RNA 
RT reverse transcription or real-time 
S. pombe Schizosaccharomyces pombe 
S2 cell Schneider-2 cell 
SD standard deviation 
siRNA small interfering RNA 
SOB Super Optimal Broth 
SSC sodium chloride/sodium citrate 
SV40 Simian Virus 40 
T thymin 
TAR transactivation response RNA 
tech. technical 
TRBP TAR RNA binding protein 
tub. tubulin 
U uracil 
UAS yeast Upstream Activating Sequence 
UTR untranslated region 
V Volt 
∆ deletion 
α anti 
°C degrees Celsius 
µ micro 
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9 Appendix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 1:
A) PageRuler Prestained Protein Marker (Fermentas) 
 Protein and DNA markers 
B) Gene Ruler DNA Ladder Mix (Fermentas) 
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Appendix 2:
A) Plasmid map for pET-28a (Novagen) 
 Vectors for recombinant expression 
B) Plasmid map for pGex-6P-1 (Amersham) 
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Appendix 3:
A) Plasmid map for pUAST; conditional UAS/Gal4 expression system 
 Expression vectors 
B) Plasmid map for pKF63; myc-GFP expression under tubulin promotor 
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Appendix 4:
Western blot from S2 cells transfected with 50 ng of various Loqs expression constructs. If the same amount of 
construct was transfected, I observed varying amounts of expression. For all experiments I adapted plasmid 
amounts for equal expression levels, however, I was unable to achieve high expression for Loqs-PC constructs. 
 Loqs-PC expression 
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Appendix 5:
Nucleotide positions refer to genomic region of loqs (http://flybase.org/reports/FBgn0032515.html); loqs-RD 
3´UTR from position 1445-1789; yellow highlighted sites mark potential poly-A sites for loqs-RD; a prediction 
algorithm for human poly-A sites was used with standard parameters (Ahmed et al., 2009) 
 Table for Poly-A prediction results 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start position Sequence Score Prediction 
1913 GTGATA 169.439 Positive 
1676 GTACTA 137.023 Positive 
1933 ATTGGC 133.975 Positive 
1816 TTATAT 104.823 Positive 
1874 TTAAAG 0.99965 Positive 
1948 TTCAAA 0.99769 Positive 
1692 TTTATA 0.95536 Positive 
1860 GCATGG 0.92238 Positive 
1607 CGTTTA 0.91568 Positive 
1663 AGCTAG 0.86657 Positive 
1827 TATTTC 0.84898 Positive 
1806 TATTTA 0.83740 Positive 
2875 AGACAA 0.83251 Positive 
1842 TTTTCA 0.76249 Positive 
1619 TCCTCA 0.68375 Positive 
2014 GCAGTA 0.68208 Positive 
2860 TACGCT 0.65299 Positive 
1959 GCGAAA 0.64682 Positive 
1969 ATGGAG 0.58881 Positive 
2792 GGCAGT 0.58617 Positive 
1565 TAATAC 0.57317 Positive 
2259 ATAATA 0.54416 Positive 
2785 TTGATT 0.53071 Positive 
2774 CACCGA 0.50245 Positive 
2279 TGAAAG 0.48552 Positive 
1710 ATATTT 0.48217 Positive 
1096 CGACAA 0.48173 Positive 
539 CAGCCA 0.47180 Positive 
1748 TGACAT 0.44816 Positive 
1768 TTAACA 0.44018 Positive 
783 AGCCGA 0.43998 Positive 
1061 ATCCAA 0.43691 Positive 
2852 AATGTA 0.41890 Positive 
519 CCCAGG 0.40346 Positive 
1788 TATTTA 0.39514 Positive 
1547 TAAATG 0.37463 Positive 
2757 ATATTT 0.35843 Positive 
1555 ATATAT 0.34197 Positive 
2815 TATGTA 0.32201 Positive 
2742 CATATA 0.29382 Positive 
1632 ATATCC 0.29366 Positive 
527 GCGCAG 0.29118 Positive 
2749 ATATAT 0.28689 Positive 
2805 GTTAAC 0.27847 Positive 
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ATGGACCAGGAGAATTTCCACGGCTCCAGCTTGCCGCAGCAGCTACAGAACCTCCACA
TCCAGCCGCAGCAGGCGTCCCCCAATCCTGTCCAGACGGGATTTGCTCCACGGCGGCA
CTATAATAACCTTGTCGGCCTGGGCAATGGAAATGCCGTCAGTGGTAGTCCGGTGAAG
GGTGCTCCGCTGGGGCAGCGCCATGTGAAGCTCAAGAAGGAGAAGATATCCGCCCAG
GTTGCGCAGCTGTCTCAGCCAGGTCAGCTGCAGCTGTCAGATGTTGGTGATCCTGCCT
TGGCGGGCGGATCGGGCTTACAAGGTGGAGTCGGCCTTATGGGCGTAATATTGCCCAG
CGACGAGGCCTTAAAGTTCGTCAGCGAAACGGACGCCAATGGACTGGCCATGAAGACG
CCCGTCAGCATTCTGCAAGAGCTGCTAAGCCGACGAGGAATTACTCCCGGCTATGAACT
TGTCCAGATCGAGGGCGCCATACATGAGCCGACCTTCCGGTTTCGCGTGTCCTTTAAAG
ACAAGGATACGCCCTTCACGGCCATGGGGGCAGGACGATCGAAGAAGGAGGCCAAGC
ATGCGGCGGCCCGTGCGCTCATCGACAAGCTGATCGGCGCGCAGCTGCCGGAATCGC
CTAGCAGCTCCGCTGGTCCGTCGGTGACTGGGCTCACGGTCGCCGGAAGCGGAGGAG
ACGGCAATGCCAATGCCACAGGCGGAGGAGATGCCAGCGACAAGACCGTTGGTAATCC
GATTGGCTGGTTGCAGGAAATGTGCATGCAACGGCGATGGCCACCGCCGTCGTACGAA
ACGGAAACGGAAGTGGGTCTTCCCCACGAGCGGCTCTTTACGATCGCCTGCTCGATAC
TCAACTACCGCGAGATGGGCAAGGGCAAAAGCAAGAAGATAGCCAAGCGCTTGGCCGC
CCACCGCATGTGGATGCGTCTGCAGGAGACTCCCATCGATTCGGGCAAAATCAGCGAC
AGCATCTGCGGCGAGTTGGAGGGCGAACCCCGCAGTAGTGAAAATTATTATGGTGAATT
GAAAGATATCTCTGTGCCGACACTGACCACGCAGCACAGTAACAAAGTATCCCAGTTCC
ATAAGACCCTAAAAAATGCAACGGGCAAAAAACTGCTTAAGTTACAGAAGACTTGCTTGA
AGAACAACAAGATTGATTACATCAAGCTGCTGGGCGAAATCGCCACGGAGAACCAGTTC
GAGGTGACCTATGTGGACATAGAGGAGAAGACCTTCTCTGGCCAGTTCCAGTGCCTGG
TTCAACTGTCCACGCTGCCCGTTGGCGTTTGCCACGGCAGCGGACCAACAGCTGCCGA
TGCCCAGCGGCATGCCGCCCAGAATGCCCTCGAGTACTTGAAGATCATGACCAAGAAG
TAG 
 
 
MDQENFHGSSLPQQLQNLHIQPQQASPNPVQTGFAPRRHYNNLVGLGNGNAVSGSPVKG
APLGQRHVKLKKEKISAQVAQLSQPGQLQLSDVGDPALAGGSGLQGGVGLMGVILPSDEAL
KFVSETDANGLAMKTPVSILQELLSRRGITPGYELVQIEGAIHEPTFRFRVSFKDKDTPFTAM
GAGRSKKEAKHAAARALIDKLIGAQLPESPSSSAGPSVTGLTVAGSGGDGNANATGGGDAS
DKTVGNPIGWLQEMCMQRRWPPPSYETETEVGLPHERLFTIACSILNYREMGKGKSKKIAK
RLAAHRMWMRLQETPIDSGKISDSICGELEGEPRSSENYYGELKDISVPTLTTQHSNKVSQF
HKTLKNATGKKLLKLQKTCLKNNKIDYIKLLGEIATENQFEVTYVDIEEKTFSGQFQCLVQLST
LPVGVCHGSGPTAADAQRHAAQNALEYLKIMTKK- 
 
Appendix 6:
Sequences corresponding to conserved dsRBD regions are marked (dsRBD1 yellow; dsRBD2 red; dsRBD3 olive); 
conserved regions were deduced from BLAST results 
 Nucleotide and amino acid sequence of Loqs-PB 
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ATGGATAACAAGTCAGCCGTATCTGCTCTACAGGAGTTTTGTGCCCGGACACAGATTAA
TCTACCAACATACAGTTTTATTCCCGGCGAAGACGGAGGGTACGTCTGTAAAGTTGAAC
TATTGGAGATAGAGGCCCTTGGAAATGGGCGTTCGAAGCGTGATGCCAAACACCTGGC
TGCCAGCAATATCTTGCGTAAAATCCAACTGCTGCCCGGCATACACGGCTTGATGAAGG
ATTCGACTGTGGGTGATCTGGATGAGGAACTGACTAACCTCAACCGGGACATGGTGAA
GGAGCTGCGTGACTACTGCGTCCGCCGCGAGATGCCACTGCCCTGCATTGAGGTAGTG
CAGCAAAGCGGCACCCCGAGCGCCCCGGAATTCGTGGCCTGTTGCTCCGTGGCCTCC
ATAGTACGCTACGGAAAGTCGGACAAAAAGAAGGATGCCCGTCAGCGAGCGGCCATTG
AAATGCTGGCCTTAATCTCCAGCAATTCGGACAATTTGCGTCCGGATCAAATGCAAGTA
GCGAGCACAAGCAAATTGAAAGTTGTTGATATGGAAGAATCTATGGAGGAATTGGAGGC
ATTGCGCAGAAAGAAATTTACCACCTACTGGGAGTTGAAGGAAGCCGGGAGCGTAGAC
CATACAGGCATGCGGCTCTGCGACCGACACAACTACTTCAAGAACTTCTATCCTACCCT
GAAAAAGGAGGCCATTGAGGCCATCAATTCAGATGAATACGAGAGCTCCAAGGATAAG
GCTATGGACGTAATGAGCTCTTTAAAGATAACACCCAAAATCAGTGAAGTGGAATCTTCA
TCGTTGGTTCCCTTGCTTAGCGTCGAGCTTAATTGTGCATTCGACGTGGTCCTTATGGC
AAAGGAGACCGATATCTACGACCATATAATAGACTATTTTCGCACCATGTTGATTTAA 
 
 
MDNKSAVSALQEFCARTQINLPTYSFIPGEDGGYVCKVELLEIEALGNGRSKRDAKHLAASNI
LRKIQLLPGIHGLMKDSTVGDLDEELTNLNRDMVKELRDYCVRREMPLPCIEVVQQSGTPSA
PEFVACCSVASIVRYGKSDKKKDARQRAAIEMLALISSNSDNLRPDQMQVASTSKLKVVDM
EESMEELEALRRKKFTTYWELKEAGSVDHTGMRLCDRHNYFKNFYPTLKKEAIEAINSDEYE
SSKDKAMDVMSSLKITPKISEVESSSLVPLLSVELNCAFDVVLMAKETDIYDHIIDYFRTMLI- 
 
Appendix 7:
Sequences corresponding to conserved dsRBD regions are marked (dsRBD1 green; dsRBD2 turquoise); 
conserved regions were deduced from BLAST results 
 Nucleotide and amino acid sequence of R2D2 
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MEDVEIKPRGYQLRLVDHLTKSNGIVYLPTGSGKTFVAILVLKRFSQDFDKPIESGGKRALFM
CNTVELARQQAMAVRRCTNFKVGFYVGEQGVDDWTRGMWSDEIKKNQVLVGTAQVFLDM
VTQTYVALSSLSVVIIDECHHGTGHHPFREFMRLFTIANQTKLPRVVGLTGVLIKGNEITNVAT
KLKELEITYRGNIITVSDTKEMENVMLYATKPTEVMVSFPHQEQVLTVTRLISAEIEKFYVSLD
LMNIGVQPIRRSKSLQCLRDPSKKSFVKQLFNDFLYQMKEYGIYAASIAIISLIVEFDIKRRQAE
TLSVKLMHRTALTLCEKIRHLLVQKLQDMTYDDDDDNVNTEEVIMNFSTPKVQRFLMSLKVS
FADKDPKDICCLVFVERRYTCKCIYGLLLNYIQSTPELRNVLTPQFMVGRNNISPDFESVLER
KWQKSAIQQFRDGNANLMICSSVLEEGIDVQACNHVFILDPVKTFNMYVQSKGRARTTEAK
FVLFTADKEREKTIQQIYQYRKAHNDIAEYLKDRVLEKTEPELYEIKGHFQDDIDPFTNENGA
VLLPNNALAILHRYCQTIPTDAFGFVIPWFHVLQEDERDRIFGVSAKGKHVISINMPVNCMLR
DTIYSDPMDNVKTAKISAAFKACKVLYSLGELNERFVPKTLKERVASIADVHFEHWNKYGDS
VTATVNKADKSKDRTYKTECPLEFYDALPRVGEICYAYEIFLEPQFESCEYTEHMYLNLQTP
RNYAILLRNKLPRLAEMPLFSNQGKLHVRVANAPLEVIIQNSEQLELLHQFHGMVFRDILKIW
HPFFVLDRRSKENSYLVVPLILGAGEQKCFDWELMTNFRRLPQSHGSNVQQREQQPAPRP
EDFEGKIVTQWYANYDKPMLVTKVHRELTPLSYMEKNQQDKTYYEFTMSKYGNRIGDVVHK
DKFMIEVRDLTEQLTFYVHNRGKFNAKSKAKMKVILIPELCFNFNFPGDLWLKLIFLPSILNRM
YFLLHAEALRKRFNTYLNLHLLPFNGTDYMPRPLEIDYSLKRNVDPLGNVIPTEDIEEPKSLLE
PMPTKSIEASVANLEITEFENPWQKYMEPVDLSRNLLSTYPVELDYYYHFSVGNVCEMNEM
DFEDKEYWAKNQFHMPTGNIYGNRTPAKTNANVPALMPSKPTVRGKVKPLLILQKTVSKEHI
TPAEQGEFLAAITASSAADVFDMERLEILGDSFLKLSATLYLASKYSDWNEGTLTEVKSKLVS
NRNLLFCLIDADIPKTLNTIQFTPRYTWLPPGISLPHNVLALWRENPEFAKIIGPHNLRDLALG
DEESLVKGNCSDINYNRFVEGCRANGQSFYAGADFSSEVNFCVGLVTIPNKVIADTLEALLG
VIVKNYGLQHAFKMLEYFKICRADIDKPLTQLLNLELGGKKMRANVNTTEIDGFLINHYYLEKN
LGYTFKDRRYLLQALTHPSYPTNRITGSYQELEFIGDAILDFLISAYIFENNTKMNPGALTDLR
SALVNNTTLACICVRHRLHFFILAENAKLSEIISKFVNFQESQGHRVTNYVRILLEEADVQPTP
LDLDDELDMTELPHANKCISQEAEKGVPPKGEFNMSTNVDVPKALGDVLEALIAAVYLDCRD
LQRTWEVIFNLFEPELQEFTRKVPINHIRQLVEHKHAKPVFSSPIVEGETVMVSCQFTCMEKT
IKVYGFGSNKDQAKLSAAKHALQQLSKCDA- 
 
Appendix 8:
Sequences corresponding to linkers between helicase domain and DUF (yellow) as well as RNAseIII domain and 
dsRBD (green) are marked; cloning primers were designed for the respective DNA regions; the ∆dsRBD-Flag-
Dcr-2 construct (pEH55; stock number 130) could not be detected by Western blotting, probably due to protein 
destabilization. 
 Amino acid sequence of Dcr-2 
 
Appendix 
 
 
129 
Appendix 9:
“parent cell line” indicates reporter cell line used for plasmid transfection; banmi4 = bantam miRNA reporter 
with 4 imperfect binding sites for bantam in the 3´UTR of GFP; bansi2 = bantam miRNA reporter with 2 perfect 
binding sites for bantam in the 3´UTR of GFP; 68-4 = miR-277 reporter with 4 imperfect binding sites for miR-
277 in the 3´UTR of GFP; 67-1D = miR-277 reporter with 2 perfect binding sites for miR-277 in the 3´UTR of GFP; 
63N1 = endo-siRNA reporter with no miRNA binding sites in the 3´UTR of GFP 
 Table giving an overview over stable cell culture lines 
 
transfected 
plasmid 
parent cell line label  transfected 
plasmid 
parent cell line label 
pEH1 banmi4 E4  pEH2 67-1D H3 
pEH1 banmi4 F6  pEH2 67-1D H4 
pEH1 banmi4 F11  pEH2 67-1D H5 
pEH1 banmi4 F5  pEH2 67-1D H12 
pEH1 bansi2 E7  pEH2 63N1 E2 
pEH1 bansi2 F3  pEH2 63N1 G9 
pEH1 bansi2 F7  pEH4 banmi4 G1 
pEH1 bansi2 F11  pEH4 banmi4 G6 
pEH1 bansi2 H3  pEH4 banmi4 G8 
pEH1 68-4 E3  pEH4 banmi4 G12 
pEH1 68-4 E4  pEH4 banmi4 H1 
pEH1 68-4 E8  pEH4 banmi4 H3 
pEH1 68-4 E9  pEH4 banmi4 H5 
pEH1 68-4 E10  pEH4 banmi4 G7 
pEH1 68-4 F4  pEH4 bansi2 A2 
pEH1 68-4 F8  pEH4 bansi2 A4 
pEH1 68-4 F9  pEH4 bansi2 B1 
pEH1 68-4 H5  pEH4 bansi2 B6 
pEH1 68-4 H6  pEH4 bansi2 C11 
pEH1 67-1D G11  pEH4 bansi2 B1 
pEH1 67-1D H1  pEH4 68-4 D1 
pEH1 67-1D H11  pEH4 68-4 D4 
pEH1 67-1D H12  pEH4 63N1 E4 
pEH1 67-1D H6  pEH4 63N1 E6 
pEH1 63N1 F1  pEH4 63N1 E11 
pEH1 63N1 F6  pEH4 63N1 F10 
pEH1 63N1 F8  pEH4 63N1 H5 
pEH2 banmi4 F12  pEH7 banmi4  
pEH2 banmi4 H6  pEH7 bansi2  
pEH2 banmi4 H10  pEH7 67-1D  
pEH2 banmi4 F5  pEH7 68-4  
pEH2 banmi4 G1  pEH7 63N1  
pEH2 bansi2 F11  pEH10 banmi4 A12 
pEH2 bansi2 F12  pEH10 banmi4 B1 
pEH2 bansi2 G3  pEH10 banmi4 B4 
pEH2 bansi2 G11  pEH10 bansi2 B2 
pEH2 68-4 D10  pEH10 bansi2 B11 
pEH2 68-4 E2  pEH10 68-4 A3 
pEH2 68-4 F1  pEH10 68-4 B2 
pEH2 67-1D H1  pEH10 67-1D A8 
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transfected 
plasmid 
parent cell line label  transfected 
plasmid 
parent cell line label 
pEH10 67-1D B3  pEH16 67-1D H7 
pEH10 67-1D B6  pEH16 67-1D H8 
pEH10 67-1D B7  pEH16 63N1 A12 
pEH10 63N1 B5  pEH16 63N1 A4 
pEH10 63N1 B10  pEH16 63N1 B1 
pEH12 banmi4 F3  pEH16 63N1 B6 
pEH12 banmi4 F5  pEH16 63N1 C4 
pEH12 banmi4 F6  pEH16 63N1 C8 
pEH12 banmi4 F9  pEH16 63N1 D7 
pEH12 banmi4 G5  pEH16 63N1 F11 
pEH12 bansi2 G3  pEH18 banmi4 D2 
pEH12 bansi2 G4  pEH18 banmi4 G1 
pEH12 bansi2 H2  pEH18 bansi2 D2 
pEH12 bansi2 H9  pEH18 bansi2 E3 
pEH12 bansi2 F7  pEH18 bansi2 E5 
pEH12 bansi2 G2  pEH18 bansi2 E6 
pEH12 bansi2 G3  pEH18 bansi2 F8 
pEH12 bansi2 G4  pEH18 bansi2 F10 
pEH12 bansi2 H2  pEH18 bansi2 H8 
pEH12 bansi2 H9  pEH18 68-4 E7 
pEH12 bansi2 F7  pEH18 68-4 E10 
pEH12 bansi2 G2  pEH18 68-4 E12 
pEH12 68-4 E9  pEH18 68-4 E11 
pEH12 68-4 F9  pEH18 68-4 F6 
pEH12 68-4 F10  pEH18 68-4 F8 
pEH12 68-4 F12  pEH18 68-4 F11 
pEH12 68-4 G7  pEH18 68-4 G2 
pEH12 68-4 G8  pEH18 68-4 G8 
pEH12 68-4 H4  pEH18 68-4 G12 
pEH12 67-1D H4  pEH18 68-4 H11 
pEH12 67-1D H7  pEH18 67-1D G2 
pEH12 63N1 G5  pEH18 67-1D H1 
pEH12 63N1 G7  pEH18 67-1D H8 
pEH12 63N1 G8  pEH18 63N1 C11 
pEH12 63N1 H2  pEH18 63N1 D4 
pEH12 63N1 H1  pEH18 63N1 F1 
pEH12 63N1 H4  pEH18 63N1 F4 
pEH16 bansi2 D7  pEH21 banmi4  
pEH16 68-4 E6  pEH21 bansi2  
pEH16 68-4 E7  pEH21 68-4  
pEH16 68-4 F2  pEH21 67-1D  
pEH16 68-4 F5  pEH21 63N1  
pEH16 68-4 F7     
pEH16 68-4 F9     
pEH16 67-1D G3     
pEH16 67-1D H5     
pEH16 67-1D H6     
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